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Mycobacterium bovis is the major causative agent of bovine tuberculosis (BTB) and 
part of the Mycobacterium tuberculosis complex (MTBC). BTB can have an impact 
on the national and international economy, affects the ecosystem via transmission to 
wildlife and is of public health concern due to its zoonotic potential. Although still 
present in some industrialized countries, BTB today mostly affects developing 
countries lacking the resources to apply expensive test and slaughter schemes. In 
Africa, the disease is present virtually on the whole continent; however, little accurate 
information on its distribution and prevalence is available. Evaluations of ante-
mortem tests for the diagnosis of BTB in Africa are scarce but a prerequisite to 
identify appropriate tools for future disease control programs. Spoligotyping and 
variable number of tandem repeat (VNTR) typing of M. bovis strains isolated from 
cattle in the UK has revealed the predominance of a single clonal complex of strains 
with subtypes of the complex being geographically localized to specific regions within 
the country. Spoligotype patterns of strains isolated from cattle from several countries 
throughout the world have been reported in a number of recent studies and the 
construction of databases (www.Mbovis.org, SPOLDB4) has facilitated their 
comparison and helped elucidate the distribution of specific strain families. 
In an attempt to gain insights into the population structure of M. bovis in Africa, we 
have isolated strains of M. bovis from cattle carcasses with gross visible lesions at 
abattoirs in Dakar (Senegal), Bamako (Mali), Sarh (Chad), Morogoro (Tanzania), 
Algiers (Algeria) and Blida (Algeria). These mycobacteria were subjected to 
spoligotyping and VNTR typing. A specific region of difference, which we have 
named RDAf1, was previously found to be absent in strains from Chad and presence 
of this deletion was assessed in our strain collection by PCR. In collaboration with 
others, additional strains of M. bovis from other African countries were subjected to 
molecular typing. 
At the abattoir of Sarh in Chad, 954 cattle were subjected to single intra-dermal 
comparative cervical tuberculin (SICCT) testing and two recently developed 
fluorescence polarization assays (FPA) prior to slaughter. Animal carcasses 
underwent standard meat inspection. Gross visible lesions were extracted, analyzed 
by microscopy and cultured. Cultured acid-fast bacilli (AFB) were further 
characterized by molecular techniques. The different diagnostic tests were evaluated 
using a sub-population of animals with either a PCR confirmed MTBC infection or no 
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visible lesions. In addition, a Bayesian model for the evaluation of multiple diagnostic 
tests in the absence of a gold standard method was developed. 
In collaboration with others, we have identified a clonal complex of strains of M. bovis 
present at high frequency in cattle in population samples from Chad, Cameroon, 
Nigeria and Mali. This closely related group of bacteria is defined by the RDAf1 
chromosomal deletion and can be identified by the absence of spacer 30 in its 
spoligotype pattern. We have named this group of strains the Bovis African1 (Af1) 
clonal complex. Strains of the Af1 clonal complex were not detected in population 
samples from other regions in Africa or other parts of the world, suggesting that the 
Af1 clonal complex is geographically localized to sub-Saharan West-Central Africa. 
VNTR typing allowed to distinguish sub-populations of the Af1 clonal complex, which 
were geographically localized to different countries. This was an unexpected result 
suggesting that the movement of strains between countries is not common in this 
area. In Mali, in addition to Af1, a second clonal group of M. bovis has been detected 
and matching VNTR patterns for some of its strains and strains from France could 
indicate a French origin. In Tanzania, also two clonal complexes of M. bovis were 
detected by spoligotyping with one clade showing a link to strains, previously 
identified in Uganda and Ethiopia and the second clade showing a link to strains 
previously isolated in South Africa. M. bovis strains isolated from Algerian cattle were 
closely related to strains from continental Europe and especially France. In 
conclusion, our work has revealed important insights into the population structure of 
M. bovis in Africa and suggests the presence of distinct clonal complexes of strains, 
geographically localized to specific areas of the continent. 
Our Bayesian model estimated the true BTB prevalence amongst the slaughterhouse 
cattle population in Sarh, Chad to be at 8%. The Bayesian and the gold standard test 
evaluation methods indicated that the ideal cut-off for positive SICCT test 
interpretation should be lowered from > 4 mm (OIE standard cut-off) to > 2 mm, in 
the Chadian setting. This result is of practical relevance and likely to apply to other 
countries in sub-Saharan Africa. Using this cut-off, sensitivity and specificity of 
SICCT was estimated at around 65% and 90%, respectively. Both FPA tests showed 
a sensitivity of less than 50% but specificities of at least 90%. Our results suggested 
that a substantial amount of lesions detected at the abattoir have been caused by 




Mycobacterium bovis est l’agent pathogène principal de la tuberculose bovine (TBB) 
et est membre du complexe Mycobacterium tuberculosis. La TBB peut affecter 
l’économie nationale et internationale, elle peut également influencer l’écosystème à 
travers la transmission aux animaux sauvages et constitue de surcroît un risque pour 
la santé publique. Bien que la TBB soit présente dans plusieurs pays industrialisés, 
elle touche principalement les pays en voie de développement, du fait de leur 
manque de ressources nécessaires pour l’implémentation d’un système de contrôle 
approprié. La maladie est endémique sur tout le continent Africain mais peu de 
données sur sa prévalence et sa distribution sont disponibles. Les études évaluant 
les tests ante mortem pour le diagnostic de la TBB menées sur le cheptel Africain 
sont rares, mais néanmoins nécessaires afin d’identifier des moyens de surveillance 
adaptés pour de futurs programmes de control adéquat. L’application du 
spoligotypage et le typage par « variable number of tandem repeat » (VNTR) sur des 
souches de M. bovis isolées de bovins britanniques a démontré la prédominance 
d’un seul complexe de bactéries avec des sous-types géographiquement localisés 
dans différentes zones du pays. Un nombre considérable de souches isolées de 
bovins des différents pays a été caractérisé par spoligotypage et intégré dans des 
bases de données internationales (www.Mbovis.org, SPOLDB4). Ceci a permis de 
comparer facilement les résultats de recherches et a facilité l’exploration de la 
distribution de certaines familles de souches. 
Afin d’avoir des informations concernant la structure de la population de M. bovis en 
Afrique, nous avons isolé des souches à partir des lésions de carcasses d’animaux 
venant des abattoirs de Dakar (Sénégal), Bamako (Mali), Sarh (Tchad), Morogoro 
(Tanzanie), Alger (Algérie) et Blida (Algérie). Ces souches ont été caractérisées par 
spoligotypage et typage VNTR. De plus, la présence d’une délétion nommée RDAf1, 
qui a été préalablement identifiée dans des souches Tchadiennes, a été testée par 
PCR. En collaboration avec différents instituts de recherche, d’autres souches 
originaires de divers pays Africains ont également été analysées au niveau 
moléculaire. 
A l’abattoir de Sarh, au Tchad, 954 animaux ont été testés avant abattage par la 
Tuberculination intradermale comparative (IDC) et deux tests de polarisation 
fluorescente (PF), lesquels ont été récemment développés. Les carcasses ont été 
inspectées post mortem et les lésions visibles ont été extraites, examinées par 
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microscopie directe et mise en culture. Les bacilles acido-alcoolo-résistants (BAAR) 
mis en évidence ont été caractérisés par des méthodes moléculaires. Ces dernières 
ont pu être évaluées en utilisant une sous-population d’animaux ayant une infection 
de M. bovis confirmée par PCR ou n’ayant aucune lésion visible. En plus, nous 
avons développé un modèle Bayesien pour l’évaluation des tests diagnostiques dans 
l’absence d’un « standard d’or ». 
En collaboration avec d’autres chercheurs, nous avons identifié un complexe de 
souches, présent fréquemment dans les populations de M. bovis du Tchad, 
Cameroon, Nigeria et Mali. Ce groupe de bactéries est caractérisé par l’absence de 
RDAf1 et du spacer 30 dans son motive de spoligotypage. Nous avons nommé ce 
groupe de bactéries le complexe « African1 » (Af1). Aucune souche Af1 n’a pu être 
détectée dans les isolements de spécimens provenant d’autres régions Africaines et 
du monde. Ces résultats indiquent, que ces Mycobactéries sont surtout localisées 
dans la région centre ouest Africaine. Le motif VNTR des souches Af1 a démontré 
que des sous-types de ce complexe sont géographiquement localisés dans différents 
pays. Cela indique que la transmission de ces souches entre les pays de cette région 
est relativement rare. Au Mali, un deuxième complexe de souches de M. bovis a été 
identifié, dont le motif VNTR de certaines souches était identique à certaines 
originaires de la France, ce qui suggère une relation avec des Mycobactéries 
Françaises. En Tanzanie, en se basant sur des résultats du spoligotypage, deux 
groupes de souches ont été identifiés dont un groupe montrait des ressemblances 
avec des souches de l’Ethiopie et de l’Uganda et l’autre montrait des similitudes avec 
des souches de l’Afrique du Sud. Les spoligotypes des souches de M. bovis isolées 
à partir de bovins Algériens suggéraient un lien avec les souches de la France. Nos 
résultats fournissent d’importantes informations concernant la structure de la 
population de M. bovis en Afrique et suggèrent la présence de différents complexes 
clonaux, localisés géographiquement dans différentes régions du continent. 
En appliquant notre model Bayesien, la prévalence réelle de la TBB à l’abattoir de 
Sarh a pu être estimée à 8%. Le model Bayesien ainsi que notre approche de 
« standard d’or » indiquaient que la valeur seuil pour une interprétation positive du 
test IDC devrait être inférieure de > 4 mm (valeur standard de l’OIE) à > 2 mm pour 
notre localité au Tchad. Ce résultat a une grande signification pratique ; en plus, iI 
est très probable que notre conclusion puissent également être valable pour de 
nombreux autres pays de l’Afrique subsaharienne. En appliquant cette valeur seuil, 
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la sensitivité et la spécificité du test IDC peuvent être estimées à 65% et 90% 
respectivement. Les deux tests de PF montraient une sensitivité de moins de 50% et 
une spécificité d’au moins 90%. Nos résultats indiquent qu’une haute fréquence de 
lésions retrouvées à l’abattoir serait causée par d’autres organismes que M. bovis. 
 
Zusammenfassung 
Mycobacterium bovis ist der hauptsächliche Erreger der Rindertuberkulose und 
bezeichnet eine Untergruppe des Mycobacterium tuberculosis Komplex. Die 
Rindertuberkulose ist für die nationale wie auch internationale Wirtschaft von 
Bedeutung, durch die mögliche Übertragung vom Hausrind auf Wildtier Populationen 
kann sie sich auf das Ökosystem auswirken und als Zoonose stellt sie eine Gefahr 
für die Gesundheit des Menschen dar. Obwohl die Krankheit in manchen 
Industrieländern endemisch ist, betrifft sie heute vor allem Entwicklungsländer, in 
welchen die nötigen Mittel zur Realisation aufwändiger Kontrollmassnahmen fehlen. 
Die Rindertuberkulose kommt in Afrika praktisch auf dem gesamten Kontinent vor, 
doch nur wenige präzise Informationen über ihre genau Verbreitung und Prävalenz 
sind bekannt. Diagnostische Tests wurden kaum für ihre Anwendung in Afrika 
evaluiert. Solche Studien wären aber hinsichtlich der Identifizierung geeignter 
Überwachungsmethoden für zukünftige Kontrollprogramme von grosser Wichtigkeit. 
Genotypisierungsverfahren wie „Spoligotyping“ und Methoden basierend auf der 
variablen Anzahl von repetierten Segmenten in Minisatelliten Regionen („VNTR“ 
Typisierung) haben ergeben, dass in Grossbritannien ein einzelner klonaler Komplex 
von M. bovis Stämmen vorherrscht. Subtypen dieses Komplexes können jedoch 
unterschiedlichen geographischen Gebieten des Landes zugeordnet werden. 
Zahlreiche weitere M. bovis Bakterienstämme aus verschiedenen Regionen der Welt 
wurden bereits mittels Spoligotyping charakterisiert und in internationalen 
Datenbanken (www.Mbovis.org, SPOLDB4) erfasst. Dies ermöglicht den einfachen 
Vergleich von Forschungsresultaten und hilft die global Verteilung spezifischer 
Stammfamilien aufzuklären. 
Um Einblicke in die Populationsstruktur von M. bovis in Afrika zu erhalten, isolierten 
wir Bakterienstämme aus Rinderkarkassen an Schlachthöfen in Dakar (Senegal), 
Bamako (Mali), Sarh (Tschad), Morogoro (Tansania), Algier (Algerien) und Blida 
(Algerien) und charakterisierten diese mittels Spoligotyping und VNTR Typisierung. 
Zusätzlich wurde mittels PCR das Vorhandensein einer genomischen Deletion 
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geprüft, welche zuvor in M. bovis Stämmen im Tschad entdeckt worden war und als 
RDAf1 bezeichnet wurde. In Zusammenarbeit mit anderen Forschungsgruppen 
wurden zusätzliche Bakterienstämme aus unterschiedlichen Regionen Afrikas in 
unsere Analysen miteinbezogen. 
Für unsere Studie in Sarh, im Tschad, testeten wir vor der Schlachtung insgesammt 
954 Rinder mittels komparativem Tuberkulin Test und zwei neuentwickelten 
Fluoreszenz Polarisations Assays. Die geschlachteten Rinder wurden während des 
Fleischbeschaus auf das Vorhandensein von Läsionen geprüft. Läsionen wurden 
mittels Mikroskopie untersucht und anschliessend kultiviert. Kulturen in welchen 
säurefeste Bakterien nachgewiesen werden konnten, wurden mittels molekularer 
Methoden typisiert. Dies ermöglichte eine Evaluation der diagnostischen Test unter 
Anwendung einer sub-Population von Tieren bei welchen entweder eine Infektion mit 
M. bovis durch PCR nachgewiesen werden konnte oder bei welchen keine Läsionen 
sichtbar waren. Zusätzlich entwickelten wir eine Bayesianische Methode zur 
Evaluation der diagnostischen Tests bei Abwesenheit eines „Goldstandards“. 
In Zusammenarbeit mit anderen Forschungsgruppen identifizierten wir einen 
klonalen Komplex von M. bovis Stämmen, welche mit grosser Häufigkeit in 
Stichproben von M. bovis Populationen aus dem Tschad, Kamerun, Nigeria und Mali 
auftraten. Dieser Komplex charakterisiert sich durch das Fehlen von RDAf1 und 
„spacer“ 30 im Spoligotyping Motiv. Wir benannten diese Gruppe von Bakterien den 
„African1“ (Af1) klonalen Komplex. Af1 Bakterienstämme konnten nicht in Proben 
anderer Regionen Afrikas und der Welt nachgewiesen werden. Dies lässt darauf 
schliessen, dass sich die geographische Ausdehnung von Af1 auf das Gebiet um 
West-Zentral Afrika beschränkt. Durch VNTR Typisierung identifizierte Subtypen von 
Af1 konnten spezifisch einzelnen Ländern zugeordnet werden. Diese wichtige 
Beobachtung legt den Schluss nahe, dass in dieser Region der Austausch von 
M. bovis Stämmen über die Ländergrenzen hinaus eher selten ist. In Mali wurde 
mittels Spoligotyping zusätzlich zu Af1 ein weiterer klonaler Komplex entdeckt. Die 
Übereinstimmung der VNTR Motive einiger Stämme mit M. bovis Stämmen aus 
Frankreich deutet darauf hin, dass dieser Komplex von ursprünglich französischer 
Herkunft sein könnte. In Tanzania wurden mittels Spoligotyping ebenfalls zwei 
klonale Komplexe entdeckt. Die erste Gruppe weist eine Verwandtschaft zu 
Stämmen aus Äthiopien und Uganda auf während die zweite Gruppe Ähnlichkeiten 
zu Stämmen aus Südafrika erkennen lässt. M. bovis Isolate aus Algerien wiesen eine 
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nahe Verwandtschaft zu Stämmen aus Europa und vor allem Frankreich auf. Die 
molekulare Charakterisierung von M. bovis Stämmen aus unterschiedlichen 
Regionen Afrikas lieferte wichtige Einblicke in die Populationsstruktur von M. bovis 
und weist auf das Vorhandensein unterschiedlicher klonaler Komplexe in 
unterschiedlichen Gebieten des Kontinents. 
Die Prävalenz der Rindertuberkulose in der Schlachthof-Rinderpopulation von Sarh 
wurde mittels Bayesianischem Modell auf 8% geschätzt. Analysen unter der 
Anwendung des Bayesianischen wie auch des Goldstandard Ansatzes ergaben, 
dass der Schwellenwert zur positiven Diagnose der Rindertuberkulose mittels 
Tuberkulin Test für die Tschadische Region von > 4 mm (OIE Standard Wert) auf 
> 2 mm herabgesetzt werden sollte. Diese Feststellung trifft mit grosser 
Wahrscheinlichkeit auch auf andere Länder Afrikas zu und ist von grosser 
praktischer Relevanz. Bei Benützung dieses Schwellenwertes ergibt sich für die 
Sensitivität und Spezifizität des Tuberkulin Tests jeweils ein Wert von 65% und 90%. 
Beide Fluoreszenz Polarisations Assays wiesen eine Sensitivität von weniger als 
50% auf und die Spezifizität betrug mindestens 90%. Unsere Analysen ergaben, 
dass ein grosser Anteil der entdeckten Läsionen in den Tschadischen 
Schlachtrindern möglicherweise durch andere Organismen als M. bovis verursacht 
wurde. 
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General introduction and research approach 
 
 A review on bovine tuberculosis with a focus on sub-Saharan Africa 
 
Introducing Mycobacterium bovis 
Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB) and 
belongs to the Mycobacterium tuberculosis complex (MTBC) of bacterial strains [1-3]. 
The MTBC is a group of very closely related pathogens, which can cause 
tuberculosis disease with similar pathology in a variety of mammalian species [1]. 
The most prominent member of the MTBC is M. tuberculosis, the principle causative 
agent of tuberculosis in humans, causing each year more than 1.5 million deaths and 
having experienced a recent re-emergence through the advent of HIV/AIDS and the 
appearance of multi drug resistant strains [4]. 
BTB is a chronic, generally respiratory disease, which is clinically difficult to diagnose 
although emaciation, loss of appetite, chronic cough and other signs of pneumonia 
could be symptoms developing at relatively late stages of the infection in cattle [5]. 
Especially in developing countries, clinical forms of many other chronic, emaciating 
diseases, like African trypanosomiasis, chronic contagious bovine pleuro-pneumonia 
(CBPP) or chronic multiparasitism, are difficult to be distinguished from BTB. BTB 
pathology is characterized by the formation of granulomatous lesions, which can 
within the course of the disease regress or exhibit extensive necrosis, calcify or 
liquefy and subsequently lead to cavity formation [6,7]. During meat inspection 
procedures on cattle carcasses in slaughterhouses, tuberculous lesions are primarily 
found in the upper and lower respiratory tract and associated lymph nodes [6]. 
However, the bacteria can also develop a systemic infection, disseminate within its 
host and affect other organs [8]. 
M. bovis is a slow growing, facultative intracellular, aerobic and gram-positive 
bacterium with a dysgonic colony shape when cultured on Löwenstein-Jensen 
medium [9]. As all Mycobacterium spp., M. bovis has an unusual cell wall surface 
structure characterized by the dominant presence of mycolic acids and a wide array 
of lipids [10]. This waxy lipid envelope confers an extreme hydrophobicity, which 
renders the bacteria acid- and alcohol-fast, a feature that can be exploited to identify 
mycobacteria via the Ziehl-Neelsen staining technique [11]. The mycobacterial 
surface lipids also have a potent biologic activity and are thought to play a crucial role 
in pathogenesis [10]. 




M. bovis can be identified on the basis of specific biochemical and metabolic 
properties. E.g., M. bovis requires pyruvate as a growth supplement, is negative for 
niacin accumulation and nitrate reduction, shows microaerophilic growth on Lebek 
medium and is generally resistant to pyrazinamide [9,12]. In contrast, M. tuberculosis 
does not require pyruvate as a growth supplement, is positive for niacin accumulation 
and nitrate reduction, shows aerophilic growth on Lebek medium, and is usually not 
mono-resistant to pyrazinamide [9,12]. However, the unequivocal validity of these 
characteristics is challenged by several studies [9,13]. 
Different molecular markers and techniques have been discovered and developed in 
the past that allow the unambiguous identification and differentiation of 
Mycobacterium spp. and the members of the MTBC [14-18]. 
 
The burden and epidemiology of Mycobacterium bovis infections 
The burden of BTB 
BTB is primarily of economic importance as it can have a considerable direct effect 
on milk and meat production and animal reproduction [19]. Moreover, national and 
international trade and other economic sectors may be indirectly affected by the 
disease [19]. BTB can also infect wildlife and thus have unpredictable consequences 
for entire ecosystems. E.g., in the southern region of the Kruger National Park in 
South Africa, 38% of the buffalos are infected with strains of M. bovis, originally 
introduced from domesticated cattle [20]. Carnivores such as lions, cheetah and 
leopards, feeding on infected animals are frequent spillover hosts [20]. Moreover, 
wildlife reservoirs of M. bovis hamper disease eradication schemes in several 
countries [21,22]. BTB also bears a zoonotic potential and it is of public health 
concern [23,24]. Infections of humans with M. bovis are rare in most countries that 
successfully apply disease control measures. However, zoonotic transmission of 
M. bovis may be frequent in countries where the disease is enzootic in cattle. In a 
recent study in the San Diego region of California, USA, M. bovis infections 
accounted for 45% of the tuberculosis cases in children [25]; most of these children 
were of Hispanic origin with ties to Mexico, where BTB is prevalent. Importantly, 
persons with M. bovis infections were 2.6 times more likely to die during treatment 
than persons with M. tuberculosis infections [25]. The poor, especially in developing 
countries, are thought to be at highest risk to contract zoonotic tuberculosis [26] and 




also the observed higher susceptibility of HIV-infected persons to M. bovis infections 
is of major concern [27]. 
The problems associated with BTB are of particular importance for many countries in 
Africa and especially the arid and semi-arid zones, where more than 50% of all 
African cattle, sheep and goats are raised [28] and where the livelihood of millions of 
people is based on livestock farming [26]. According to Thornton et al., there are an 
estimate of 556 million poor livestock keepers in the world with 30% of them living in 
sub-Saharan Africa and being most severely affected by the consequences of BTB 
[26,29]. However, data on disease prevalence in cattle or wildlife or the frequency of 
zoonotic transmission is generally scarce. This is mostly due to the absence of 
disease surveillance, insufficient laboratory capacity and the lack of veterinary 
expertise and may lead to a general underestimation of the disease prevalence in 
these regions [5]. 
 
BTB epidemiology 
M. bovis can infect most mammalian species although bovids and especially cattle 
are the main hosts [30]. Transmission between animals is mostly thought to occur by 
inhalation of contaminated aerosol [30]. Evidence for a generally respiratory route of 
infection has first come from studies of the tuberculous lesion distribution in cattle. 
Most commonly, the upper and lower respiratory tract and associated lymph nodes 
are affected by lesions and the minimum dose required to establish disease in 
artificially infected cattle appeared to be 1000 times less for the respiratory route than 
for the oral route [6]. However, infection can also occur via the gastro-intestinal tract 
when animals ingest contaminated food, water or milk. In this case, lesion distribution 
is characterized by the presence of mesenteric lymph node lesions [30]. In a study in 
Ethiopia, mesenteric lymph node lesions were more often found in grazing animals 
compared to animals kept indoors [31]. Therefore, infection via the gastro-intestinal 
tract may be more important in cattle subjected to extensive livestock production 
systems as they are commonly observed in Africa. Because close contact between 
animals is relatively rare in extensive production systems, aerosol transmission of 
M. bovis is most likely occurring at water points, or when animals are gathering at 
night for protection from predators or during the daytime under trees when seeking 
shelter from the sun [5]. Different routes of transmission may take place if 
tuberculosis infection becomes systemic and other organs such as the urinary tract 




or the mammary glands become involved [8,30]. Especially the latter can be 
responsible for early infections in calves [30]. Moreover, consumption of 
contaminated milk represents the most important route of zoonotic tuberculosis 
transmission although disease communication can be easily prevented by milk 
pasteurization [5,32]. 
Commonly found risk factors for tuberculosis disease in cattle are close contact of 
animals such as in intensive livestock production systems [5,31-33], increasing herd 
size [33] and increasing age [34-36]. Another important risk factor is the contact or 
proximity of cattle and wildlife reservoirs of M. bovis, which obstruct disease 
eradication schemes in a number of countries. E.g., in the UK the Eurasian badger 
(Meles meles) represents a maintenance host for M. bovis [37]. White-tailed deer 
(Odocoileus virginianus) has been identified as a disease reservoir in Michigan, USA 
[38], the brush tail possum (Trichosurus vulpecula) is a disease reservoir in New 
Zealand [39,40] and the African buffalo (Syncerus caffer) has been identified as a 
main reservoir host for M. bovis in southern Africa [21]. Recent work also indicates 
an important influence of host genetics on disease susceptibility. In this respect, a 
report from Ethiopia described lower disease prevalence in African cattle breeds 
compared to exotic animals [31,41,42]; but also differences between distinct zebu 
breeds have been described in Chad [43].  
The main risk factors for M. bovis infections in humans are poverty, malnutrition, HIV-
infection, the consumption of raw milk and close contact to livestock [5,32]. 
 
Distribution and prevalence of bovine tuberculosis in sub-Saharan Africa 
BTB has been largely eradicated in the industrialized world with the exception of a 
few countries in which the presence of a wildlife reservoir obstructs disease 
elimination even though extensive control measures are applied [30]. However, it is 
well known that BTB is present in many developing countries [32]. Nevertheless, due 
to the absence of disease surveillance and control, little accurate information is 
available on the prevalence and distribution of M. bovis infections.  
Within a Wellcome Trust funded project, we have recently established a network of 
scientists and veterinary authorities from major livestock producing countries in Africa 
in order to discuss the problem of BTB and promote appropriate interventions. The 
first workshop with participants from West Africa was conducted in June 2007 in 
Bamako, Mali, where the representatives of each country also conveyed detailed 




information on the situation of BTB in their country. The compiled information 
obtained from this BTB network meeting and published data from peer reviewed 
journals on BTB in sub-Saharan Africa shall be presented below. Information 
presented at the BTB network meeting that could not be found in peer reviewed 
journals is referenced as a personal communication (pers. comm.); all presentations 
are downloadable from the African BTB network website (http://www.africa-btb.net/). 
 
Senegal and Gambia 
Previously performed studies on the prevalence of BTB in Senegal have shown a 
relatively low occurrence of the disease with most of the cases being identified in 
animals originating from Mali (M. Mbengue, pers. comm.; [44]). In a recent study of 
the International Trypanotolerance Centre, also a rather low occurrence of 
tuberculosis disease was detected in cattle from the Gambia [45]. 
 
Mali 
In a recent study of Sidibé et al. in 36 herds and 1087 animals in the peri-urban 
region of Bamako, a reactor prevalence of 19% was reported, using the single intra-
dermal comparative cervical tuberculin (SICCT) test. The herd prevalence was at 
94% [46]. In our own study at the Bamako abattoir, the apparent lesion prevalence 
was only at 2%; however, most of these animals were likely originating from the 
pastoral areas and were raised in an extensive livestock production system [47]. 
 
Burkina Faso 
In a slaughterhouse study in Bobo-Dioulasso in 1995, an average lesion prevalence 
rate of 4% was reported and M. bovis was isolated from 38 of 100 animals with gross 
visible lesions [48]. In addition, one isolate was identified as a strain of 
M. tuberculosis. [48]. An abattoir study in Ouagadougou in 2005, reported a 
prevalence of 2% (G. Poda, pers. comm.) and other studies in Burkina Faso 
published prevalence rates of up to 28% (G. Poda, pers. comm.). In a study 
conducted in the region of Bobo-Dioulasso, of six herds tested by SICCT, only one 
appeared to be free of reactors [49]. Of 199 animals slaughtered, 38 showed gross 
visible lesions of which 20 presented a positive culture for pathogenic mycobacteria 
[49]. 






An abattoir survey in Shaki revealed an apparent lesion prevalence of 13% [45]. In 
one study, among 174 isolated MTBC strains from humans, none was of M. bovis 
[50], but an increase in the prevalence of extra-pulmonary tuberculosis cases in 
humans has recently been observed (I. Maikano, pers. comm.). 
 
Ghana 
In 1983 and 1986, surveys in cattle using the single caudal fold tuberculin test 
revealed reactor prevalence rates between 0% and 2% in northern Ghana [45]. 
However, in more recent studies using SICCT testing, a reactor prevalence of 14% 
was detected in the area of Dangme and Great Accra, a prevalence of 14% was also 
detected in Dodowa district, a 19% reactor prevalence was detected in Ningo sub-
district [45]. Prampram and Osudoku districts recorded both an 11% reactor 
prevalence [45]. Of 64 MTBC strains isolated from human tuberculosis patients at the 
Korle-Bu teaching hospital between January and July 2003, 3% of the strains were 
identified as M. bovis by biochemical methods [51]. 
 
Nigeria 
In a survey conducted in Ibadan by Cadmus et al., strains of MTBC isolated from 
human tuberculosis patients and from slaughter cattle carcasses were subjected to 
molecular typing [52]. Of altogether 60 MTBC strains isolated from humans, three 
(5%) were identified as strains of M. bovis, six (10%) as strains of M. africanum and 
the rest as M. tuberculosis. Of 17 MTBC strains isolated from cattle, two were 
identified as M. tuberculosis, with one of them showing a spoligotype pattern that was 
also detected in strains of M. tuberculosis isolated from humans. Altogether, 15 of 17 
strains from cattle were identified as M. bovis and the spoligotype patterns of all 
these strains characteristically lacked spacer 30 in the standard spoligotyping 
scheme [53]. One of the spoligotype patterns detected in strains from cattle was also 
found in a strain of M. bovis from humans, thus indicating the zoonotic transmission 
of strains of M. bovis from animals to humans in Nigeria [52]. Evidence for zoonotic 
transmission of M. bovis has also come from other studies [45,54,55]. The 
prevalence in cattle has been assessed by a number of studies in several regions 




using different methods; it ranged between 1% and 13% but appeared to be higher in 
the southern area of the country (S.I.B. Cadmus, pers. comm.). Mycobacterium spp. 
were also successfully isolated from milk (S.I.B. Cadmus, pers. comm.; [45]). 
 
Chad 
Schelling et al. reported a reactor prevalence of 17% for SICCT testing of animals 
from 13 herds in the Chari-Baguirmi and Kanem region of Chad [56]. Delafosse et al. 
investigated the prevalence of BTB in cattle herds of the Abéché region and reported 
a positive reaction to bovine tuberculin in 1% of the animals and 12% of the herds 
examined. Positive reaction to avian tuberculin was reported for 2% of the animals 
and 18% of the herds [57]. A slaughterhouse study at the N’Djaména abattoir 
revealed an apparent lesion prevalence of 7% [43]. Interestingly, strains of M. bovis 
were significantly more often isolated from the Mbororo zebu breed compared to the 
Arab zebu breed and it was hypothesized that this observation may have been due to 
a differential susceptibility of the two breeds to M. bovis infections [43]. With few 
exceptions, the spoligotype pattern of the strains isolated from Chadian cattle 
characteristically lacked spacer 30 as observed in Nigeria [43]. Prior to this study, it 
was believed that most of the gross visible lesions observed in cattle carcasses at 
N’Djaména abattoir were due to bovine farcy, which is caused by M. farcinogenes 
(C. Diguimbaye-Djaïbe, PhD thesis). Indeed, in addition to M. bovis, several different 
species of non-tuberculous mycobacteria (NTM) were isolated in a large proportion of 
animals with lesions [58]. In our study at Sarh abattoir in southern Chad, gross visible 
lesions were found in 11% of the sampled slaughter animals [59]. Using a Bayesian 
modeling approach, the true prevalence of BTB could be estimated at 8% [60]. Our 
results suggested that 72% of the suspected tuberculosis lesions detected during 
standard meat inspections were due to other pathogens than M. bovis [60]. 
 
Cameroon 
Njanpop-Lafourcade et al. reported the molecular characterization of M. bovis strains 
isolated from cattle in three different provinces of Cameroon [61]. The spoligotype 
pattern of all the strains lacked spacer 30 as described for strains from Chad and 
Nigeria, indicating the presence of possibly one single clonal complex of strains of 
M. bovis in the Central African region. On the basis of the similarity of spoligotype 
patterns of strains from France and Cameroon and the longstanding history of cattle 




importation from France, the authors stated the possibility of an introduction of 
M. bovis from France into Cameroon [61]. 
 
Sudan 
In a study conducted by Sulieman & Hamid in 2002, altogether 120 animals 
exhibiting caseous lesions were sampled from different abattoirs in Sudan. 
Microscopic examination detected acid fast bacilli (AFB) in specimens from 64 
animals [62]. Bacterial growth was detected in cultures of lesions from 54 animals. 
Strains of M. bovis could be isolated from 25 animals. Moreover, 21 strains of 




In a slaughterhouse study conducted from November 2001 to April 2002 at Addis 
Ababa abattoir by Asseged et al., a lesion prevalence of 2% was reported for cattle if 
a detailed post-mortem examination was applied [63]. A retrospective analysis of 
meat inspection records from 1992 to 2001 also revealed an annual increase of 
whole carcass condemnations by 0.34% [63]. A similar study at Hossana municipal 
abattoir detected a lesion prevalence of 5% if a detailed post-mortem examination 
was applied [64]. Other studies in Ethiopia revealed a higher prevalence of BTB in 
cattle kept indoors compared to free-grazing animals [31] and a higher susceptibility 
to M. bovis infection of exotic Holstein Bos taurus cattle compared to local zebu cattle 
[42]. Moreover, a study by Ameni et al. revealed a better performance of SICCT in 
Ethiopia if the cut-off value for positive test interpretation was lowered from > 4 mm 
(OIE standard cut-off) to > 2 mm [65]. The spoligotype pattern of 17 strains of 
M. bovis, isolated from a herd with a high prevalence of BTB was identical for all 
animals and recently published [66]. Berg et al. provided a comprehensive 
investigation on BTB in Ethiopia and showed a widespread distribution of the disease 
at an average prevalence of approximately 5% [67]. 
 
Uganda 
Oloya et al. reported an SICCT reactor prevalence of 2% and a herd prevalence of 
51% for cattle from different pastoral herds from Karamoja region and Nakasongola 




district [36,68]. Also, molecular analysis of bacteria isolated from lesions of cattle 
slaughtered at Kalerwe abattoir was performed [69]. The spoligotype patterns of the 
different strains of M. bovis allowed the identification of at least two distinct clonal 
groups of which one was characterized by the absence of spacers 3-7 [69]; 
interestingly, lack of spacer 3-7 was also observed in strains from Ethiopia [66]. 
Moreover, in the same study, multiple strains of NTM were isolated from cattle [69]. 
Asiimwe et al. have recently reported a lesion prevalence of 0.5% for slaughter cattle 
at a city abattoir [70]. AFB were detected in cultures of 20% of the animals with 
lesions; these consisted of 11 strains of M. bovis and 6 strains of NTM [70]. 
 
Democratic Republic of Congo 
Mposhy et al. reported the isolation of Mycobacterium spp., identified by Ziehl-
Neelsen staining and microscopy, from 8% of altogether 1500 animal carcasses 
slaughtered at Goma abattoir [71]. Intra-dermal tuberculin skin testing of 1000 
animals from the same region subsequently revealed a reactor prevalence of 8%. 
Based on these results, the authors speculated, that zoonotic transmission of 
M. bovis may had accounted for the high prevalence of tuberculosis cases observed 
in the pastoralist communities of North-Kivu [71]. 
 
Kenya 
Limited information is available on BTB in Kenya although neighboring countries 
report endemicity of the disease in cattle. Kang’ethe et al. recently reported a 
tuberculin reactor prevalence of 10% in cattle from urban and peri-urban areas in 
Nairobi [72] and previously, M. bovis was isolated from Kenyan baboons feeding on 
abattoir offal [73]. 
 
Tanzania 
A survey in the zone of lake Victoria, identified an average of 0.2% of SICCT reactors 
in a total of 8190 cattle from 42 herds [74]. In another study in Dar es Salaam region 
1% of the animals reacted positively to bovine tuberculin and the herd prevalence 
was at 10% [75]. In the Lugoba area, 1% of tuberculin reactors were found in cattle 
and herd prevalence was at 21% [75]. In a study, in the southern Highlands, 13% of 
the cattle reacted positively to SICCT and the herd prevalence was at 51% [34]. More 




recently the SICCT reactor prevalence in cattle from extensive and intensive 
production systems in the eastern zone of Tanzania was assessed. In the extensive 
pastoral production systems reactor prevalence was at 1% and in the intensive 
production systems at 2% [76]. A cross sectional study in 10’549 cattle from 622 
herds in northern Tanzania revealed a low SICCT reactor prevalence of 1% and a 
herd prevalence of 12% [33]. Risk factors identified for BTB were age, herd size, 
keeping cattle inside at night, contact to wildlife and annual flooding of villages [33]. 
In other studies in Tanzania, M. bovis could be isolated from milk [77] and zoonotic 
transmission of M. bovis was shown by means of molecular typing techniques [78]. 
Also, one study described the isolation of strains of M. bovis from wildlife [79]. 
 
Malawi 
In a country-wide cross sectional study in 1986, a random sample of 3481 cattle was 
tested for BTB using SICCT [80]. The overall reactor prevalence was at 4% but 
varied by district, breed and sex (males were more often affected than females); 
however, most of the differences in prevalence by district were explained by 
differences in breed and sex [80]. 
 
Zambia 
In a cross sectional study in Monze district, 7% of altogether 2226 cattle tested, 
reacted positively in the tuberculin skin test and 33% of the herds contained reactors 
[81]. Phiri reported in 2006 that out of 32’717 cattle slaughtered at three abattoirs in 
the western Province of Zambia, 183 animal carcasses were totally condemned with 
83% of these condemnations having been attributed to BTB [82]. In a cross sectional 
study in the Kafue basin, SICCT was used to test cattle from 106 herds. True herd 
level prevalence was estimated at 50%, however, with considerable differences 
between study areas [83]. In another study, 944 cattle from 111 herds from the 
livestock/wildlife interface areas of Zambia were tested. In Lochinvar and the Blue 
Lagoon area, the SICCT reactor prevalence was at 5% and 10%, respectively [35]. In 
Kazungula, an area outside the livestock/wildlife interface, SICCT reactor prevalence 
was only at 1% [35]. Other studies also reported tuberculosis in Zambian wildlife and 
specifically the Kafue lechwe (Kobus leche) [45,84]. More recently, different 
genotypes of strains of M. bovis isolated from cattle from the Kafue basin have been 
described [85]. 






BTB is believed to have been initially introduced into South Africa by European 
settlers; moreover, additional imports of infected live cattle from several different 
countries may have contributed to shape the relatively heterogeneous M. bovis 
population structure that is observed today [20,86]. In 1969, South Africa has 
launched a BTB control program and hereafter, prevalence rates have considerably 
dropped in domesticated cattle to 0.4% in 1995, but occasional outbreaks still occur 
[86]. Animal tuberculosis infections have first only been detected in domesticated 
cattle, however, sharing of rangeland or frequent contact between domesticated 
animals and wildlife may have later on lead to the spread of the disease into new 
animal populations [20]. As a result, M. bovis has caused a dramatic epidemic in 
several wildlife populations with the African buffalo (Syncerus caffer) representing the 
most important maintenance host of M. bovis (see chapter on the importance of 
bovine tuberculosis in African wildlife further below) [20]. The introduction of M. bovis 
from domesticated cattle into wildlife is likely to have occurred in other parts of Africa, 
as well, but possibly remained largely undetected due to poor surveillance [79]. 
 
Madagascar 
In a sample survey using intra-dermal tuberculin skin testing, Quirin et al. found 
reactor prevalence rates between 0% and 30% [87]. Molecular typing of strains of 
M. bovis isolated from cattle in different regions of Madagascar revealed a 
homogenous population structure and no geographical localization of strain types 
within Madagascar [88]. Spoligotype patterns of M. bovis strains suggested the 
presence of a single clonal complex, which was characterized by the absence of 
spacers 3-5 and 8-10 [88]. This pattern has so far not been found in M. bovis strains 
outside Madagascar. Matching molecular types of strains isolated from humans and 
animals also indicated the zoonotic transmission of M. bovis in Madagascar [88]. 
 
Economics of bovine tuberculosis 
BTB affects the national and international economy in different ways. 
The most obvious losses from BTB in cattle are direct productivity losses (reduced 
benefit), which can be categorized into slaughter and “on-farm” losses [89]. Slaughter 




losses comprise the cost of cattle condemnation and retention, with the loss from 
condemnation being essentially the purchased value of a slaughter animal and the 
loss from retention being a fraction of the value of a carcass. On-farm losses 
comprise the losses from decreased milk and meat production, the increased 
reproduction efforts and replacement costs for infected cattle [89]. 
Effects of BTB on cattle productivity have been previously reviewed by Zinsstag et al. 
[19]. Early studies in Germany estimated a decrease in milk and meat productivity in 
totally infected livestock of 10% ± 2.5% and 4% ± 2%, respectively [19]. Similar milk 
productivity losses were also estimated in studies from Canada, Spain and the U.S. 
[19,89,90]. The study in Canada also estimated the reproduction losses to one fewer 
calf in infected cows; the replacement losses were estimated at 15% for infected 
animals [19]. Gilsdorf et al., assumed a 20% reduction in calf weight and a 5% 
replacement cost for their cost effectiveness analyses in the U.S. [89]. More figures 
and references are given in the studies of Zinsstag et al. [19], Gilsdorf et al. [89] and 
Bernues et al [90]. 
Apart from direct productivity losses, BTB has profound economic consequences for 
national and international trade. On an international scale, BTB affects access to 
foreign markets due to import bans on animals and animal products from countries 
where the disease is enzootic. This situation has also major implications for other 
economic sectors, which are linked to livestock production. Moreover, BTB can 
create inefficiencies in the world market as e.g. economically inefficient but disease-
free exporting countries will receive more revenues than economically efficient 
countries, which cannot export animal products due to enzootic BTB [89]. 
Presence of the disease in wildlife has considerable economic consequences. Not 
only is disease eradication more difficult and costly but BTB can theoretically affect 
entire ecosystems with unpredictable impact on many areas of private interest such 
as e.g. tourism (also see next section [19,91]). 
Finally, BTB has a zoonotic potential and can cause disease in humans. Depending 
on the rate of zoonotic transmission this can have important effects on the public 
health sector. 
At our BTB network meeting in 2007 in Bamako, Mali, all participants from West-
Africa emphasized the economic importance of BTB in their countries albeit 
comprehensive economic assessments were largely missing. Cadmus estimated the 
losses due to BTB in Nigeria at 12-20 million USD annually. Poda noted that previous 




studies in Burkina Faso have calculated a decrease in weight of 12-29% in infected 
cattle compared to uninfected cattle. A study from 2001 revealed that meat 
confiscations in 8% of all cattle slaughtered at abattoirs in Burkina Faso have lead to 
a total loss of meat corresponding to 22 million FCFA (G. Poda, pers. comm.). In 
Mali, approximately 41 tons of meat have been lost in 2006 because of meat 
confiscations (pers. comm. of representatives of the Direction Nationale des Services 
Vétérinaires, DNSV). Sahraoui estimated the slaughter losses in Algeria from 
carcass condemnations at 940 Euros / total condemnation. In Chad, the livestock 
production sector accounts for 15% of the gross domestic product and 30% of the 
exported goods. In 2006, approximately 6 tons of meat have been lost due to meat 
confiscations (C. Diguimbaye-Djaïbe and B.N.R. Ngandolo, pers. comm.). At Port 
Bouët abattoir in Ivory Coast, the slaughter losses in 2006 were estimated at 20.5 
million FCFA (L. Achi, pers. comm.). 
The economic impact of BTB in Africa is exacerbated through a number of factors. 
First, the fast growing population, especially in urban areas, causes an increase in 
demand especially for diary products and meat and promotes the intensification of 
livestock production in peri-urban areas [19,92]. Importantly, intensive livestock 
production systems show generally a higher prevalence of BTB than extensive 
production systems [5,31,32,93]. Second, developing countries lack the financial 
resources for disease control. This leads to a vicious cycle in which increased 
poverty affects the means for disease control and vise versa. Third, wildlife reservoirs 
in Africa are difficult to control; also, contact between transhumant cattle herds and 
wildlife may be particularly difficult to prevent in Africa. Forth, African countries have 
little access to the international trade and sanitary measures in industrialized 
countries may be used for protectionist purposes. Fifth, the public and political 
awareness are very low [19]. Most of the representatives from the various West-
African countries at the BTB network meeting in Bamako in 2007 reported a 
generally low public awareness, a low to fair awareness of the cattle holders and in 
the research community in Africa and generally a lack of governmental commitment. 
Few studies exist that assess the costs and the benefits of BTB control schemes 
rather than only the costs and almost none that specifically investigate the situation in 
Africa [19]. Cost-effectiveness studies of BTB intervention and control schemes must 
consider the costs and benefits in all the sectors affected (animal health, public 
health, etc.) [19]. In a cost-effectiveness study of a mass-vaccination campaign in 




livestock against Brucellosis in Mongolia, the intervention was profitable if the 
benefits of public health, agriculture and the private households were considered 
[94]. This may particularly apply to BTB in Africa, where the disease affects many 
aspects of human life. However, classical test and slaughter campaigns as they have 
been carried out in industrialized countries may not be feasible in Africa due to the 
lack of financial resources; therefore, new strategies may have to be assessed for 
BTB control in Africa. Options considered by the OIE are to create disease free 
zones by sequestration of infected animals and repopulation with disease free 
animals. Particular emphasis for such disease free zones should be given to 
intensive peri-urban production systems and control measures may be coupled to the 
systematic pasteurization of milk produced for commercial use. However, such 
strategies may be unusable to target BTB in extensive livestock production systems. 
 
The importance of Mycobacterium bovis infections in African wildlife 
M. bovis infections in wildlife can affect the ecosystem; moreover, the disease 
constitutes a threat to endangered species and can hamper BTB eradication and 
control schemes in domestic cattle. Tuberculosis in wildlife poses serious difficulties 
for BTB control in the UK and Ireland where the badger (Meles meles) represents an 
important disease reservoir [95,96]. In New Zealand, the brush-tailed possum 
(Trichosurus vulpecula) is a maintenance host of M. bovis [39]. White-tailed deer 
(Odocoileus virginianus) has been identified as a reservoir for M. bovis in Michigan, 
USA [38]. In central and eastern Europe, M. bovis has been isolated from wild boars 
(Sus scrofa) [22,97,98]. In fact, since the awareness concerning the importance of 
wildlife reservoirs of M. bovis rose, an increasing amount of reports has been 
published that describe the isolation of the agent from a big variety of mammalian 
hosts in different regions throughout the world [20,22]. 
Relatively little is known about the importance of M. bovis infections in wildlife on the 
African continent. However, available data from southern Africa suggests that the 
prevalence of wildlife tuberculosis has reached a dramatic dimension [20]. The 
African buffalo (Syncerus caffer) is considered the most important reservoir of 
M. bovis [20]. Also, the Kafue lechwe (Kobus leche) has been identified as a 
maintenance host of M. bovis and other species such as the greater kudu 
(Tragelaphus strepsiceros) may represent additional disease reservoirs. Therefore, 
today, BTB in Africa is considered a “multi-species host-pathogen system” [20].  




In the Kruger National Park in South Africa, a gradient of infection from south to north 
has been detected with 38% of the buffalos being infected in the southern region, 
16% in the central region and 2% in the northern region [20]. Spillover to carnivores 
such as lions (Panthera leo), leopards (Panthera pardus), cheetahs (Acinonyx 
jubatus) and Hyenas (Crocuta crocuta) but also other animal species like the chacma 
baboon (Papio ursinus), and warthog (Pharcovhoerus aethiopicus) has been 
observed repeatedly [20,21]. 
Control measures to prevent transmission of M. bovis between domesticated cattle 
and wildlife include test and slaughter schemes in buffalo populations along with 
breeding programs to produce disease-free buffalo calves and the separation of 
domesticated animals and wildlife through electrified perimeter fences. However, it is 
believed that vaccination programs for cattle and wildlife would be the most effective 
control measures [20]. Unfortunately, the only currently available vaccine (the Bacille 
Calmette-Guérin strain; BCG) for cattle shows a rather low protective efficacy and 
further research in vaccine development is urgently needed [20]. 
In Zambia, mycobacteria have been isolated from free ranging Kafue lechwe and 
bushbuck (Tragelaphus scriptus) [84] and BTB prevalence in cattle has been found 
to be higher in wildlife/livestock interface areas [83]. In Tanzania, M. bovis was 
isolated from migratory wildebeest (Connochaetes taurinus), topi (Damaliscus 
lunatus) and lesser kudu (Tragelaphus imberbis) [79]. Antibody enzyme 
immunoassays have detected M. bovis specific antibodies in 4% of a collection of 
serum samples (N = 184) from Serengeti lions (Panthera leo), in 6% of the samples 
(N = 17) from buffalo (Syncerus caffer) and in 2% of the serum samples (N = 41) 
from wildebeest [79]. M. bovis has also been isolated from buffalo and warthog 
(Phacochoerus aethiopicus) in the Ruwenzori National Park in Uganda [99,100]. 
Interestingly, in the same study, NTM have also been isolated from lesions of both 
animal species [99,100]. In other preliminary studies on tuberculosis in Tanzanian 
and Ethiopian wildlife, only NTM have been isolated from animals with gross visible 
lesions (T. Lembo and R. Tschopp, pers. comm.). 
More research is needed to assess the magnitude and importance of M. bovis 
infections in wildlife populations. However, considering the particular livestock 
production system in Africa, currently available information suggests that tuberculosis 
in wildlife could play an important role with regards to the persistence of the disease 
in certain areas and cattle populations. 





Zoonotic infections of Mycobacterium bovis in Africa 
In Europe, cases of M. bovis infections in humans were of great importance until 
implementation of BTB control programs in many European countries through animal 
test and slaughter campaigns and regular milk pasteurization schemes lead to a 
drastic decrease of zoonotic tuberculosis cases and to a lower prevalence of BTB in 
general [23,27]. Although sporadic tuberculosis cases due to M. bovis are still 
occurring in industrialized countries they are generally considered to be of minor 
importance [23,27]. However, several studies were able to show an association 
between M. bovis infections and exposure to infected animals and animal products 
[27,101,102]; another important risk factor is the co-infection with HIV [23,27,103]. 
Considering the high prevalence of BTB in cattle and HIV positive individuals in 
Africa, the close contact between cattle holders and animals and the fact that the 
regular pasteurization of milk is not well implemented in most African countries, these 
findings are of major concern with regards to the public health significance of BTB in 
Africa [5,32]. 
The contribution of M. bovis infections to tuberculosis cases in humans in Africa is 
not well known. This is primarily due to the lack of diagnostic laboratories with the 
means to distinguish strains of M. tuberculosis and M. bovis [5]. 
However, numerous population based studies on human tuberculosis in Africa did 
not find any evidence for transmission of M. bovis from animals to humans [104-110]. 
In one of our previous studies in Chad, 40 M. tuberculosis but no M. bovis strains 
could be isolated from human sputum samples [111]. Only M. tuberculosis strains 
could be detected in sputum samples from 46 tuberculosis patients at Dantec 
Hospital in Dakar, Senegal (own unpublished results). Table 1 lists a selection of 
population based studies in which M. bovis infection was detected by molecular or 
biochemical methods in African patients with pulmonary or extra-pulmonary 
tuberculosis. In three studies from Tanzania [33,112,113], in one study from Nigeria 
[55] and in one study from Uganda [114], M. bovis accounted for 20% or more of the 
MTBC strains isolated. In all other reports [51,52,54,115-122], The contribution of 
M. bovis to human tuberculosis cases was relatively low and comparable to 
prevalence rates found in European settings [32,123]. 
Interestingly, high proportions of M. bovis infections in humans were particularly 
detected in rural settings. This is most evident from the available data for Tanzania. 




In a recent study in Dar es Salaam, 147 M. tuberculosis but no M. bovis infections 
could be detected in human tuberculosis cases [105]; however, in the rural areas of 
Tanzania, M. bovis accounted for 20% of the MTBC infections detected (table 1). 
Similarly, strains of M. bovis were isolated in 30% of the MTBC infections found in 
pastoralist communities in rural Uganda but in less than 0.5% of the tuberculosis 
cases in urban Kampala (table 1). Relatively few information is available on 
tuberculosis in pastoralist communities in other African countries although they seem 
to be prone to M. bovis infections. Importantly, nomadic and transhumant pastoralists 
are often excluded from the public health services as they are difficult to reach. 
Conversely, nomadic and transhumant pastoralists are less likely to seek treatment 
as their and their families’ livelihood largely depends on livestock farming. This 
difficultly allows the members of a pastoralist community to seek treatment in urban 
health centers for extended periods of time. Therefore, adapted, mobile health 
services would be required to provide effective tuberculosis treatment to mobile 
populations [124].  
More research is needed to assess the importance of human tuberculosis due to 
M. bovis in Africa. However, currently available information suggests that zoonotic 







Country Study setting Total MTBC M. bovis % M. bovis Reference
Cameroon 15 district hospitals in Ouest province 455 1 0.2% Niobe-Eyangoh et al., 2003
Djibouti Unknown 85 1 1.2% Koeck et al., 2002
Egypt Six fever hospitals in different cities 67 1 1.5% Cooksey et al., 2002
Ghana Korle-Bu Teaching Hospital 64 2 3.1% Addo et al., 2007
Guinea-Bissau Unknown 229 4 1.7% Källenius et al., 1999
Madagascar Antananarivo, Antsirabe, Fianarantsoa, Mahajanga 400 5 1.3% Rosolofo-Razanamparany et al., 1999
Nigeria 2 hospitals in Ibadan 60 3 5.0% Cadmus et al., 2006
Nigeria Lagos 91 4 4.4% Idigbe et al., 1986
Nigeria 3 hospitals in Jos 50 10 20.0% Mawak et al., 2006
Tanzania 4 districts of Manyara (Arusha) Region 34 7 20.6% Cleaveland et al., 2007
Tanzania Pastoralist communities in the North and South 38 7 18.4% Kazwala et al., 2001
Tanzania Rural and semi-rural districts of Arusha 34 7 20.6% Mfinanga et al., 2004
Uganda Kampala 344 1 0.3% Asiimwe et al., 2008
Uganda Kampala 234 1 0.4% Niemann et al., 2002
Uganda Pastoralists of transhumant areas in Karamoya 10 3 30.0% Oloya et al., 2007
 
Table 1. A selection of reports on zoonotic tuberculosis infections in Africa. 
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Methods for molecular epidemiological investigations 
The different genotyping techniques used for the molecular characterization of MTBC 
strains have been reviewed extensively [17,125-128]. 
Molecular typing of bacterial strains can offer general insights into the population 
structure of pathogens. In the case of MTBC, a high degree of genetic homogeneity 
of strains isolated from patients from a given setting indicates recent transmission of 
tuberculosis. Conversely, a heterogenic population structure, especially in a low 
prevalence area, could suggest that tuberculosis reactivation may be more frequent 
[126]. Moreover, molecular epidemiological tools can help to identify transmission 
chains, risk factors for tuberculosis infections [125] and they have been useful for the 
detection of laboratory cross-contaminations [128]. The most important techniques 
that have been used throughout our studies shall be presented below. 
 
Spacer oligotyping (Spoligotyping) 
Spoligotyping makes use of the variability of the MTBC chromosomal direct repeat 
(DR) locus for strain differentiation [53]. The DR region is composed of multiple well 
conserved direct repeats of 36 bp which are separated by distinct, non-repetitive 
spacer sequences of similar size [129]. In the standard spoligotyping scheme, a PCR 
with primers complementary to the DR-sequence is used to amplify all spacer 
sequences of a given strain. One of the two primers is labeled with a biotin marker. 
The PCR products are denatured and hybridized to a standard set of 43 
oligonucleotides covalently linked to a membrane. These oligonucleotides 
correspond to 37 spacers from M. tuberculosis H37Rv and 6 additional spacers from 
M. bovis BCG P3. If any of these spacers are also present in an investigated strain, 
they will be amplified during the PCR and hybridized to the spacers on the 
membrane. The successful hybridization can be visualized by incubation with 
Streptavidin peroxidase (which binds to the biotin molecule), subsequent addition of 
a chemiluminescent Streptavidin peroxidase substrate and exposure to a light 
sensitive film [53]. Figure 1 provides a schematic overview of the spoligotyping 
procedure and gives an example of spoligotype patterns for different strains. 
Compared to other molecular typing techniques, spoligotyping is not very 
discriminatory although its resolving power could be increased by inclusion of 
additional spacers in an extended spoligotyping protocol [130]. The technique has 
been proven to be useful for a first assessment of the MTBC strain diversity in many 




population surveys [102,131-134]. Spoligotyping also allows the differentiation of 
MTBC members; e.g., M. bovis strains characteristically lack spacers 3, 9, 16 and 39-
43 [1]. Moreover, strain groups and families can be readily identified [135] and 
extensive databases (www.Mbovis.org and SpolDB4 [136]) have facilitated the 
comparison of strains isolated in different countries. It is assumed that the DR locus 
has a unidirectional evolution (spacers can only be lost and not reacquired) and 






Figure 1: The spoligotyping method. A: Schematic overview of the spacer 
amplification during PCR on the left. Primers hybridize within the direct repeats (DR) 
with one primer being linked to a biotin molecule. PCR products of variable length are 
generated. Detection of amplified spacers on the right. PCR products hybridize to 
complementary spacer oligonucleotides linked to a membrane. Streptavidin 




peroxidase associates with the biotin molecule and light is emitted upon addition of a 
peroxidase substrate [enhanced chemiluminescence (ECL) substrate]. B: Example of 
spoligotype patterns obtained for seven different samples and a negative control 
when 43 spacers are being represented on the membrane as described by 
Kamerbeek et al. [53]. 
 
Variable number of tandem repeat (VNTR) typing 
Several genomic loci of MTBC with tandemly repeated minisatellite sequences have 
been identified [125]. In VNTR typing, the number of tandem repeats for a given 
locus is assessed by PCR amplification of the repeats with primers targeting their 
flanking regions. From the size of the PCR product, the number of repeats can be 
deduced. Tandem repeats showing variability between distinct strains have been 
identified in various studies [138-140] and by combining VNTR typing for different 
loci, a significantly higher discriminatory power can be achieved than for 
spoligotyping [141-143]. Moreover, VNTR typing is a relatively simple technique and 
the results consist of a digit code, which can be easily communicated and compared. 
However, the technique is not well standardized [125] and large databases as for 
spoligotyping are missing. Therefore, VNTR typing is often used as an additional tool 
to sub differentiate clusters of strains with identical spoligotype patterns [1] 
 
Large sequence polymorphism (LSP) analysis 
LSPs generally refer to large genomic deletions or insertions. Large genomic 
deletions (also called regions of difference, RD) are widely used for the phylogenetic 
analyses of MTBC but are not appropriate for molecular epidemiological studies, due 
to a low mutation rate [1,144,145]. A major drawback of spoligotyping and VNTR 
typing is the possible occurrence of homoplasies; that is, the development of identical 
molecular types in unrelated strains [1]. Such events are very unlikely to occur for 
large genomic deletions unless an LSP is associated with repetitive and transposable 
elements. Moreover, because of the suspected absence of horizontal gene transfer 
in MTBC, large genomic deletions cannot be reacquired and the direction of evolution 
can be determined without the use of an outgroup [1]. 
Large genomic deletions can be discovered through comparative genomic 
hybridization using bacterial genomic DNA and oligonucleotide microarrays. After 




specific LSPs or RDs have been identified, simple PCR protocols to rapidly assess 
their presence or absence in population surveys can be developed. 
 
The evolution and population structure of Mycobacterium bovis 
Evolution of M. bovis 
The MTBC is defined as a complex of seven distinct bacterial species named 
M. tuberculosis, M. canettii, M. africanum, M. pinnipedii, M. microti, M. caprae and 
M. bovis. Although strains of the MTBC show a remarkable sequence similarity of at 
least 99.9% [1], the different bacterial species show a certain host tropism. E.g., 
M. bovis most commonly affects cattle, M. tuberculosis affects humans, M. microti is 
most frequently isolated from voles, etc. [1,137,145]. Nevertheless, spill over to other 
hosts has been observed for most of the bacteria [1,146,147]. Figure 2 shows the 
different clades of the MTBC and the phylogentically informative large genomic 
deletions (RDs) that allow their differentiation (adapted from Brosch et al. [145]). On 
the basis of these and other observations, it has been suggested, that the MTBC 
should rather be considered as a group of different “ecotypes”, adapted to distinct 
hosts [137]. Generally, ecotypes can be described as the entirety of all individuals 
that occupy a specific ecological niche and that can be identified as a clustered group 
using specific genomic markers [148]. The identification of ecotypes of the MTBC 
and their defining molecular traits is still ongoing. In fact, host adaptation of MTBC 
strains may not necessarily be restricted to the species level but could be more 
specific [137,149]. Indeed, in a recent study, Gagneux et al. suggest a variable host-
pathogen compatibility between distinct strains of M. tuberculosis and human hosts 
of different ethnicity [150]. 
Except for M. canettii [151], there is little evidence for horizontal gene transfer 
between other ecotypes of the MTBC [1]. Therefore, the population structure of 
MTBC can be considered as highly clonal if M canettii is excluded. The clonality of 
the MTBC and its ecotypes can be most evidently shown by the matching 
phylogenetic trees that have been constructed using different molecular markers 
[1,144]. Also, the observation of a linkage disequilibrium between 12 independent 
microsatellite loci in strains of M. tuberculosis has suggested a clonal population 
structure [152]. The reason for the strict clonality of the MTBC could be due to an 
infrequent encounter of the different ecotypes [137], mutations in the recA gene or 






Figure 2: Evolutionary scenario of the MTBC (adapted from Brosch et al. [145]). Phylogentically informative large genomic deletions 
and single nucleotide polymorphisms (SNP) are indicated. 
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Because of the smaller genome size of M. bovis compared to M. tuberculosis and 
because no significant chromosomal regions are present in M. bovis but absent in all 
strains of M. tuberculosis, it can be inferred that M. bovis emerged from an 
M. tuberculosis-like ancestor. Therefore, it has been suggested that tuberculosis 
disease was first present in humans prior to animals [145]. This hypothesis has been 
a matter of controversial discussions [1]; however, recent work has added new 
evidence to this theory. In two independent studies, analysis of the VNTR and SNP 
profiles, respectively, of an extensive collection of MTBC strains allowed to 
differentiate two major clades of the MTBC. The first clade exclusively comprised 
strains of the human pathogen M. tuberculosis. However, the second clade 
comprised strains of M. tuberculosis and in addition all strains of M. africanum, 
M. pinnipedii, M. microti, M. caprae and M. bovis [2,3]. Parsimony thus suggests that 
the last common ancestor of both clonal groups already constituted a human host 
adapted pathogen [1-3]. Using Bayesian statistics, Wirth et al. estimated the age of 
the MTBC at 40’000 years. The calculated time of the MTBC emergence would thus 
coincide with the expansion of ‘‘modern’’ human populations out of Africa [2]. 
 
The population structure of M. bovis in the UK 
Our knowledge about the global population structure of M. bovis is very limited and 
only few representative national surveys have been conducted, up to date. Most 
insights into the population structure of M. bovis came from molecular 
epidemiological studies from the UK, where BTB is still prevalent despite 
longstanding attempts to eradicate the disease [153]. The BTB control program in the 
UK started in 1935 and became highly successful in the 1960s and 70s when very 
low tuberculin reactor incidences were reached. However, incidence rates have 
again drastically increased since the late 1980s [153]. It has been shown that the 
Eurasian badger (Meles meles) represents a maintenance host for M. bovis in the UK 
and probably the establishment of this wildlife reservoir has accounted for the 
increase of the BTB prevalence in the UK [37]. 
The spoligotype patterns of most strains of M. bovis isolated from cattle in the UK 
characteristically lack spacers 6 and 8-12. Therefore, it has been suggested that the 
majority of strains found in the UK belong to a single clonal complex [1]. M. bovis 
population surveys in France, Spain and other countries of continental Europe 
indicated that the clonal complex existing in the UK is not present at high frequency 




outside the British Isles [1]. Using a combined approach of spoligotyping and VNTR 
typing, different molecular types of M. bovis could be discriminated at a high 
resolution [154]. It has been shown that these different types were geographically 
localized to specific regions where they have reached fixation or represent the 
majority of strains isolated [1]. Moreover, VNTR typing of strains showing the two 
most common spoligotype patterns, indicated that the frequency of the VNTR 
patterns could not be explained solely by random mutation and drift and may be best 
explained by a series of clonal expansions [154]. Due to the BTB control schemes in 
the UK, M. bovis experienced a severe bottleneck in the 1960s/70s. Therefore, the 
observed clonal expansion and the geographical localization of distinct molecular 
types could have been a result of population sampling as different clones invaded 
new ecological niches (founder effect) [154]. However, the clonal expansions could 
also be explained by selection [154]. It has been suggested that the strains of 
M. bovis in the UK may have been selected for their ability to maintain themselves in 
the badger population [154]. Alternatively, they may be more efficient in evading the 
BTB control scheme as the most common molecular types of M. bovis in the UK are 
different from the type of strain used for tuberculin production [154,155]. 
 
Immunology of bovine tuberculosis 
Based on the predominance of tuberculous lesions in the respiratory tract and 
associated lymph nodes of diseased cattle, it was early believed, that BTB is 
transmitted from animals to animals through inhalation of infectious aerosols [6]. 
Further evidence for this route of transmission has come from a number of other 
studies [6]. Bacteria entering the respiratory tract, passing the mucociliary layer and 
gaining access to the alveolar space are thought to be phagocytized by 
macrophages, which may constitute the main cellular host for mycobacteria in vivo 
[7]. Following uptake into the phagosome, macrophages attempt to kill the bacteria 
by phago-lysosome fusion and acidification. However, mycobacteria are able to 
prevent lysosomal delivery by manipulating the host cell signal transduction 
pathways using an array of bacterial effector lipids and proteins [156]. Mycobacteria 
are therefore believed to reside and multiply primarily within the phagosomes before 
they eventually destroy the phagocytes. However, this assumption has been 
challenged by a recent study of van der Wel et al., describing the translocation of 
M. tuberculosis from phago-lysosomes to the cytosol of myeloid cells, from the 




second day after phagocytosis [157]. Although infected macrophages are not 
believed to act as the main antigen presenting cells (APC) they can trigger an 
immune response through the secretion of pro-inflammatory cytokines (e.g. TNF-α) 
and chemokines, leading to the recruitment of other phagocytes and lymphocytes to 
the lung [7,158]. 
The most important APCs in tuberculosis infection are probably dendritic cells, which 
also play a major role in modulating the host immune response. Mycobacteria may 
get access to the lung tissue through M-like cells in the bronchi. From there, they can 
penetrate to the underlying lymphoid tissues, get phagocytized by dendritic cells and 
transported to the draining lymph nodes, where immune responses are initiated [7]. 
The interaction of M. bovis with bovine dendritic cells leads to cell maturation and 
increases expression of surface molecules involved in T-cell interactions [159]. 
Moreover, altered cytokine profiles and especially the secretion of IL-12 and TNF-α 
are observed upon infection of bovine dendritic cells with M. bovis [159]. The 
secretion of these cytokines and mycobacterial antigen presentation on the surface 
of dendritic cells help triggering an adaptive cell mediated immune (CMI) response 
[158]. This CMI response is commonly known as the Th1-type immune response and 
characterized by the secretion of high levels of IFN-γ and IL-2 by Th1 CD4 T-cells 
[158]. The production of IFN-γ and IL-2 by Th1 cells can activate macrophages in 
order to become highly microbiocidial. Following activation, macrophages may be 
able to kill most of the mycobacteria within the phagosome by releasing increased 
amounts of hydrolytic enzymes, reactive oxygen intermediates and reactive nitrogen 
intermediates (including nitric oxide) [7,158]. Interestingly, activation of bovine 
dendritic cells enhances their ability to kill ingested M. bovis to a lesser extend and 
significant numbers of live bacilli are able to persist. Dendritic cells may therefore 
constitute a reservoir for pathogenic mycobacteria [7]. However, in an non-activated 
state, dendritic cells are more potent in killing ingested bacteria than macrophages 
[7]. 
Natural Killer (NK) cells and γδ T-cells are crucial in the early innate immunity against 
mycobacterial infections. They release IFN-γ when activated through the interaction 
with dendritic cells and thus contribute to the Th1 biased immune response [7]. 
Conversely, NK and γδ T-cells also play a role in fully activating dendritic cells [7]. 
Control of infection is ultimately dependent on the induction of a strong CMI response 
and granuloma formation, in which CD4 but also CD8 T-cells play a pivotal role. If the 




immune response against mycobacterial infection is strong enough to contain 
bacterial growth, active disease does not develop although infection may never be 
fully cleared. If the balance between the host’s defenses and the persisting 
mycobacteria is tipped in favor of the pathogen, active disease occurs and the 
granuloma formation progresses [160]. At a late stage, BTB granulomas are 
characterized by extensive necrosis which can lead to liquefaction and cavity 
formation. Rapture of these cavities into the bronchi consequently allow aerosol 
spread of the bacteria [158]. In a study of Cassidy et al., microscopic lesions were 
observed in experimentally infected cows as early as seven days after inoculation of 
M. bovis [161]. Gross lesions were detected in the upper respiratory tract, in the 
lungs and the lymph nodes draining these areas at 14 days post-infection [161]. At 
the slaughterhouse, granulomatous lesions are most often detected in lymph nodes 
(especially mediastinal or bronchial). This is due to the fact that fluids in an animal 
together with activated macrophages eventually pass through the lymph nodes 
where the pathogens are filtered [158]. 
Although necessary for protection, the CMI response in tuberculosis infection can 
also contribute to the immuno-pathogenesis of tuberculosis [7]. The Th2-type 
immune response functions as a regulatory element to counteract and downregulate 
the pro-inflammatory CMI response, elicited by IFN-γ producing cells [7]. It is also 
associated with an increased humoral immune reaction and is mainly triggered by 
CD4 Th2 cells and the secretion of IL-4. It is believed that Th1-type immune 
responses wane towards late disease stages. In contrast, humoral Th2-type immune 
responses increase as disease and pathology progresses and bacterial load 
increases [162]. Although the factors that trigger the transition from a Th1- to a Th2-
type immune response are not well known, it is thought that the CMI response is 
most relevant to determine protection; in contrast, the humoral response is 
considered detrimental [158]. 
 
Diagnosis of bovine tuberculosis and vaccine development 
Diagnosis of BTB 
Today, the two most widely used tests for the diagnosis of BTB are the single intra-
dermal comparative cervical tuberculin (SICCT) test and the Bovigam® test (Prionics) 
[162]. Both are based on the detection of the early CMI response in tuberculosis 
infection. The SICCT test measures the delayed-type hypersensitivity response to 




intra-dermally injected bovine and avian tuberculin. Tuberculin or the so-called 
purified protein derivative (PPD) is a crude extract of water soluble proteins from a 
heat-treated culture of M. bovis (PPD-B) or M. avium (PPD-A) [162]. PPD-B and 
PPD-A are injected side by side into the skin of an animal’s neck and skin swelling is 
measured 72 hours later. According to the OIE standard procedure, the test result is 
considered positive, if the difference in the increase of skin thickness at the site of 
PPD-B injection is more than 4 mm greater (> 4 mm) than the increase in skin 
thickness at the site of PPD-A injection [163]. 
The Bovigam® test measures the in vitro IFN-γ production of whole blood cells after 
exposure to PPD-B and PPD-A for 16-24 hours [162,164]. IFN-γ production is 
quantified by a sandwich enzyme-linked immunosorbent assay (ELISA). A large 
disadvantage of the Bovigam® test is the requirement to quickly process the blood 
samples soon after collection; however, the method appeared to be somewhat more 
sensitive than SICCT [162,164]. 
CMI response based diagnostic tests allow a relatively early detection of M. bovis 
infection in cattle. At late disease stages, the CMI response can wane as opposed to 
a generally increasing humoral immune response and SICCT or Bovigam® tests can 
give false negative results [162,165,166]. Therefore, late stage diseased animals are 
thought to be more accurately detected by serological tests, which are based on the 
detection of antibodies for M. bovis specific antigens [167]. Importantly, there is 
evidence that such skin test anergic animals are heavily diseased, shed higher 
amounts of bacteria and may be one cause of persistent and severe herd 
breakdowns [162,165,168]. Also, in countries without BTB control programs such 
animals are likely to be more prevalent and may contribute to a larger extent to the 
spread of the disease than animals at an early disease stage [165]. 
Some ELISA based serological tests for the diagnosis of BTB have been developed 
[162,169]. However, the currently available serological tests generally show a low 
sensitivity and could not yet replace the CMI response based diagnostic tests. More 
recently, a fluorescence polarization assay (FPA) for the detection of antibodies 
against MPB70 has been assessed for the diagnosis of BTB in naturally infected 
cattle [170]. Although test sensitivity was relatively low (62%), specificity was nearly 
100% [170]. 
 




Vaccination against M. bovis infections 
The development of a cattle vaccine against M. bovis infection has been considered 
a major priority for the control of BTB in the UK [171]. Provided an effective vaccine 
is available, cattle vaccination may be the most cost effective BTB control strategy 
and therefore also especially useful for interventions and disease control in 
developing countries [7]. The only currently available vaccine against tuberculosis in 
animals and humans is M. bovis BCG, which was developed through multiple 
passaging of a strain of M. bovis on glycerol soaked potato slices by Calmette and 
Guerin in 1921 [7]. However, BCG is not satisfactorily efficient in preventing disease 
and generally shows a variable efficacy. This variability has been attributed to several 
factors such as the vaccine strain itself [172], the regionally predominant infecting 
strains [173] or host genetics [7]. Moreover, it was shown that exposure to 
environmental NTM can influence the protective efficacy of BCG [174]. A particular 
obstacle of BCG is its sensitization of cattle to the tuberculin skin test and Bovigam®, 
making the discrimination of infected and vaccinated animals (differential diagnosis) 
impossible [155]. Current research in development of vaccines and new diagnostic 
tools must therefore be conducted in a coordinated manner to consider all these 
influencing factors in a pragmatic way [155]. 
Some recent studies could show an increased protective capacity or at least an 
improved CMI response upon administration of newly developed vaccine candidates 
compared to BCG [7]. A heterologous prime-boost strategy in cattle using a cocktail 
of three DNA vaccines for priming and BCG for boosting showed a better protection 
than BCG alone [175]. A similar approach using BCG for priming and boosting with 
modified vaccine virus Ankara (MVA) expressing the mycobacterial antigen Ag85A, 
showed very promising results in humans [176] and improved CMI responses in 
cattle [177]. 
Another strategy, which may offer increased protection, is the neonatal vaccination of 
calves. This approach has shown to enhance the Th1 bias of the immune response 
and circumvents the potential problems caused by pre-exposure to environmental 
mycobacteria, which may be of considerable importance in Africa [155,178]. 
 
 Study rationale 
BTB is primarily affecting poor populations in developing countries with no functional 
disease control programs. Moreover, very few information is available on the 
prevalence or distribution of BTB in these most severely affected regions of the 
world. 
As shown before in the example of the UK, molecular genotyping of strains of 
M. bovis can help elucidate the general population structure of bacterial strains in a 
given area. Also, molecular typing of bacteria can be used to investigate the 
relationship of strains from different regions, to assess the spread of particular 
genotypes and to identify areas of strain-exchange. 
In our study, we attempted to investigate the strain diversity and population structure 
of M. bovis in important livestock producing countries of different regions in Africa. 
The countries involved in our surveys were Senegal, Mali and Chad in the Sahel 
region of Africa, Tanzania as an important livestock producing country in East Africa 
and Algeria as a representative of the Maghreb region. By combining our data with 
the previously published records from other surveys in Africa and throughout the 
world, we were able to identify countries with identical genotypes of M. bovis. In 
particular, we were interested in identifying areas of strain exchange within Africa and 
evidence for the introduction of M. bovis from Europe into Africa, e.g. during the 
colonial period. 
Our research has contributed in providing first insights into the distribution and 
relationship of M. bovis strains in different zones of Africa. These results are of great 
importance for the effective development of locally adapted interventions and control 
programs. Moreover, our work has contributed in deciphering the evolutionary history 
of M. bovis in Africa. 
 
Attempts to evaluate diagnostic tests for BTB in naturally infected cattle in Africa are 
scarce but a prerequisite for the implementation of future surveillance schemes and 
control measures. BTB is characterized by a cell mediated immune response at early 
disease stages and a humoral immune response at later stages. Currently available 
diagnostic tests can be categorized on the basis of detecting either of both immune 
reactions. 
Based on the hypothesis that in the absence of disease control schemes the 
frequency of late stage tuberculosis diseased cattle may be considerably higher in 
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Africa compared to industrialized countries, we were interested in evaluating the 
intra-dermal comparative tuberculin skin test (a CMI response based test) and two 
recently developed fluorescence polarization assays (which are humoral response 
based diagnostic tests) in an African high BTB prevalence setting. The results of this 




Aims and objectives 
Aim 
The aims of the study were (1) to contribute to the understanding of the population 
structure and evolutionary history of Mycobacterium bovis in Africa using molecular 
epidemiological techniques and (2) to evaluate multiple tests for the diagnosis of 








To investigate the interrelationship of M. bovis strain populations within Africa and 
between Africa and Europe 
 
Objective 3: 
To evaluate single intra-dermal comparative cervical tuberculin testing, two recently 
developed fluorescence polarization assays, meat inspection, microscopy, culture 
and PCR for the diagnosis of M. bovis infections in southern Chad 
 
Objective 4: 
To assess the importance of non-tuberculous mycobacteria and other infections for 
the diagnosis of bovine tuberculosis in southern Chad 
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Study sites and research partnerships 
 
For our research activities in Africa we have established collaborations with 
institutions from our different study sites in Senegal, Mali, Chad, Tanzania and 
Algeria. The collaboration centers and the corresponding contact persons are 
indicated in figure 3 below. 
For our work on the population structure of Mycobacterium bovis in Africa we have 
also set up a collaboration with Prof. R. Glyn Hewinson from the Veterinary 
Laboratories Agency (VLA), New Haw, Surrey, UK and Dr. Noel H. Smith from the 
University of Sussex, Falmer, UK. 
In Switzerland, mycobacterial culture and part of the molecular work was performed 
in collaboration with Prof. E.C. Böttger at the Institute of Medical Microbiology (IMM) 
of the University Hospital in Zurich. 
An integral part of the research collaboration with our African partners included the 
technology transfer of molecular epidemiological methods to several African 
laboratories. We have provided laboratory equipment to the TB research laboratories 
of the Ecole Inter-Etats des Sciences et Médecine Vétérinaires (EISMV) in Dakar, 
Senegal, Laboratoire de Recherches Vétérinaires et Zootechniques (LRVZ) in 
N’Djaména, Chad and the Sokoine University of Agriculture (SUA) in Morogoro, 
Tanzania. Laboratory technicians or students of the different institutes have been 
trained in PCR and VNTR typing. In particular, spoligotyping has been successfully 
(re-) established in the laboratory of Prof. R. Kazwala at SUA in Tanzania. 
Dr. N. Sahraoui from the University of Saad Dahlab has been trained on PCR and 
VNTR typing at the Swiss Tropical Institute (STI) in Basel. Mr. B.N.R. Ngandolo has 
been trained on various molecular techniques at STI and VLA and he has received 
an extensive training on mycobacterial culture techniques at IMM. 
Training of lab technicians has partially also been conducted under the umbrella of a 





Figure 3: Overview of the collaborating institutions in Africa. 
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Mali is one of the most important livestock producers of the Sahel region of Africa. A 
high frequency of bovine tuberculosis (BTB) has been reported but surveillance and 
control schemes are restricted to abattoir inspections only. The objective of this study 
was to conduct, for the first time, molecular characterization of Mycobacterium bovis 
strains isolated from cattle slaughtered at the Bamako abattoir. Of 3330 animals 
screened only 60 exhibited gross visible lesions. From these animals, twenty strains 
of M. bovis were isolated and characterized by spoligotyping. 
 
Results 
Organ lesions typical of BTB were most often detected in the liver, followed by the 
lung and the peritoneum. M. bovis was isolated from 20 animals and 7 different 
spoligotypes were observed among these 20 strains; three of the patterns had not 
been previously reported. Spoligotype patterns from thirteen of the strains lacked 
spacer 30, a characteristic common in strains of M. bovis found in Chad, Cameroon 
and Nigeria. However, unlike the other three Central African countries, the majority of 
spoligotype patterns observed in Mali also lacked spacer 6. Of the remaining seven 




Two groups of M. bovis were detected in cattle slaughtered at the Bamako abattoir. 
The spoligotype pattern of the first group has similarities to strains previously 
observed in Chad, Cameroon and Nigeria. The additional absence of spacer 6 in the 
majority of these strains suggests a Mali specific clone. The spoligotype patterns of 
the remaining strains suggest that they may have been of European origin. 
 
Background  
Bovine tuberculosis (BTB) is considered a neglected and poverty related zoonosis 
[26]. It has a major economic impact on livestock productivity [19], can persist in 
wildlife reservoirs and thus affect entire ecosystems [20] and it is of public health 
concern due to its zoonotic potential [5,23,32]. Although still prevalent in the 




developed world [132,154,179], BTB today mostly affects developing countries, 
which lack the financial and human resources to control the disease [5,32]. The 
Sahel region of Africa is extremely important in terms of animal production with Mali 
being amongst the principal cattle producing countries [180,181]. Mali has previously 
reported a high frequency of BTB but does not apply specific control measures, 
except carcass inspection at abattoirs [32]. In a recent prevalence study in dairy 
cattle herds from the peri-urban region of Bamako, 19% of the animals reacted 
positively to the comparative tuberculin skin test [46]. 
Spacer oligonucleotide typing (spoligotyping) [53] has been shown to be a valuable 
tool for investigations of the population structure of Mycobacterium bovis in a number 
of settings [43,52,61,132,179]. Furthermore, the international designation of 
spoligotype patterns (www.Mbovis.org, [136]) has facilitated the comparison of 
results from different countries and helps elucidate the distribution and spread of 
strains. Assuming that spoligotype spacers can only be lost and not regained, 
phylogenetic relationships between strains can be suggested [1,182]. A number of 
Mycobacterium tuberculosis complex (MTBC) strain families are readily identifiable 
through spoligotyping [135,183,184]. 
Variable number of tandem repeat (VNTR) typing is another simple method for 
M. bovis genotyping with a higher discriminatory power than spoligotyping [1,142]. 
However, extensive worldwide databases are presently not available and VNTR 
typing can today mainly be considered a valuable tool for sub-differentiation of strain 
groups initially identified by spoligotyping [1]. 
For M. bovis, previous studies in Chad, Cameroon and Nigeria have shown that 
virtually all spoligotype patterns lack spacer 30 with strains bearing spoligotype 
pattern SB0944 being the most frequent [43,52,61]. In Cameroon, because of the 
similarity to patterns of strains isolated in France [179] it was suggested that M. bovis 
could have been imported to this region during the French colonial period [61]. 
However, strains lacking spacer 30 were so far rarely found outside Chad, Cameroon 
and Nigeria. 
The objectives of this study were to conduct an initial molecular characterization of 
M. bovis in Mali using spoligotyping and to identify potential exchange of strains with 
other regions. 
 





At the abattoir of Bamako, Mali, a case series of 3330 slaughter animals were 
sequentially screened during standard meat inspection in March and April 2007. A 
total of 182 specimens from 60 animals with gross visible lesions (apparent lesion 
prevalence: 1.8%; 95% CI: 1.4 – 2.3%) were collected. Organ lesions were most 
often detected in the liver (N = 22) followed by the lung (N = 14) and the peritoneum 
(N = 11). The specimens were put in culture and acid-fast bacilli were further 
characterized by spoligotyping and typing of the M. bovis specific RD4 region. 
Infection with M. bovis was confirmed for 20 animals. From two animals, strains of 
the Mycobacterium fortuitum complex were isolated as identified by partial 
sequencing of the 16S rRNA gene. In one case it appeared to be a single infection 
and in the other case a mixed infection of an M. fortuitum complex strain and 
M. bovis. In this animal, the M. fortuitum complex strain was isolated from liver 
lesions and M. bovis was isolated from lesions of the lungs and bronchial lymph 
nodes. 
Infection with M. bovis was highly associated with the presence of lung lesions 
(N = 44, Χ2 = 23.7, p < 0.001); in 79% of the animals exhibiting lung lesions, M. bovis 
infection could be confirmed. The association was less strong for liver lesions 
(N = 48, Χ2 = 3.9, p < 0.05); only 41% of the animals with liver lesions were shown to 
be infected with M. bovis. However, in all 9 cases where M. bovis infection was 
detected in animals with liver lesions, lung lesions were present as well. No 
association was found between infection with M. bovis and lesions in organs other 
than the liver and lungs. Strains of M. bovis isolated in different organs of the same 
animal showed the same spoligotype pattern. Altogether among the 20 strains of 
M. bovis isolated, seven different spoligotypes were observed; four had been 
previously reported (SB0944, SB0300, SB0134 and SB0944) and the remaining 









Figure 4: Spoligotypes and VNTR typing patterns of M. bovis strains isolated from slaughter cattle at Bamako abattoir in Mali. Spacers 
39-43 were absent from all spoligotype patterns. SB numbers were taken from www.Mbovis.org. VNTR typing targeted loci ETR A – F 
[138]. 
Molecular characterization of M. bovis isolated from Malian cattle 
————————————————————————————————————— 
The distinctive lack of spacer 30 was observed in the spoligotype pattern of 13 
strains; the majority of those in addition lacked spacer 6 (12/13; figure 4). The 
remaining seven strains were linked by the absence of spacers 4 and 5 (figure 4). 
VNTR typing using the exact tandem repeats (ETR) A-F described by Frothingham et 
al. [138] allowed to further differentiate strains with the most frequent spoligotype 
patterns SB0300 and SB0134 (figure 4). Within the strains analyzed, only VNTR loci 
ETR A, B and C showed variation; ETR D, E and F profiles were identical in all the 
strains. One isolate exhibited two different VNTR alleles (3 and 5 tandem repeats) for 
locus ETR C (figure 4), indicating either a mixed infection with two distinct strains or a 
microevolution in this population of strains. 
 
Discussion  
The apparent prevalence of 1.8% gross visible lesions in Malian slaughter cattle was 
surprisingly low compared to published results from other Sahelian countries 
[43,63,64] and also lower than the previous tuberculin skin test results of cattle from 
Bamako indicated (reactor prevalence of 19%) [46]. This suggests that the cattle 
population slaughtered in the abattoir of Bamako originates largely from extensive 
pastoral rather than intensive peri-urban production systems, where BTB prevalence 
is usually higher [31]. Because lesion prevalence was so low and because we could 
not gauge the sensitivity of lesion detection we did not estimate the true prevalence 
of BTB at the Bamako abattoir. However, it is likely to be at least two to three fold 
higher than the observed prevalence [63,64]. 
Only the presence of lung lesions was strongly associated with the detection of 
M. bovis infection, suggesting that the lung was the primary site of M. bovis infection; 
the association of liver lesions and M. bovis infection was weaker. Furthermore, in all 
the cases where M. bovis infection could be confirmed in animals with liver lesions, 
lung lesions were also present (N = 9). In 12 animals liver lesions were recorded 
without associated lung lesions, however, in these animals we were unable to isolate 
M. bovis by culture. One animal exhibited a mixed infection of a M. fortuitum complex 
strain isolated from the liver and M. bovis, isolated from lesions associated with the 
lung and the bronchial lymph nodes. This indicates that some of the lesions outside 
the lung, and particularly the liver, have been caused by pathogens other than 
M. bovis. The amount of lesion causing infections due to other organisms than 
M. bovis might be considerable as only one third of the animals with lesions could be 




confirmed to be infected with M. bovis. Tuberculous gross visible lesions may be 
caused by an array of pathogens amongst which non-tuberculous mycobacteria 
(NTM) could play a crucial role in Africa (unpublished results, [58,69]). This 
suggestion is supported by a previous study in Chad where M. fortuitum complex 
was repeatedly isolated from lesions in slaughtered cattle [58]. It may be worthwhile 
to address the role of NTM infections on animal productivity in relation to BTB in 
African cattle. 
Bacteria could only be isolated from 21 out of 60 animals with gross lesions; this was 
less than in other studies [43,69]. Failure to cultivate bacteria could have been due to 
long-term storage of tissue samples in the freezer prior to cultivation. Because of 
frequent power cuts, we cannot exclude that some of the specimen might have 
undergone multiple freeze-thaw cycles while they were stored. A high amount of 
completely calcified lesions, without viable tubercle bacilli, could also explain the low 
recovery of bacteria (references within [64]). 
The strains identified here can be divided into two groups by spoligotype pattern 
(figure 4). The first group is marked by the distinct loss of spacer 30 and accounts for 
65% of the strains detected (figure 4). The absence of spacer 30 has previously 
found to be characteristic of spoligotype patterns for strains of M. bovis isolated in 
Chad, Cameroon and Nigeria [43,52,61]. In addition to the absence of spacer 30, 
most of the strains from Mali (12/13) also lack spacer 6, a characteristic not seen in 
isolates from Central African countries [43,52,61]. The most often detected M. bovis 
strains in Mali with spoligotype pattern SB0300 could have evolved from strains with 
spoligotype pattern SB0944 either by drift or a selective sweep. This is supported by 
the fact that two of the three VNTR types identified in Malian strains with spoligotype 
pattern SB0300 were identical to VNTR types of previously isolated Nigerian M. bovis 
strains with spoligotype pattern SB0944 [52]. Altogether, the results suggest a close 
relationship between strains from Mali and those from Central Africa. The spread of 
related strains over this large area could be explained by the predominant long 
distance transhumant livestock production system in the Sahel, mainly practiced by 
Fulbe pastoralists [185]. However, considering the fact that, except for pattern 
SB0944, none of the spoligotype patterns found in Mali are present in any of the 
three Central African countries and considering that strains with spoligotype pattern 
SB0944 were rarely detected in Mali we suppose that the spread of M. bovis strains 
over this large distance is relatively slow. 




The second group of related spoligotype patterns is characterized by the absence of 
spacers 4 and 5 (figure 4). The most often detected spoligotype belonging to this 
group is commonly found in strains from France and Spain (SB0134 [179,186]), 
suggesting a link between M. bovis strains from Mali and mainland Europe. VNTR 
profile 6 5 5 4 for ETR loci A-D identified in 2/6 Malian strains of M. bovis with 
spoligotype pattern SB0134 has also been detected in a strain isolated from French 
cattle in the Normandy in 1996 with the same spoligotype pattern [187]. Moreover, 
three other Malian M. bovis strains with ETR A-D profile 7 5 5 4 and spoligotype 
pattern SB0134 could be closely related to SB0134 M. bovis strains with ETR A-D 
profile 7 4 5 4, which is frequently found in M. bovis strains from the Normandy [187]. 
However, identical spoligotype patterns have also been found in strains from 
northern Algeria (unpublished results) and livestock migrations from Algeria to Mali 
through the Sahara desert have been reported. Comprehensive genotyping of strains 
from West Africa, North Africa and Europe using highly polymorphic markers would 
be necessary to further elucidate the interrelationship of M. bovis strains from these 
different regions. 
Njanpop-Lafourcade et al., have previously suggested an influence of the French 
colonial history based on the similarity of the predominant spoligotype pattern 
(SB0944) in Cameroon to the BCG-like spoligotype pattern that is commonly seen in 
strains from France [61]. In a similar manner it is possible to suggest that strains of 
M. bovis with spoligotype pattern SB0134 were originally imported from Europe. If 
both assumptions are true this would suggest that either M. bovis was not present in 
the Central or West African region before introduction from Europe to Africa or 
previously existing “native” M. bovis strains have been largely replaced. 
 
Due to the small sample size, the limited survey period and the sampling at only one 
study location, the M. bovis strains collected cannot reflect the country-wide bacterial 
population structure. Therefore, frequencies of strains with a specific spoligotype may 
not necessarily mirror the actual frequency of these strains in the population although 
more frequent strains are also more likely to be detected in a random sample. 
Moreover, other groups of M. bovis strains than the two that were observed may be 
present in Mali. However, due to the predominant long distance transhumant 
livestock production system, we believe that the slaughter cattle encountered at the 




abattoir of Bamako and consequently their associated M. bovis strains, represent a 
sample from a large area of the country. 
 
Conclusions  
This study presents the first molecular characterization of M. bovis strains from Mali. 
The results suggest that the most often detected strains are related to strains that are 
prevalent in Chad, Cameroon and Nigeria. A second group of strains shows 
spoligotype patterns similar to those abundant in mainland Europe and could have 
been imported directly from Europe or via northern Africa. Our results can serve as a 





Samples were collected from a sequential series of slaughter cattle at the Bamako 
abattoir, Mali in March and April 2007. The cattle population consisted of crossbreeds 
between N’Dama, zebu and exotic breeds. The origin of the cattle could not be 
traced due to poor documentation and multiple selling-on of the animals before 
slaughter. However, we originally assumed that the cattle originate from the peri-
urban region of Bamako as well as the principle areas of cattle production throughout 
the country. After slaughter, animals underwent a standard meat inspection and 
organs showing gross visible lesions were confiscated. No ethical clearance was 
required for this study because it was done on slaughtered animals and organ 
confiscation was part of a routine monitoring. Tissue samples of 60 animals with 
gross visible lesions were collected. The samples were transported on ice to the 
Central Veterinary Laboratory in Bamako. Upon arrival, samples were immediately 
liberated from connective tissue and fat under a bio-safety cabinet and by use of 
sterile dissection instruments. The samples were seared on the outside in order to 
reduce superficial contamination, sealed into sterile stomacher bags and stored at -
20°C for maximum one and a half months until they were shipped to Switzerland for 
culture. Because of frequent power cuts we cannot exclude that some of the 
specimen might have undergone multiple freeze-thaw cycles while they were stored. 
Shipment to Switzerland occurred in a refrigerated box; the temperature of the 




samples was monitored at all times by use of a data-logger (HoboTemp by 
OnsetCorp) and never exceeded -10°C. 
 
Tissue preparation, culture and DNA extraction 
At the Swiss Reference Centre for Mycobacteria, samples were stored at -80°C until 
processed. Specimen were dissected and approximately 2 g were homogenized for 2 
minutes in 10 ml phosphate buffer saline (PBS) using the ULTRA-TURRAX® Tube 
Drive homogenizer with DT-20 tubes (IKA, Staufen, Germany).  A 5 ml aliquot of the 
suspension was decontaminated for 15 minutes with 5 ml of decontamination 
solution (0.5% N-acetyl-L-cystein/2% NaOH/1.45% Na-Citrate solution). The 
decontamination was stopped by addition of 15 ml PBS, the suspension was 
centrifuged at 3500 rpm for 15 minutes and the pellet was re-suspended in 2 ml PBS. 
Then, 0.5 ml of the suspension was added to a BBL™ MGIT™ Mycobacterium 
Growth Indicator Tube containing OADC enrichment and PANTA™ antibiotic mixture 
(BD) and incubated in a BACTEC™ MGIT™ 960 mycobacterial Detection System. In 
addition, 0.25 ml of the suspension was inoculated onto Löwenstein-Jensen and 
7H10 culture media and incubated at 37°C. Cultures were incubated until growth was 
detected or for at least 8 weeks. Presence of acid-fast bacilli was tested by Ziehl-
Neelsen staining and Microscopy and DNA of positive cultures was extracted using 
the InstaGeneTM Matrix (Bio-Rad®). 
 
Molecular characterization 
Spoligotyping was conducted as previously described [53]. VNTR typing was 
performed according to the method of Frothingham et al. [138] with adaptations 
described elsewhere [86]. According to the findings of Brosch et al., strains were 
confirmed as M. bovis by the absence of region RD4. [145]. The 16S rRNA gene 
amplification and sequencing was carried out as described by Zucol et al., (2006) 
[188]. Species identification was carried out by comparison with the sequences of the 
SmartGene Integrated Database Network System (IDNSTM) 3.4.0. 
Statistical analysis 
Statistical analysis was carried out using Intercooled Stata 9.2 for Windows 
(StataCorp LP, USA). The association between the presence of lesions in each 
organ and confirmed M. bovis infection was tested by a chi-squared test. 
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Bovine tuberculosis is prevalent in Algeria despite governmental attempts to control 
the disease. The objective of this study was to conduct, for the first time, molecular 
characterization of a population sample of Mycobacterium bovis strains isolated from 
slaughter cattle in Algeria. Between August and November 2007, 7250 animals were 
consecutively screened at the abattoirs of Algiers and Blida. In 260 animals, gross 
visible granulomatous lesions were detected and put into culture. Bacterial isolates 
were subsequently analyzed by molecular methods. 
 
Results 
Altogether, 101 bacterial strains from 100 animals were subjected to molecular 
characterization. M. bovis was isolated from 88 animals. Other bacteria isolated 
included one strain of M. caprae, four Rhodococcus equi strains, three non-
tuberculous mycobacteria (NTM) and five strains of other bacterial species. The M. 
bovis strains isolated showed 22 different spoligotype patterns; four of them had not 
been previously reported. The majority of M. bovis strains (89%) showed spoligotype 
patterns that were previously observed in strains from European cattle. Variable 
number of tandem repeat (VNTR) typing supported a link between M. bovis strains 
from Algeria and France. One spoligotype pattern has also been shown to be 
frequent in M. bovis strains from Mali although the VNTR pattern of the Algerian 
strains differed from the Malian strains. 
 
Conclusions 
M. bovis infections account for a high amount of granulomatous lesions detected in 
Algerian slaughter cattle during standard meat inspection at Algiers and Blida 
abattoir. Molecular typing results suggested a link between Algerian and European 
strains of M. bovis. 
 
Background  
Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB) and 
belongs to the Mycobacterium tuberculosis Complex (MTBC), a group of closely 
related bacteria causing tuberculosis in various mammalian hosts [1]. 




BTB has a major economic impact on livestock productivity [19], can persist in wildlife 
and thus affect entire ecosystems [20] and it is of public health concern due to its 
zoonotic potential [5,23,32]. Although still prevalent in the developed world 
[132,154,179], BTB today mostly affects developing countries, which lack the 
financial and human resources to control the disease [5,32]. BTB is also known to be 
prevalent in Algeria despite governmental attempts to control the disease [5,32]. 
However, control is restricted to abattoir meat inspection and biannual intra-dermal 
tuberculin skin testing of cattle from intensive dairy farms [189]. Moreover, the 
majority of Algerian cattle are not registered and cattle movement control schemes 
are not well established. Most of the BTB cases in Algeria are discovered during 
meat inspection in slaughter cattle at abattoirs when gross visible lesions typical of 
the disease are detected. However, in two recent studies in Chad and Uganda, non-
tuberculous mycobacteria (NTM) were isolated from more than 40% of the animals 
exhibiting lesions [58,69]. This suggests that NTM infections in cattle might be of 
considerable importance in some African countries. 
Spacer oligonucleotide typing (spoligotyping) and variable number of tandem repeat 
(VNTR) typing have been shown to be valuable tools for molecular epidemiology of 
M. bovis infections in a number of settings [61,138,142,179]. Spoligotyping can be 
used to identify distinct groups of strains, which can often be further differentiated by 
VNTR typing due to the latter’s higher discriminatory power [1]. Extensive worldwide 
databases of spoligo- and VNTR typing patterns facilitate the comparison of results 
from different countries and help to elucidate the distribution and spread of strains 
(www.Mbovis.org, [136]). The objectives of this study were to molecularly 
characterize a population sample of strains of M. bovis from Algeria using 




At the abattoirs of Algiers and Blida in Algeria a consecutive case series of altogether 
7250 slaughter animals was examined during standard meat inspection from August 
to November 2007. Lesions suggestive of BTB were sampled from 260 animals 
(apparent lesion prevalence: 3.6%; CI: 3.2 – 4.0%) and put into culture. Cultures from 
106 animals with lesions did not show bacterial growth. Cultures from 20 animals 
showed contaminations and the remaining cultures from altogether 134 animals 




showed bacterial growth without visible contaminations. A sample of bacterial 
cultures from altogether 100 of these animals were further characterised by deletion-, 
spoligo- and VNTR typing, and sequencing of the 16S rRNA gene. Strains of 
M. bovis were identified by the deletion of RD4 in the genome sequence and by 
spoligotyping; M. bovis was detected in samples from 88 animals (table 2). In 
cultures of one of these animals in addition to M. bovis, a strain of Rhodococcus equi 
could be detected. One strain of the M. caprae clade was identified by the presence 
of the RD4 region and the deletion of RD12 in its genome sequence [1]. Altogether, 
four animals were shown to be infected with R. equi (including the animal with the M. 
bovis/R. equi mixed infection). NTM infections were detected in three animals (table 
2). The 16S rRNA gene sequence of one NTM strain was most similar to the 16S 
rRNA gene sequence of M. chitae (97.7% sequence identity); the second NTM strain 
was most closely related to M. brasiliensis (98.4% sequence identity) and the third 
NTM strain showed highest sequence similarities to M. acapulcensis and M. 
flavescens (99.7% sequence identity for both). However, species identification of the 
NTM strains by 16S rRNA sequencing did not meet the requirements reported by 
Bosshard et al. and may have to be considered with caution [190]. Ureibacillus 
thermosphaericus and bacteria of the genus Corynebacterium, Paenibacillus, 
Pseudomonas and Streptococcus were each detected in samples from one animal 
(table 2). 





Animals screened 7250 100%
Animals with lesions 260 4%
Bacterial strains isolated: 101 100%
Mycobacterium bovis* 88 87%
Mycobacterium caprae 1 1%
Non-tuberculous Mycobacteria 3 3%
Rhodococcus equi* 4 4%
Ureibacillus thermosphaericus 1 1%
Corynebacterium  spp. 1 1%
Paenibacillus  spp. 1 1%
Pseudomonas  spp. 1 1%
Streptococcus  spp. 1 1%
* One mixed infection of M. bovis  and R. equi 
was detected in one animal
 
Table 2. Identification of 101 bacteria isolated from tuberculous lesions of 100 
slaughtered cattle in Algeria. 
 
Spoligotyping of the 89 MTBC strains isolated revealed altogether 23 different 
spoligotype patterns (figure 5); 18 of them had been previously reported and 5 were 
new, including the pattern of the M. caprae strain [146,191,192]. Previously 
unreported M. bovis spoligotype patterns were named SB1447, SB1448, SB1449 
and SB1450 by www.Mbovis.org and the new M. caprae spoligotype pattern was 
named SB1451 (figure 5). The four most frequent spoligotype patterns (SB0120, 
SB0121, SB0134, SB0941) accounted for 40%, 22%, 7% and 7% of the M. bovis 
strains, respectively. Of the 22 M. bovis spoligotypes, 8 were clustered and the 
remaining 14 were unique patterns (allelic diversity = 0.78). 
All the MTBC strains were VNTR typed using the loci ETR A-E (see appendix 2) 
[138]. For the M. bovis strains, 35 VNTR types with 16 clustered and 19 unique 
patterns could be identified (allelic diversity = 0.93). Spoligotyping combined with 
VNTR typing allowed us to distinguish 51 distinct types of M. bovis strains with 11 of 
them being clustered (allelic diversity = 0.95). The VNTR patterns of the four most 
common spoligotypes (SB0120, SB0121, SB0134 and SB0941) are shown in table 3. 
Spoligo- and VNTR types of all the 89 MTBC strains are summarized in appendix 2. 
It is noteworthy that the frequency of the various M. bovis genotypes detected did not 
markedly differ between the two study locations Algiers and Blida. 
 
 SB number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 N %
SB0120 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 35 39%
SB0121 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 19 21%
SB0134 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6 7%
SB0941 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 6 7%
SB0822 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2%
SB0850 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 2 2%
SB0860 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 0 1 1 2 2%
SB1450 1 1 0 0 0 1 1 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 1 1 1 1 2 2%
SB0132 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1%
SB0162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1%
SB0331 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1%
SB0828 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1%
SB0831 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1%
SB0837 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1%
SB0867 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1%
SB0873 1 1 0 1 1 1 1 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1%
SB1086 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1%
SB1200 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1%
SB1447 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 1 1%
SB1448 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 0 1 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1%
SB1449 1 1 0 0 0 1 1 1 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1%
SB1452 1 1 0 1 1 1 1 0 0 0 1 1 1 1 0 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1%




Figure 5. Spoligotype patterns of MTBC strains isolated from slaughter cattle at the abattoirs of Algiers and Blida in Algeria. Spacers 
39-43 were absent from all spoligotype patterns. SB numbers were taken from www.Mbovis.org. Previously unreported M. bovis 
spoligotype patterns were named SB1447, SB1448, SB1449 and SB1450 by www.Mbovis.org and the new M. caprae spoligotype 





VNTR type Frequency VNTR type Frequency VNTR type Frequency VNTR type Frequency
4 5 5 4* 3 6 6 4 3 4* 3 16 7 4 5 4* 3 3 6 5 3 4* 3 5
5 5 2 4* 3 4 4 3 5 3* 3 1 3 5 5 5* 3 1 6 7 3 4* 3 1
4 5 3 4* 3 3 5 3 5 4* 3 1 4 4 5 3* 4 1
4 5 5 3* 3 3 6 4 4 4* 3 1 7 5 3 5* 3 1
4 4 5 4* 3 2
4 5 5 2* 3 2
5 3 5 4* 3 2
5 5 5 4* 4 2
3 2 5 4* 3 1
3 4 5 3* 3 1
3 5 5 4* 4 1
4 5 2 4* 3 1
4 7 3 4* 3 1
4 8 5 4* 3 1
5 4 4 4* 3 1
5 4 5 4* 3 1
5 5 5 4* 3 1
5 6 5 4* 3 1
7 5 4 3* 3 1




Table 3. VNTR allele profiles (in order of loci ETR A-E) of strains with spoligotype patterns SB0120, SB0121, SB0134 and SB0941. 
 
Molecular characterization of M. bovis isolated from Algerian cattle 
————————————————————————————————————— 
Discussion  
To our knowledge, this is the first study conducting the molecular characterization of 
strains of M. bovis isolated from slaughter cattle in Algeria. However, routine abattoir 
meat inspection and periodic intra-dermal tuberculin skin testing of cattle from 
intensive dairy farms have already previously revealed the presence of BTB in 
Algeria [5,32]. In our study, MTBC infections were detected in 89/7250 animals (1% 
of all sampled animals). Considering the imperfect sensitivity of meat inspection and 
culture and the fact that only 100 of the 134 positive cultures have been 
characterized, the true prevalence of MTBC infections in the sampled cattle 
population in fact may has been considerably higher. Ayele et al. previously reported 
a low sporadic incidence of BTB in Algeria [15]; therefore, our results indicate a more 
frequent occurrence of M. bovis infections in Algerian cattle than previously 
suspected. 
Unlike reported for Chad and Uganda, where NTM strains were isolated from more 
than 40% of the animals with lesions [58,69], only 3 of 100 Algerian cattle showed 
NTM infections. R. equi, which was detected in samples of 4 animals, has so far not 
been reported in connection with cattle infections in Africa. Taken together, these 
results suggest that there may be a difference in the bacterial species causing 
pulmonary infection and lesion formation in cattle between Algeria and some 
countries of sub-Saharan Africa. 
The calculated allelic diversity of spoligotype patterns among the M. bovis strains 
isolated in Algeria (0.78) was relatively low compared to France (0.91) but similar to 
strain diversities reported from the UK (0.79) and many other places in the world 
[1,43,61,179]. However, considering the fact that the sample of M. bovis genotypes 
characterized in our study may not be representative of the country wide population 
of M. bovis, the calculated allelic diversity should be considered with care. 
Of the 22 M. bovis spoligotype patterns detected, 13 patterns, accounting for 89% of 
all the strains isolated, have previously been detected in strains isolated from French 
cattle [179]. The three spoligotype patterns most frequently detected in strains from 
Algeria (SB0120, SB0121, SB0134) are also the three most frequent types observed 
in France [179] and are also known to be common in strains from other continental 
European countries [97,131,132,193]. Live animal importation from Europe to Algeria 
is documented. It presumably started during the French colonial period (1830-1962), 
has continued up to the present time and has mainly aimed at increasing the Algerian 




population of highly productive dairy cattle. Therefore, the observed similarity of 
spoligotypes may reflect the introduction of M. bovis from mainland Europe to 
Algeria. 
Interestingly, in a previous study we have identified strains of spoligotype pattern 
SB0134 (figure 5) as highly prevalent in cattle from neighbouring Mali [47]. Strains of 
that spoligotype pattern are also the third most frequent strains detected in France. 
VNTR typing results for loci ETR A-E were available for strains from Algeria and Mali 
but no matches were found (table 4). ETR A-D patterns for strains with spoligotype 
pattern SB0134 from the Normandy region in France have previously been published 
[187]. Pattern 7 4 5 4 for loci ETR A-D was detected in strains from France and 
Algeria and pattern 6 5 5 4 for loci ETR A-D was present in France and Mali (table 4). 
We obtained VNTR patterns of M. bovis strains isolated in France with spoligotype 
pattern SB0120 (M. Boschiroli, unpublished data) and found matching ETR A-D 




3 5 5 5* 3 5 5 5 4* 3 2 4 5 4
4 4 5 3* 4 6 5 5 4* 3 3 3 3 4
7 4 5 4* 3 7 5 5 4* 3 3 4 5 7
7 5 3 5* 3 4 5 5 4
6 5 5 4
7 4 5 4
 
 
Table 4. ETR A-E and ETR A-D typing results of strains with spoligotype pattern 
SB0134 from Algeria, Mali [47] and from the region of Normandy in France [187], 
respectively. Matching patterns of strains are indicated in color. The presence of a 24 
bp deletion in one of the repeats of ETR D (in our analysis marked with *) was not 
declared in the French study. 
 
Due to the small sample size in the studies in Mali and Algeria and the sampling at 
only two abattoirs in northern Algeria and one abattoir in Mali, we cannot infer the 
absence of strain exchange between Algeria and neighbouring Mali. However, our 
data indicates that some strains of M. bovis found in Algeria and Mali may have been 
independently introduced from France (or more generally continental Europe). Live 




animal importation from Europe into Algeria is continuing up to date. However, 
nowadays, a negative tuberculin skin testing result must be certified before 
importation. During the colonial period, import restrictions may have been less 
rigorous for cattle imported from France. Also, the increased efforts to control BTB in 
Europe during the second half of the 20th century have lead to a decreased 
prevalence of the disease in cattle of many European countries [194]. Therefore, 
supposedly, introduction of strains of M. bovis into Algeria could have most likely 
occurred during the colonial time. However, occasional importation of diseased but 
undetected live cattle might still be possible. Introduction of M. bovis from Europe into 
other countries has been suggested several times [61,134,179,195,196] and further 
investigations on the relationship between European strains and strains from other 
parts of the world might be worthwhile in order to elucidate the global spread of 
M. bovis. 
Due to the small sample size, the limited survey period and the sampling at only two 
abattoirs in northern Algeria, the population sample of M. bovis strains collected may 
not reflect the country-wide bacterial population structure. Therefore, frequencies of 
strains with a specific spoligotype do not necessarily mirror the actual frequency of 
these strains in the population. Moreover, it is possible that animals from some 
regions have been overrepresented in our sample. The origin of the animals could 
not be traced due to poor documentation and multiple selling-on of the animals prior 
to slaughter. However, we assume that the majority of animals were dairy cattle and 
that only few animals originated from the same herds. Due to the characteristics of 
the local livestock production system we further assume that the animals originated 
from a large area of northern Algeria with a majority of them presumably coming from 
the central northern part. Indeed, there was evidence that some of the cattle 
slaughtered at the abattoir of Algiers originated from an approximately 300km distant 
region around Sétif. The implementation of a tracing system for animals would be of 
great value to further enhance BTB surveillance through abattoir meat inspection or 
molecular epidemiological studies. A tracing system could possibly also help in the 
early detection of BTB outbreaks and their localization. 
 
Conclusions  
This study presents the first molecular characterisation of a population sample of 
strains of M. bovis isolated from Algerian cattle. BTB accounted for a high amount of 




granulomatous lesions detected in Algerian slaughter cattle during standard meat 
inspection at Algiers and Blida abattoir. Spoligotyping as well as VNTR typing results 
suggest a close link between the strains isolated from Algerian cattle and M. bovis 
strains from mainland Europe. This study highlights the importance of both 
spoligotype and VNTR typing databases and standardized protocols to assist global 




Samples were collected between August and November 2007 from a sequential 
series of slaughter cattle at two abattoirs in Algeria (in Algiers and Blida), 
approximately 50 km apart from each other. The cattle population consisted mainly of 
young males and old cows with males being significantly more often slaughtered at 
the abattoir of Algiers and cows more often slaughtered at the abattoir of Blida. Of 
altogether 7250 animals examined, 93% of the cattle were exotic breeds (Holstein 
and Montbelliard), 6% were cross-breeds and only 1% local breeds. Altogether, 4980 
animals (69%) were males and 2270 (31%) were females. The origin of the cattle 
could not be traced due to poor documentation. We assume that the majority of 
animals were dairy cattle and only few animals from the same herds. The animals 
encountered at Algiers and Blida abattoir possibly originated from a large area of 
northern Algeria with a majority of them presumably coming from the central northern 
part. Tissue samples of 260 animals with gross visible lesions were collected. The 
samples were transported on ice to the Institut Pasteur d’Alger for further processing. 
 
Tissue preparation, culture and DNA extraction 
At the Institut Pasteur in Algiers, specimens from all 260 animals, which exhibited 
gross visible lesions, were dissected and manually homogenised using a mortar. 
Samples were decontaminated by addition of 4ml of 4% H2SO4 and neutralised with 
6% NaOH using bromothymol blue as an indicator for the pH. Two Löwenstein-
Jensen slants, supplemented with either sodium pyruvate or glycerol, were 
inoculated with 3 ml of the suspension and incubated at 37°C until bacterial growth 
was visible or for at least 12 weeks. Presence of Acid-Fast Bacilli was tested by 
Ziehl-Neelsen staining and microscopy. Cultures from 106 animals did not show 




bacterial growth. Cultures from 20 animals showed contaminations and the remaining 
cultures from altogether 134 animals showed bacterial growth without visible 
contaminations. 
A sub-sample of 101 bacterial cultures from 100 animals was sent to the National 
Reference Centre for Mycobacteria in Zurich, Switzerland. DNA of all cultures was 
extracted using the InstGeneTM Matrix (Bio-Rad®). 
 
Molecular characterization 
Spoligotyping was conducted at the Veterinary Laboratories Agency in Weybridge, 
UK as previously described [53]. VNTR typing was carried out as previously 
described using primers targeting the loci ETR A, ETR B, ETR C, ETR D and ETR E 
according to protocols of Frothingham et al. [138]. The ETR-D locus contains a 24 bp 
deletion in one of the repeats and the naming convention indicates the presence of 
this deletion by a * i.e. 4* (= 3 x 77 bp repeats and one 53 bp repeat) [86]. Allelic 
diversity was calculated according to the method of Selander et al. [197]. Strains 
were identified as M. bovis by the absence of the region RD4 and as M. caprae by 
the absence of RD12 and presence of RD4 as described by Brosch et al. [145]. The 
16S rRNA gene amplification and sequencing was carried out as described by Zucol 
et al. [198]. Species identification was carried out by comparison with the sequences 
of the SmartGene Integrated Database Network System (IDNSTM) 3.4.0. Criteria for 
species identification were taken from Bosshard et al. [190]. 
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We have identified a clonal complex of Mycobacterium bovis present at high 
frequency in cattle in population samples from several sub-Saharan, West-Central 
African countries. This closely related group of bacteria is defined by a specific 
chromosomal deletion (RDAf1) and can be identified by the absence of spacer 30 in 
the standard spoligotype typing scheme. We have named this group of strains the 
African1 (Af1) clonal complex and defined the spoligotype signature of this clonal 
complex as the same as BCG vaccine strain but with the deletion of spacer 30. 
Strains of the Af1 clonal complex were found at high frequency in population samples 
of M. bovis from cattle in Mali, Cameroon, Nigeria and Chad and using a combination 
of VNTR typing and spoligotyping we show that the population of M. bovis in each of 
these countries is distinct, suggesting that the recent mixing of strains between 
countries is not common in this area of Africa. 
Strains with the Af1 specific deletion (RDAf1) were not identified in M. bovis isolates 
from Algeria, Burundi, Ethiopia, Madagascar, Mozambique, South Africa, Tanzania 
and Uganda. Furthermore, the spoligotype signature of the Af1 clonal complex has 
not been identified in population samples of bovine TB from Europe, Iran and South 
America. These observations suggest that the Af1 clonal complex is geographically 
localized, albeit to several African countries, and we discuss the demographic and 
evolutionary scenarios that may have led to this localization. 
 
Author Summary 
This article summarizes the work of a very large collaboration of African and 
European scientists working to understand the origin, distribution and evolution of 
bovine tuberculosis (Mycobacterium bovis) in cattle in Africa. We identify a closely 
related clonal complex of M. bovis strains that are present in high frequency in Mali, 
Cameroon, Chad and Nigeria. The strains of this clonal complex all possess the 
same chromosomal deletion and therefore, in this clonal organism, are all descended 
from the same ancestral cell. We show that this clonal complex of strains, called 
African 1 (Af1), is geographically localized to these sub-Saharan, West-Central 
African countries and is not prevalent in East African countries, Europe or South 
America. 
Surprisingly, by advanced genotyping of the strains, it was possible to identify 
country specific populations of Af1 suggesting that the recent movement of bovine 




TB throughout this region of Africa is not common. This manuscript shows how the 
identification and analysis of bovine TB clonal complexes can help to elucidate the 
demography and evolution of this important veterinary and human pathogen as well 
as pointing the way to future work that may generate important epidemiological 
methods to help in the identification and elimination of the disease. 
 
Introduction 
Mycobacterium bovis causes bovine tuberculosis (bovine TB), an important disease 
of domesticated cattle that has a major economic and health impact throughout the 
world [1,23,199]. This pathogen is a member of the Mycobacterium tuberculosis 
complex which includes many species and subspecies that cause similar pathologies 
in a variety of mammalian hosts. The most notable member of the complex is 
Mycobacterium tuberculosis, the most important bacterial pathogen of humans. In 
contrast to M. tuberculosis, which is largely host restricted to humans, M. bovis is 
primarily maintained in bovids, in particular domesticated cattle, although this 
pathogen can frequently be recovered from other mammals including man [1]. Bovine 
TB is found in cattle throughout the world and has been reported on every continent 
where cattle are farmed [200]. 
Bovine TB has been reduced or eliminated from domestic cattle in many developed 
countries by the application of a test-and-cull policy that removed infected cattle 
[1,5,23,32,199-201]. However, in Africa, although bovine TB is known to be common 
in both cattle and wildlife, control policies have not been enforced in many countries 
due to cost implications, lack of capacity and infrastructure limitations [5,20,32,201]. 
In 1998, Cosivi et al. reported of bovine TB “Of all nations in Africa, only seven apply 
disease control measures as part of a test-and slaughter policy and consider bovine 
TB a notifiable disease; the remaining 48 control the disease inadequately or not at 
all” [32]. In the intervening years the situation is not thought to have improved [5]; 
however, preliminary surveys of bovine TB have been carried out in some African 
countries [47,52,61,66,69,78,86,88]. 
The most common epidemiological molecular typing method applied to strains of 
M. bovis is spoligotyping. This method identifies polymorphism in the presence of 
spacer units in the direct repeat (DR) region in strains of the M. tuberculosis complex 
[53,202]. The DR is composed of multiple, virtually identical, 36-bp regions 
interspersed with unique DNA spacer sequences of a similar size (direct variant 




repeat or DVR units). Spacer sequences are unique to the DR region and copies are 
not located elsewhere in the chromosome [182]. The DR region may contain over 60 
DVR units; however, 43 of the spacer units were selected from the spacer sequences 
of the M. tuberculosis reference strain H37Rv and M. bovis BCG strain P3, and are 
used in the standard application of spoligotyping to strains of the M. tuberculosis 
complex [202,203]. The DR region is polymorphic because of the loss (deletion) of 
single or multiple spacers, and each spoligotype pattern from strains of M. bovis is 
given an identifier by www.Mbovis.org. 
Several studies of the DR region in closely related strains of M. tuberculosis have 
concluded that the evolutionary trend of this region is primarily by loss of single DVRs 
or multiple contiguous DVRs [182,203,204]; duplication of DVR units or point 
mutations in spacer sequences were found to be rare. The loss of discreet units 
observed by Groenen et al., [203] led them to suggest that the mechanism for spacer 
loss was homologous recombination between repeat units. However, a study by 
Warren et al., [205] suggested that for strains of M. tuberculosis insertion of IS6110 
sequences into the DR region and recombination between adjacent IS6110 elements 
were more important mechanisms for the loss of spacer units. 
The population structure of the M. tuberculosis group of organisms is apparently 
highly clonal, without any transfer and recombination of chromosomal sequences 
between strains [1,154,206,207]. In a strictly clonal population the loss by deletion of 
unique chromosomal DNA cannot be replaced by recombination from another strain 
and the deleted region will act as a molecular marker for the strain and all its 
descendants. Deletions of specific chromosomal regions (Regions of Difference or 
Large Sequence Polymorphisms) have been very successful at identifying 
phylogenetic relationships in the M. tuberculosis complex 
[1,14,137,144,145,149,150,208,209]. However, because the loss of spoligotype 
spacer sequences is so frequent, identical spoligotype patterns can occur 
independently in unrelated lineages (homoplasy) and therefore the deletion of 
spoligotype spacers may be an unreliable indicator of phylogenetic relationship 
[1,205]. 
In samples of M. bovis strains from Cameroon, Nigeria, Chad and Mali spoligotyping 
was used to show that many of the strains had a similar spoligotype pattern which 
lacked spacer 30, and it has been suggested that strains from these four countries 
are phylogenetically related [43,47,52,61]. We have extended the previous 




observations of spoligotype similarities between strains from these countries and 
confirmed the existence of a unique clonal complex of M. bovis all descended from a 
single strain in which a specific deletion of chromosomal DNA occurred. We have 
named this clonal complex of M. bovis strains African 1 (Af1) and show that this 
clonal complex is dominant in these four West-Central African countries but rare in 
east and southern Africa. 
Extended genotyping, using VNTR, of strains with the most common spoligotype 
patterns suggests that each of these four West-Central African countries has a 
unique population structure. Evolutionary scenarios that may have led to the present 
day distribution of the Af1 clonal complex are discussed. 
 
Results 
Strains with spacer 30 absent 
It has previously been shown that many strains of M. bovis isolated from cattle in 
Mali, Chad and Cameroon have a spoligotype pattern lacking spacer 30 [43,47,61]. 
In a small sample of 15 strains from the Ibadan slaughterhouse in south-western 
Nigeria the spoligotype patterns also lacked spacer 30 [52]. To supplement this 
observation we spoligotyped another 163 strains from the same Nigerian source 
(table 5). Only strains isolated from cattle were used in this analysis and throughout 
this manuscript. All spoligotype patterns of strains from these four countries show the 
loss of spacer 30 except for two of the 65 strains from Chad (SB1102) and seven of 
the 20 strains from Mali (spoligotype patterns SB0134 and SB0991). The three most 
common spoligotype patterns from each of the four countries, representing over 65% 
of strains from each of these countries, are shown in table 6. In general, over 96% of 
the 338 strains sampled from these countries lacked spacer 30 in their spoligotype 
pattern (table 5 and appendix 3). 
 
 Spoligotype Frequency % Spoligotype Frequency % Spoligotype Frequency % Spoligotype Frequency %
SB0944 26 40 SB0944 47 62.7 SB0944 82 46.1 SB0300 8 40
SB1025 13 20 SB1461 8 10.7 SB1027 25 14 SB0134* 6 30
SB0951 7 10.8 SB1460 6 8 SB1025 8 4.5 SB1410 2 10
SB1027 4 6.2 SB0951 5 6.7 SB1421 6 3.4 SB0944 1 5
SB0952 3 4.6 SB1459 2 2.7 SB0328 5 2.8 SB1411 1 5
SB1098 2 3.1 SB0952 2 2.7 SB1432 4 2.2 SB1412 1 5
SB1102* 2 3.1 SB0955 2 2.7 SB1444 4 2.2 SB0991* 1 5
SB1103* 2 3.1 SB1419 1 1.3 SB0951 3 1.7
SB1101 2 3.1 SB1462 1 1.3 SB0952 3 1.7
SB1099 1 1.5 SB1463 1 1.3 SB1420 3 1.7
SB1100 1 1.5 SB1439 3 1.7
SB0328 1 1.5 SB1440 3 1.7






















Total 65 75 178 20
* Not a member of the Af1 clonal complex. International names for these spoligotype patterns were assigned by www.Mbovis.org
Chad Cameroon Nigeria Mali
 
 







Country Spoligotype 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 Frequency (%)
SB0944 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 40
SB1025 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 0 0 0 20
SB0951 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 0 1 0 0 0 0 0 11
SB0944 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 63
SB1461 1 1 0 1 1 1 1 1 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 11
SB1460 1 1 0 1 1 1 1 1 0 1 1 1 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 8
SB0944 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 46
SB1027 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 0 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 14
SB1025 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 0 0 0 4
SB0300 1 1 0 1 1 0 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 40
SB0134 1 1 0 0 0 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 30
SB1410 1 0 0 1 1 0 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 0 0 0 0 10







Table 6. The three most common spoligotype patterns in each of four West-Central African countries. 
 
African 1; an epidemiologically important clonal complex of M. bovis 
————————————————————————————————————— 
 
Identification of a specific deletion - RDAf1 
The absence of specific spoligotype spacers can be characteristic of a clonal 
complex of M. bovis; a closely related group of strains all descended from a single 
common ancestor [1]. However, the loss of spoligotype spacers can independently 
occur in unrelated lineages (homoplasy) and may misidentify members of a clonal 
complex [1,205]. Deletions of chromosomal DNA (RDs, or LSPs) are less likely to 
generate homoplasies provided that the deleted region is not flanked by repetitive 
sequences that generate identical deletions at high frequency [145]. 
To identify a suitable phylogenetically informative deletion, chromosomal DNA from 
two strains from Chad lacking spacer 30 in their spoligotype pattern were applied to 
an M. tuberculosis/M. bovis composite amplicon-array and subjected to microarray 
analysis. As expected, the results of this analysis were compatible with the deletion 
of RD4, 7, 8, 9, 10, 12 and 13 [145]; however, a previously unreported deletion of 
approximately 5.3kb was identified in both strains and named RDAf1. In contrast, a 
strain from Chad with spoligotype spacer 30 present (SB1102) was intact for this 
region by microarray analysis. Sequencing of the RDAf1 region showed that 5322bp 
were deleted compared with the chromosomal sequences of M. bovis BCG [210] and 
M. bovis AF2122 [211]. The RDAf1 deletion removed Mb0587c - Mb0589c and parts 
of Mb0586c and Mb0590c (corresponding to Rv0572c-Rv0574c and parts of 
Rv0571c and Rv0575c in M. tuberculosis H37Rv). The flanking regions of the 
deletion showed no similarity to insertion sequences or repetitive DNA and were not 
GC rich suggesting that this region was not prone to generating homoplasies. We 
concluded that RDAf1 could be a suitable marker for a clonal complex of strains 
present at high frequency in Mali, Cameroon, Nigeria and Chad. 
 
Distribution of RDAf1 in West-Central Africa strains 
To determine if the RDAf1 deletion could be used as a marker for an important clonal 
complex we used a PCR method to survey the state of RDAf1 in all available strains 
from Chad and Mali and a representative sample of strains from Nigeria and 
Cameroon, a total of 239 strains (appendix 3). 
From Nigeria, 148 strains, including the 15 strains published by Cadmus et al., 2006 
[52], were tested as well as a sample of 17 strains representing the population of 
M. bovis from Cameroon. All 165 strains from Nigeria and Cameroon were deleted 




for the Af1 region. In the sample of 20 strains from Mali, seven strains were intact at 
the RDAf1 region and these strains had spoligotype patterns SB0134 and SB0991; 
spacer 30 is present in both these spoligotype patterns. Among the 65 strains from 
Chad four strains were intact at the RDAf1 region in contrast to the remaining 61 
strains from that country; two strains with spacer 30 present (spoligotype pattern 
SB1102) but also two strains with both spacer 30 and 31 absent (spoligotype pattern 
SB1103) (table 5). In general, for 250 strains surveyed from these four West-Central 
African countries, 239 strains 15 were deleted for the RDAf1 region; all 239 strains 
lacked spacer 30 in their spoligotype pattern (appendix 3). 
To confirm that the RDAf1 deletion was identical by descent we sequenced across 
the RDAf1 deletion boundaries in a total of twenty strains originating from different 
countries and showing distinct spoligotype patterns of the Af1 complex (appendix 3). 
In all twenty strains the deletion boundaries of RDAf1 were identical suggesting that 
this deletion is identical by descent in strains from these four countries. 
We concluded that a single clonal complex of M. bovis strains, defined by the 
deletion of RDAf1, and marked by the loss of spacer 30, was present at high 
frequency in Mali, Chad, Cameroon and Nigeria. We named this M. bovis clonal 
complex African 1 or the Af1 clonal complex. 
 
Af1 in other African countries. 
Previously published population surveys of bovine TB strains from Uganda, South 
Africa and Madagascar have shown that, in general, spacer 30 was present in the 
spoligotype patterns of strains from these countries suggesting that the Af1 clonal 
complex was not present at high frequency [69,86,88,110]. To confirm this 
observation a sample of strains chosen to represent the spoligotype diversity of the 
population in each country were surveyed by PCR for the status of the RDAf1 region. 
For representative strains from Burundi (N = 10), Madagascar (N = 8), South Africa 
(N = 11), and Uganda (N = 13) the RDAf1 region was intact. In most of these strains 
spacer 30 was present (appendix 3). We also surveyed the status of the RDAf1 
region in previously unpublished collections of strains from Algeria (N = 23), Ethiopia 
(N = 15), Mozambique (N = 20) and Tanzania (N =14). In most strains spacer 30 was 
present in the spoligotype pattern and in all strains surveyed the RDAf1 region was 
intact (appendix 3). 




We concluded that the distribution and frequency of strains of the Af1 clonal complex 
was not uniform throughout Africa; Af1 strains were at high frequency in the four 
West-Central African countries but were rare or absent in Algeria, Burundi, Ethiopia, 





Figure 6. The localization of the African 1 clonal complex of M. bovis to West-Central 
Africa. Panel A: The four West-Central African countries where Af1 strains were 
found to be dominant are shown in yellow. Countries where Af1 strains were not 
found are shown in grey. Panel B: Cattle distribution on the continent of Africa (grey 
shaded area). Modified from Hanotte et al., 2002 [212] with the author’s permission. 
 




Geographical localization of genotypes to each country 
The population structures of the Af1 strains in Cameroon, Nigeria and Chad are 
superficially similar; in each of these countries over 90% of the strains included in this 
study are members of the Af1 clonal complex and strains with spoligotype pattern 
SB0944 are most common. However, strains from Mali show a distinct difference in 
population structure compared to the other three West-Central African countries 
(table 5) although some caution is needed for this interpretation because of the small 
number of isolates. In Mali, the majority of Af1 strains lack spacer 6 in the spoligotype 
patterns in addition to the loss of spacer 30; strains of the Af1 clonal complex lacking 
spacer 6 are rare or absent from Chad, Nigeria or Cameroon. Furthermore, in Mali, 
members of the Af1 clonal complex make up only 60% of the sampled population 
and a second group of strains with RDAf1 intact, spacer 30 present but lacking 
spacers 4 and 5 are also common (spoligotype patterns SB0134 and SB0991, 40% 
of strains, table 6) [47]. This contrasts with the three other West-Central African 
countries where strains of the Af1 clonal complex are apparently ubiquitous (table 5). 
These observations suggest that the population of M. bovis in Mali is markedly 
different from the three other West-Central African countries analyzed here. 
To further extend this observation we VNTR typed (ETR-A to F) all available strains 
with spoligotype pattern SB0944 from Cameroon, Nigeria and Chad to give a 
genotype for these strains consisting of a combination of spoligotype pattern and 6-
loci VNTR pattern. Table 7 shows the genotypes of strains with spoligotype pattern 
SB0944 from Cameroon, Chad and Nigeria. 
It is clear from table 7 that strains with the most common spoligotype pattern in 
Nigeria and Chad (SB0944) differ significantly in VNTR pattern. Only two of the 16 
genotypes found in Nigeria are also found in Chad. For Nigerian strains a ‘5’ allele is 
common at the ETR-A locus (53 of 59 strains) whereas in Chad only one of 19 
strains had this allele. Furthermore, the most common genotype in Nigeria (SB0944; 
5 5 3 4* 3 3.1), found in 22 of the 59 Nigerian strains, is rare in Chad. The small 
sample of strains from Cameroon with spoligotype pattern SB0944 also suggest that 
this population is unique compared to Nigeria and Chad. Four of the six strains 
genotyped from Cameroon have a 2.1 allele at the ETR-F locus, which is not found in 
the 78 strains with spoligotype pattern SB0944 from the other two countries from 






SB0944 ; 3 6 5 4* 3 3.1 2 SB0944 ; 5 5 3 4* 3 3.1 22 SB0944 ; 5 5 5 4* 3 2.1 3
SB0944 ; 4 5 5 2 3 3.1 2 SB0944 ; 5 5 5 4* 3 3.1 19 SB0944 ; 5 5 3 4* 3 3.1 2
SB0944 ; 4 5 6 5* 3 3.1 2 SB0944 ; 4 5 5 4* 3 3.1 2 SB0944 ; 5 3 4 4* 4 2.1 1
SB0944 ; 4 7* 5 4* 3 3.1 2 SB0944 ; 5 4 5 4* 3 1.3 2
SB0944 ; 4 8 5 4* 3 3.1 2 SB0944 ; 5 4 6 4* 3 3.1 2
SB0944 ; 3 5 3 4* 3 3.1 1 SB0944 ; 5 5 3 4* 3 1.3 2
SB0944 ; 3 5 5 4* 3 3.1 1 SB0944 ; 3 5 5 4* 3 3.1 1
SB0944 ; 4 3 5 4* 3 3.1 1 SB0944 ; 4 4 3 4* 3 3.1 1
SB0944 ; 4 5 6 4* 2 3.1 1 SB0944 ; 5 3 5 4* 3 3.1 1
SB0944 ; 4 6 5 4* 3 3.1 1 SB0944 ; 5 4 5 4* 2 1.3 1
SB0944 ; 4 7 5 4* 3 3.1 1 SB0944 ; 5 4 5 4* 3 3.1 1
SB0944 ; 4 7 6 4* 3 3.1 1 SB0944 ; 5 5 4 4* 3 3.1 1
SB0944 ; 4 8 5 3* 3 3.1 1 SB0944 ; 5 5 6 4* 3 3.1 1
SB0944 ; 5 5 3 4* 3 3.1 1 SB0944 ; 5 6 5 4* 3 3.1 1
SB0944 ; 6 4 5 4* 3 3.1 1
SB0944 ; 6 4 7 4* 3 3.1 1
Total 19 59 6






Table 7. The genotypes of strains with spoligotype pattern SB0944 from Chad, Nigeria and Cameroon. 
 
African 1; an epidemiologically important clonal complex of M. bovis 
————————————————————————————————————— 
The genotypes of strains with the second most common spoligotype pattern in Chad 
(SB1025) also suggest a difference in the population structure between Nigeria and 
Chad. Seven of eight strains from Nigeria with spoligotype pattern SB1025 had 5 
alleles at both the ETR-A and ETR-B locus whereas eight of ten strains from Chad 
had 4 and 3 alleles at the ETR-A and B loci respectively (appendix 3). 
These observations suggest that the strains sampled from Mali, Chad and Nigeria 
each have a country specific population structure. That is, given a strain blind from 
one of these countries it would be possible, with reasonable accuracy, to identify the 




We have identified an epidemiologically important clonal complex of M. bovis 
dominant in Mali, Cameroon, Nigeria and Chad and have named this clonal complex 
African 1 (Af1). This clonal complex is epidemiologically important because it is at 
high frequency in these four countries; we do not yet know how phylogenetically 
distinct this clonal complex is from other strains of M. bovis. Members of this clonal 
complex are defined by a 5.3 kb deletion of chromosomal DNA which we have 
named Region of Difference Af1 (RDAf1). Sequencing of the RDAf1 region in many 
strains has shown that the deletion boundaries are identical and, in the absence of 
repetitive elements flanking RDAf1 and the apparent strict clonality of M. bovis, we 
conclude that this deletion is identical by descent in strains from these four countries. 
That is, RDAf1 was deleted from the most recent common ancestor of this clonal 
complex and this region is therefore deleted in all descendents. A definition and 
summary of the Af1 clonal complex is shown in table 8. 
Strains of the Af1 clonal complex can be identified by the loss of spacer 30 in the 
spoligotype pattern although this characteristic is not necessarily specific. It is 
theoretically possible for strains with the RDAf1 deletion to have spacer 30 present 
although we have not yet identified such an isolate. Furthermore, because the loss of 
spacers in spoligotype patterns can be homoplastic [1,205], strains that are not 
members of the Af1 clonal complex (RDAf1 region intact) can also lack spacer 30; for 
example the strains with spoligotype pattern SB1103 from Chad. 




African 1 (Af1) clonal complex of M. bovis
Definition Presence of deletion RDAf1 (5.3kb, between Mb0586c and Mb0590c)
Spoligotype marker Absence of spacer 30
Spoligotype signature* 1101111101111110111111111111101111111100000 (SB0944)
Distribution At high frequency in sub-Saharan West-Central Africa (Mali, Cameroon, 
Chad and Nigeria)
* The spoligotype signature represents the assumed spoligotype pattern in the progenitor strain of this 
clonal complex and is shown as a series of 1s and 0s with 1 representing hybridisation to the spacer 
and 0 representing absence of hybridisation. International name for this spoligotype pattern was 
assigned by www.Mbovis.org
 
Table 8. The definition of the Af1 clonal complex. 
 
We have surveyed for the presence of strains of the Af1 clonal complex in small 
samples of strains from other African countries and have shown that RDAf1-deleted 
strains are not represented in our samples from Algeria, Burundi, Ethiopia, 
Madagascar, Mozambique, South Africa, Tanzania, and Uganda (figure 6). Although 
the number of strains sampled in each of these countries is small, the high frequency 
of Af1 in the four West-Central African countries supports our conclusion that the Af1 
clonal complex is not uniformly distributed throughout Africa but is dominant in sub-
Saharan West-Central Africa. Previously published large-scale spoligotype 
population surveys of M. bovis strains from Europe (France, Spain, UK, Italy, 
Germany, Belgium, Czech Republic and Portugal) 
[1,97,98,131,132,146,155,179,187,213-215], the Middle East (Iran) [216], and South 
and Central America [196,217,218] do not show a high frequency of strains with 
spacer 30 missing, suggesting that if Af1 strains are present they are not at the high 
frequency seen in West-Central Africa and supporting our suggestion of geographical 
localization of the Af1 clonal complex to this region of Africa. 
 
National localization of Af1 genotypes 
The population structure of M. bovis in Mali is clearly different from the population 
structure in the three other West-Central African countries (table 5). We extended 
this observation to show that the genotypes (spoligotype plus VNTR type) of the most 
common types found in Chad and Nigeria also differ in both frequency and type. 
However, it could be suggested that these samples are non-representative of the 
population structure of M. bovis in Chad and Nigeria; that is, for the short period 




when the strains were collected a subset of the total M. bovis population present in 
each country was sampled. However, the strains from Chad were collected over a 
three year period and the two sets of Nigerian strains, although collected at the same 
abattoir, were sampled over a year apart; In both these samples from Nigeria the ‘5’ 
allele at the ETR-A locus was common in contrast to strains from Chad. A second 
small group of five strains with spoligotype pattern SB0944, collected at an abattoir in 
southern Chad at least 400km from the collection site of the original Chadian strains 
in N’Djaména and three years later, was also distinct when compared to Nigerian 
strains (unpublished data). Taken together these data strongly suggest a distinct, 
country-specific population structure for M. bovis in each of these West-Central 
African countries. This is notable because it is known that there is extensive 
movement of cattle, both commercial and transhumance, between Chad, Nigeria and 
Cameroon, however, our results suggest there is not enough local transmission of 
extra-national strains of M. bovis to obscure the country specific population structure. 
It is common for livestock sold from Chad to either Cameroon or Nigeria to be 
directed to large city abattoirs and not resold to mix with the local populations. In a 
similar way, large cattle populations are sold in Mali for slaughtering in Abidjan (Côte 
d’Ivoire) and do not mix with local cattle population [219]. The observation of a 
country specific population structure is somewhat surprising as these West-Central 
African countries have a century-old, long-distance transhumant livestock production 
systems and trade routes of cattle between the Sahelian countries and the large 
coastal cities, which were considered as important determinants of the regional 
spread of bovine TB [220-222]. More important, our results show that it would be 
worthwhile for each of these countries to establish simple genotype surveillance of 
M. bovis using spoligotyping and VNTR typing to monitor the import of extra-national 
strains in a bovine TB control or eradication campaign. 
Although our data do not address within-country geographic localization of M. bovis 
genotypes, as is commonly seen in Great Britain [1], we are aware that the previous 
population survey of M. bovis strains in Cameroon suggests a difference in the 
genotype of strains isolated in the north and the south of the country [61]. This 
observation implies that it may be worthwhile to carry out more extensive studies of 
the geographical localization of M. bovis genotypes, which, together with an in-depth 
knowledge of contemporary livestock trade and transhumance routes within Chad, 
Mali and Nigeria, could lead to the development of useful epidemiological tools 




(genotype-location maps) to identify key determinants of transmission and to aid the 
control of bovine tuberculosis in these countries. 
 
The evolution of the Af1 clonal complex 
The simplest explanation for the observed distribution and population structure of the 
Af1 clonal complex throughout these sub-Saharan West-Central African countries is 
that a single strain or clonal complex of M. bovis spread between these four countries 
in cattle naïve to bovine tuberculosis. The progenitor strain would have had spacer 
30 missing and carried the RDAf1 deletion and this would account for the presence 
of strains descended from this progenitor Af1 strain in each of these four countries 
(table 8). Country specific population structures could have evolved by drift either 
during the spread of the Af1 clonal complex between countries (a series of founder 
events) or subsequently as the population expanded in each country. In Mali, for 
example, the founding Af1 clone has lost spacer 6 and this subclone has become 
dominant, while in each of the three other West-Central African countries differences 
in VNTR profile have evolved. All spoligotype patterns of the Af1 clonal complex in 
these four West-Central African countries can be derived from the spoligotype 
pattern of the progenitor strain by loss of spoligotype spacers. In support of the 
suggestion of a single introduction of bovine TB and subsequent spread through a 
population of cattle naïve to bovine tuberculosis it is interesting to note that Alhaji, 
writing in 1976, reports that bovine tuberculosis first appeared in West Africa in the 
Cameroons in 1913 and that much of the bovine TB identified in Nigerian abattoirs in 
the 1940s came from cattle imported from Cameroon [223]. The localization of the 
Af1 clonal complex to this region of West-Central Africa may have been governed by 
geographical barriers. To the north of the Af1 range is the Sahara desert and to the 
South are the forest areas in the Congo. These geographical features reduce both 
cattle density (figure 6B) and movement and therefore may have limited the spread 
of Af1 strains. There are no major geographical barriers between Chad, Mali, 
Cameroon and Nigeria and cattle density throughout the region is fairly uniform 
(figure 6B). The absence of Af1 in East Africa, particularly in Ethiopia, can be 
explained by poor trade links between West-Central and East Africa or the prior 
establishment of an M. bovis population in East Africa countries that may have 
limited the introduction of the Af1 clonal complex. We assume that other countries in 
this region, especially Niger, will also be dominated by strains of the Af1 clonal 




complex and that these countries will have country-specific population structures 
(figure 6). It is noteworthy that a strain of M. bovis with spacer 30 missing in the 
spoligotype pattern has been isolated from a human with pulmonary tuberculosis in 
Ghana [224]. 
It may seem unreasonable that a single strain spread between these countries with 
both a chromosomal deletion and the deletion of a spoligotype spacer. However, we 
can assume that the population of M. bovis that gave rise to the Af1 progenitor was 
very small (a founder population) and, under those conditions, in a clonal organism, 
the fixation of otherwise deleterious mutations may be quite common [1]. Whether 
the progenitor of the Af1 clonal complex evolved in Africa or elsewhere and was 
subsequently imported to Africa is unknown although this may be resolved when the 
phylogenetic relationship of the Af1 clonal complex to strains from other countries is 
determined. 
Strains of the Af1 clonal complex have virtually reached fixation in Nigeria, Cameroon 
and Chad and the suggestion of a single strain spreading throughout the region and 
subsequently establishing country-specific populations is, to a certain extent, 
dependent on the absence of M. bovis strains in these three countries prior to the 
spread of Af1. However, if each country had a prior population of M. bovis that was 
replaced by the Af1 clone then it is difficult to explain, without invoking selection, how 
strains of this clonal complex went to fixation by drift, independently, in three 
countries. If we assume West-Central African cattle were infected with a prior 
population of M. bovis, then the Af1 clone could have arisen with a selective 
advantage and spread throughout the region, going to fixation in Nigeria, Cameroon 
and Chad and replacing the previous population. 
It would be tempting to suggest that the RDAf1 deletion generated a phenotype that 
was selectively advantageous. For some M. bovis deletions a phenotype has been 
described, for example, deletion RD4 induces a truncated form of a phenolic 
glycolipid [225]; however any selective advantage of this phenotype is unknown. In 
general, attempts to assign selective advantages to the many other deletions in 
members of the M. tuberculosis complex have not been overly successful. 
Exceptions are the deletion of the esxAB genes and flanking regions seen in BCG 
(RD1), M. microti (RDMic), and the Dassie bacillus [226-228], and the loss of an 
immunoregulatory locus from an epidemic strain of M. tuberculosis [229]. The loss of 
the esxAB region in several independent deletion events is strong evidence for an 




unknown selective advantage for the deletion of this locus. However, before a 
selective advantage is assumed for any particular chromosomal deletion it should be 
remembered that in a clonal organism deletions that are not advantageous can easily 
go to fixation by hitchhiking with a selectively advantageous mutation (SNP or 
deletion) located elsewhere on the chromosome [1]. 
Homology searches in the databases at NCBI suggest that the five genes (Mb0586c 
- Mb0590c) affected by the RDAf1 deletion are conserved among several related 
Mycobacterium species but none of the genes has yet been functionally 
characterized. However, Mb0589c (Rv0574c) shares homology with the gene for 
CapA from Bacillus anthracis and PgsAA from Bacillus subtilis; these proteins are 
proposed to be part of a complex for poly-gamma-glutamate biosynthesis [230]. 
In Mali, two major clonal complexes of M. bovis have been described [47]. Strains of 
Af1 make up 60% of the population whereas a second clonal complex, marked by the 
loss of spacers 4 and 5 and the presence of spacer 30 in the spoligotype pattern, is 
also present at high frequency (spoligotype SB0134 and related patterns) [47]. This 
second clonal complex of strains in Mali, provisionally named Af5, has been shown to 
have spoligotype similarities to strains from Europe [47]. Whether the Af1 clonal 
complex went to high frequency in Mali by either drift or selection the simplest 
explanation for the presence of the Af5 clonal complex is that it was introduced after 
Af1 had established; however we have no evidence to indicate the relative time of 
establishment of Af1 and Af5 or the phylogenetic relationship between them except 
that strains of Af5 are not members of the Af1 clonal complex. 
 
Global distribution of clonal complexes of M. bovis 
The local dominance of specific clonal complexes of M. bovis, identified initially by 
spoligotype signatures, is becoming a feature of the global population structure of 
this economically important pathogen [155]. A clonal complex of limited diversity, 
provisionally called Eu1, dominates in the British Isles and historic trading partners 
[1] and we also suspect that a second clonal complex of M. bovis dominates in East 
Africa countries (Af2) and a third in Madagascar (Af3). 
Identification of these clonal complexes will assist not only the epidemiological 
analysis and the international movement of M. bovis strains in cattle but also in 
humans [217]. A strain of M. bovis isolated in 2005 from a human at the Midlands 
Regional Centre for Mycobacteriology, Birmingham, UK had the commonest 




genotype seen in our Nigerian sample (SB0944 ; 5 5 3 4* 3 3.1) [231]. This genotype 
is quite distinct from the genotypes currently isolated from cattle and humans in the 
British Isles and we have shown that this strain is deleted for the RDAf1 region and 
therefore a member of the Af1 clonal complex (unpublished data). It is interesting to 
note that this patient was born in West-Central Africa. Furthermore, a strain of 
M. bovis with spoligotype pattern SB1025, the second most common spoligotype 
identified in our sample from Chad, was isolated from a mother and daughter of 
Canadian origin in France in 2003. These strains were also deleted for the RDAf1 
region (unpublished data) and the infection was presumably acquired in Africa. 
These cases illustrate how the identification and analysis of M. bovis clonal 
complexes and genotypes can be used to suggest possible sources of infection. 
 
Materials and Methods 
Bacterial strains 
All strains analyzed in this manuscript were isolated from cattle and further 
information is given in the appendix 3. Of 89 M. bovis strains isolated from Chadian 
cattle, 65 were isolated from animals sampled in the years 2000-2002 at the 
N’Djaména abattoir [43,142]; 24 additional strains originated from cattle sampled 
between July and November 2005 at the abattoir of Sarh, in southern Chad 
approximately 400 km away from N’Djaména. Of 178 M. bovis strains isolated from 
Nigerian cattle, 15 strains isolated at the Bodija abattoir in Ibadan, Nigeria in 2003 
were previously published [52] while 163 strains isolated at the same abattoir 
between April and August 2004 are described in this study for the first time. The 75 
strains from Cameroonian cattle were collected in 1989-1990 and 1995-1996 from 
cattle in different abattoirs and were published previously [61]; a representative 
subset of 17 strains was used for molecular analyses in this study. The 20 strains 
from Mali were isolated in March and April 2007 from cattle at the Bamako abattoir 
and have been previously described [47]. All strains were characterized by 
spoligotyping, and the majority were subjected to VNTR typing, RD4 typing and 
RDAf1 typing (appendix 3). Population sample of M. bovis from Madagascar (N = 8), 
South Africa (N = 11), Uganda (N = 13), Burundi (N = 10), Tanzania (N = 14), 
Ethiopia (N = 15), Mozambique (N = 20) and Algeria (N = 23) were also analyzed by 
spoligotyping and RDAf1 deletion typing (appendix 3). M. tuberculosis H37Rv and 
M. bovis AF2122/97 were included as reference strains in our experiments.  





Spoligotyping and VNTR typing 
Strains were spoligotyped according to the method of Kamerbeek et al. [53] with 
minor modifications [52]. VNTR typing targeted the six loci originally described by 
Frothingham et al. [138] according to the protocol described by Cadmus et al. [52]. 
Presence of a 24 bp deletion frequently observed in one of the tandem repeats of the 
ETR-D locus was indicated by a * i.e. 4* (=3 x 77 bp repeats and one 53 bp repeat). 
The ETR-F locus contains two sorts of tandem repeats of different length (79 bp and 
55 bp). We displayed the repeat number of the 79 bp repeats followed by the repeat 
number of the 55 bp repeats separated by a period. All strains were VNTR typed at 
VLA, Weybridge, UK. 
 
Microarray analysis 
For the microarray analysis, four isolates (No. 86, 111, 486 and 515; appendix 3) 
were selected from the Chadian M. bovis collection, each representing a different 
spoligotype. The isolates either lacked spacer 30 (strains 111 and 486), spacers 20-
22 (strain 515) or a combination of both (strain 86). Approximately 1-4 µg whole 
genomic DNA for each isolate was extracted as described [232]. The array used in 
this study contained non-redundant protein coding sequences (CDS) from the two 
sequenced M. tuberculosis strains, H37Rv, CDC1551 and from the sequenced 
M. bovis strain, AF2122/97 (http://bugs.sghms.ac.uk). Random amplification, labeling 
of genomic DNA and microarray hybridizations were performed as described [233]. 
GeneSpring 5.0 was used for the data analysis and a cut-off for the normalized 
test/control ratio of <0.5 was used to create gene deletion lists. Deletions found in 
regions associated with repetitive elements and insertion sequences, which are 
known to be prone to deletion events, were disregarded in this study. 
 
Deletion typing 
The majority of the strains from Nigeria, Chad, Mali and Cameroon identified as 
M. bovis by spoligotyping were additionally confirmed by the deletion of RD4 [1,145]. 
The presence or absence of RDAf1 was assessed by multiplex PCR with a set of 
three primers (RDAf1 primer set A); two primers targeting the flanking regions of 
RDAf1 (Mb0586c FW: 5’-ACTGGACCGGCAACGACCTGG and Mb0590c Rev: 5’-




CGGGTGACCGTGAACTGCGAC) and one primer hybridizing with the internal region 
of RDAf1 (Mb058xc Int Rev: 5’-CGGATCGCGGTGATCGTCGA). A 350 bp (RDAf1 
intact) or a 531 bp PCR product (RDAf1 deleted) was identified by agarose gel 
electrophoresis. RDAf1 primers and control strain supernatants are available from 
the corresponding author on request. PCRs contained per reaction 1µl of supernatant 
of heat-killed mycobacterial cells, a final concentration of 1xHotStartTaq Master Mix 
(Qiagen), 1µM of primer Mb0586c FW, 0.5 µM of primer Mb0590c Rev and Mb058xc 
Int Rev and sterile distilled water to a final volume of 20 µl. Thermal cycling was 
performed with an initial denaturation step of 15 min at 96°C, 30 cycles of 30 sec at 
96°C, 30 sec at 65°C and 1 min at 72°C, followed by a final elongation step of 10 min 
at 72°C. PCR products were separated on a 1% agarose gel. 
 
Sequencing 
The RDAf1 deletion junctions of a sample of 20 strains of the Af1 clonal complex and 
from different countries were sequenced using primers Mb0586c FW and Mb0590c 
Rev described for RDAf1 deletion typing (appendix 3). The designation of the strains 
analyzed and the corresponding Gene Bank accession numbers are: 11b: 
EU887538; 17b: EU887539; 24b: EU887540; 53b: EU887541; 950 gg mam P: 
EU887542; 806 rein P: EU887543; 57 HPS pm P: EU887544; 526 gg prescap P: 
EU887545; 208 gg prescap G: EU887547; 18 HPS pm G: EU887548; 81: EU887549; 
45: EU887550; 50: EU887551; 52b: EU887552; C1-128: EU887553; C7-3438: 
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Effective surveillance of bovine tuberculosis (BTB) in developing countries where 
reliable data on disease prevalence is scarce or even absent is a precondition for 
considering potential control options. We conducted a slaughterhouse survey to 
assess for the first time the burden of BTB in southern Chad. 954 slaughter animals 
were sampled consecutively and tested using the single intra-dermal comparative 
cervical tuberculin (SICCT) test, a recently developed fluorescence polarization 
assay (FPA) and routine abattoir meat inspection after slaughter. Gross visible 
lesions were detected in 11.3% (CI: 9.4 - 13.5%) of the animals examined and they 
were mostly located in lymph nodes and the lung. Significantly more Mbororo zebus 
(15.0%) were affected by lesions than Arab zebus (9.9%; OR = 2.20, CI: 1.41 - 3.41; 
p < 0.001). Altogether, 7.7% (CI: 6.2 - 9.6%) of the animals were tested positive for 
Mycobacterium bovis infection using SICCT according to OIE guidelines. However, 
receiver operating characteristic (ROC) analysis using Mycobacterium tuberculosis 
complex (MTBC) infected animals as the positive population and lesion negative 
animals as the negative population, revealed a better SICCT performance if the cut-
off value was decreased to > 2 mm. SICCT reactor prevalence rose to 15.5% (CI: 
13.3 - 18.0%) and FPA did not perform better than SICCT, when this setting adapted 
cut-off was applied. 
 
Introduction 
Bovine tuberculosis (BTB) is a considerable threat in many respects. It causes 
economic loss by its effects on animal health and productivity and by international 
trade restrictions [19]. BTB has also a high impact on animal wellbeing in wildlife 
populations and hence entire ecosystems [20]. Moreover, infected wildlife serves as 
an animal reservoir and hampers BTB eradication programs in several countries 
[234]. BTB is also of concern for public health as it can cause zoonotic disease in 
humans, e.g. through close contact to the animals or consumption of raw milk [5,32]. 
In Africa, the disease is present virtually on the whole continent with only very few 
countries being able to apply control measures due to the lack of financial resources. 
Moreover, laboratory and technical capacity is very limited in most countries with 
diagnosis of tuberculosis relying exclusively on microscopy [5,32,45] 
In a representative survey, Schelling et al. found 17% of transhumant nomadic cattle 
to be positive by single intra-dermal comparative cervical tuberculin (SICCT) testing 




[56]. A subsequent study at the abattoir of N’Djaména in Chad revealed that 7.3% of 
the animals had gross visible BTB suspect lesions with Mbororo zebu breeds being 
more affected than Arab zebus. The differential susceptibility was even more 
significant, when only confirmed Mycobacterium bovis infected animals were 
considered [43]. Spoligotyping [53] demonstrated a homogeneous population 
structure of the isolated bacteria with the most predominant strains showing the 
same patterns as previously identified in studies from northern Cameroon and 
Nigeria [43,52,61]. 
Current ante mortem diagnosis of BTB mainly relies on SICCT testing, which 
although imperfect could not yet be replaced by any other more accurate or 
satisfactory diagnostic method [162]. Also the Interferon-γ (IFN-γ) test (Bovigam®, 
Prionics) has gained increasing importance for BTB diagnosis in cattle [164].  
SICCT and the IFN-γ test are both based on cell mediated immune (CMI) responses 
against tuberculosis infection. TB in cattle is characterized by an early Th1 type CMI 
response, whilst humoral immune responses develop as disease progresses. CMI 
responses can wane and animals become anergic, and SICCT as well as IFN-γ tests 
have been shown to give false negative results in such disease stages 
[162,165,235]. Anergic animals are thought to be heavily diseased and highly 
infective [165]. In low income countries, where control measures are absent, the 
predicted higher prevalence of such animals might considerably affect disease 
spread and persistence [162,165,168]. Thus, development of a diagnostic test 
targeting late stage diseased animals is of specific importance for high-incidence 
countries with restricted resources for BTB surveillance and control. 
Anergic animals may be detected by serological tests if the host’s immune response 
shifts from a predominantly CMI response to an antibody-based response. In this 
context, a number of tests have been developed, however sensitivity and/or 
specificity was low compared to SICCT [162]. Fluorescence polarization (FP) 
constitutes an alternative technique for antibody detection with a shown potential for 
diagnostic purposes [236]. An assay for the detection of Mycobacterium bovis 
antibodies has been described some years ago, utilizing fluorescein-labeled MPB70 
protein as antigen [170,237-239]. The assay has been modified employing a 
polypeptide-based tracer derived from MPB70 protein, named F-733 [170]. The 
present study aimed for the first time at estimating the prevalence of bovine 




tuberculosis of slaughter cattle in southern Chad by the comparative use of ante-
mortem and post-mortem methods.  
 
Materials and Methods 
Animals 
In the absence of a sampling frame, a total of 954 slaughter animals were sampled 
during three intervals of approximately one month between July and November 2005 
at abattoirs in southern Chad. Sample size calculation for diagnostic test comparison 
was based on a prevalence of 17%, a standard error of the estimate < 10% and a 
difference in sensitivity to be detected of 10% (sensitivity of the SICCT test was 
assumed to be 82%, level of confidence of 95%, power of 80%; www.openepi.com, 
2004). The far majority (944 animals) was sampled at the abattoir of Sarh and a few 
(10 animals) at the abattoir of Moundou. The study area was located approximately 
500 km from N’Djaména, where a previous slaughterhouse survey was conducted 
[43]. The animals were raised in a long distance transhumant livestock production 
system with frequent trans-border movements of herds between the Central African 
Republic and Chad [222]. Because of the regional farming system, focusing primarily 
on milk production [180], relatively small amounts of animals (surplus males and old 
cows) are usually sold from the same herd to different traders, which in turn, sell on 
their animals to different butchers. Therefore, we assume that the tested animals can 
be considered a representative sample of animals from a large number of different 
herds and a big area around southern Chad. However, because of poor 
documentation and the multiple selling-on the origin of the animals could not be 
traced. All available animals were subjected to this study. The reticence of some 
butchers limited the number of animals that could be sampled to approximately one 
third of the animals slaughtered during our presence at the abattoir. Different zebu 
breeds were frequently intermixed in the same cattle herds. None of the animals has 
ever undergone tuberculin skin testing. Four types of phenotypic breeds were 
encountered: Arab (N = 658), Mbororo (N = 286), Bogolodjé (N = 7) and cross-
breeds (N = 3) of which only the former two were used for statistical analysis.  
 




Physical examination of animals 
All 954 animals were physically examined before slaughter. Body condition was 
assessed by assigning one of the following three scores: 1 – good body condition, 2 
– bad body condition, 3 – very bad body condition. Classification of the animals was 
based on the bodyweight and external characteristics (dermatosis, etc.). 
Lymph adenopathy was assessed by examination of the left and right pre-scapular 
and superficial inguinal lymph nodes and assigning different scores of hyperplasia: 
1 – normal, 2 – medium hyperplasia of the lymph node, 3 – severe hyperplasia of the 
lymph node. 
 
Fluorescence polarization assay (FPA) 
In our study, a polypeptide-based tracer derived from MPB70 protein, named F-733 
was used for FPA in microtiter (GENios Pro) and single tube format (SENTRY 100) 
[170]. 
 
a. GENios Pro/Microtiter plate format: 
Blood samples from all 954 animals were subjected to GENios Pro FPA. The assay 
was performed as direct assay using fluorescein labeled F-733 tracer followed by a 
confirmatory inhibition assay using fluorescein labeled F-733 tracer in combination 
with a large excess of unlabeled 733 peptide as described by Jolley et al. [170]. 
Assay buffer (0.01 M sodium phosphate pH 7.5, containing 9 g/l sodium chloride, 1 
g/l sodium azide and 4 g/l lithium dodecyl sulfate) of a volume of 100 µl and 100 µl of 
serum sample were applied into microtiter plate wells (96-well flat bottomed black 
microtiter plates, Greiner, catalogue no. 7.655 209), mixed thoroughly for 5 min on a 
microplate shaker and incubated for 25 min at room temperature. After background 
reading, 10 µl of F-733 tracer solution (125 nM in 0.01% sodium phosphate buffer, 
pH 7.5, containing 9 g/l sodium chloride, 1 g/l sodium azide and 100 mg/l bovine 
gamma globulin) was added, mixed thoroughly for 5 min on a microplate shaker and 
incubated at room temperature for further 5 min. Then the background-subtraced FP 
of the tracer was determined. For the confirmatory assay, the assay was performed 
using unlabeled peptide (10 µl, added to 90 µl of buffer) instead of 100 µl of buffer. 
The samples were analyzed in duplicates without inhibitor and retested in duplicate 
with inhibitor. All FP measurements were performed with the GENios ProTM (Tecan 
AG) microplate reader. 





b. SENTRY 100/Single tube format: 
Blood samples from all 954 animals were subjected to SENTRY 100 FPA; however, 
valid test results were available for 953 animals. Assay buffer (0.01 M sodium 
phosphate pH 7.5, containing 9 g/l sodium chloride, 1 g/l sodium azide and 1 g/l 
lithium dodecyl sulfate; 900 µl) and 100 µl of the serum sample were added to 
borosilicate glass test tubes (Culture tubes, Durex, 10x75 mm; VWR cat. no: 47729-
568) and mixed vigorously for 5 sec. After 2 h of equilibration at room temperature, 
background reading was performed. 10 µl of F-733 tracer solution (125 nM in 0.01% 
sodium phosphate buffer, pH 7.5, containing 9 g/l sodium chloride, 1 g/l sodium azide 
and 100 mg/l bovine gamma globulin) was added. The reagents were again mixed 
thoroughly for 5 sec and equilibrated for 30 min at room temperature. FP 
measurements were made using the SENTRY 100 fluorescent polarization 
instrument (Diachemix LLC, USA). Calibration was performed according to 
manufacturer’s instructions. Three negative and one positive control were included in 
each batch of sera tested. 
 
Comparative intra-dermal tuberculin skin testing 
Valid SICCT testing results were available for 930 animals. To be able to perform 
SICCT on slaughter animals, an arrangement was made with the slaughterhouse 
management to maintain animals three day prior to slaughter in the animal 
confinement area of the slaughterhouse. The skin test was performed using bovine 
(50’000 IU/ml) and avian (25’000 IU/ml) tuberculin produced by the Istituto 
Zooprofilattico Umbria e Marche, Perugia, Italy. SICCT testing was effected by intra-
dermal injection of 0.1 ml of bovine “Purified Protein Derivative” (PPD-B) and 0.1 ml 
of avian PPD (PPD-A) on 2 different sites of the mid-neck previously shaved, which 
gives a dose of 5 000 IU of PPD-B and 2 500 IU of PPD-A per animal. Reading of the 
skin swelling was performed with a caliper 72 h later. The outcomes were interpreted 
as recommended by the OIE (Council Directive 64/432/EEC [163]): The result was 
considered positive if the increase in skin thickness at the PPD-B site of injection was 
more than 4 mm greater (> 4 mm) than the reaction shown at the site of the PPD-A 
injection, inconclusive if the reaction to PPD-B was between 1-4 mm greater than to 
PPD-A and negative if the reaction was equal or less for PPD-B. 
 





After slaughter, all 954 animals underwent standard meat inspection including organ 
and lymph node palpation, visual inspection and incision of organs and lymph nodes 
according to standard procedures [240]. Meat inspection was done by local meat 
inspectors at the abattoirs of Sarh and Moundou, Chad. Gross visible lesions were 
detected in altogether 108 of the 954 sampled animals. 
 
Specimen collection, processing and culture 
From all 108 animals, which exhibited gross visible lesions during standard meat 
inspection, lesion containing tissue specimens from all visibly affected organs and 
lymph nodes were collected and transported on ice to the Chadian National 
Veterinary and Animal Husbandry Laboratory (Laboratoire de Recherches 
Vétérinairies et Zootéchniques de Farcha) and stored at -20°C prior to processing. 
Extracted lesions were homogenized as previously described [43]. The samples were 
decontaminated with N-acetyl-L cysteine sodium hydroxide (0.5% NALC 2% NaOH) 
and inoculated into two Middlebrook 7H9 medium flasks containing OADC and 
PANTA (polymyxin, amphotericin B, nadilixic acid, trimethoprim, azlocillin) and either 
glycerol (0.75%) or pyruvate (0.6%). Samples were put in culture until growth was 
detected or at least for 8 weeks. Presence of acid-fast bacilli (AFB) was examined by 
Ziehl-Neelsen staining and microscopy. Manipulations were carried out as described 
previously [43]. 
 
Culture inactivation and DNA extraction 
Bacterial growth was detected in cultures of 102 animals; cultures of 50 animals 
showed presence of AFB by Ziehl-Neelsen staining. An aliquot of the corresponding 
cultures was subjected to heat-killing. For each culture containing AFB, 0.5 ml of the 
bacterial suspension was centrifuged for 5 min at maximum speed, the supernatant 
was removed and the pellet re-suspended in 0.5 ml of sterile distilled water. The 
samples were inactivated by incubation at 95-100°C for 15 min in a boiling water bath 
and stored at -20°C until further processing. Samples were shipped to Switzerland for 
genetic identification of Mycobacterium tuberculosis complex (MTBC) and non-
tuberculous mycobacteria (NTM) strains. DNA extraction from thermo-lysates 
occurred by means of the InstaGeneTM Matrix (catalogue no. 732-6030; Bio-Rad). 





Light Cycler® PCR 
DNA extracts from the 50 animals showing growth of AFB in culture were subjected 
to Light Cycler® PCR for identification of MTBC and NTM strains as previously 
described by Lachnik et al. [241] with some modifications. A PCR-mix was made 
containing 2.5 mM MgCl2, a pair of primers at a concentration of 0.5 µM, each and 
two pairs of Fluorescence Resonance Energy Transfer (FRET) probes at a 
concentration of 0.2 µM, each, for the detection of mycobacteria and MTBC species, 
respectively. 0.1 U of Uracil-N-Glycosylase (UNG) was added for the prevention of 
carry-over contaminations and the mix was incubated at room temperature for 30 
min. 13 µl of the PCR-mix were combined with 2 µl of a commercially available 
ready-to-use hot start reaction mixture (Light Cycler® Fast Start DNA Master 
Hybridization Probe; catalogue no. 03 003 248 001; Roche Diagnostics) containing 
Fast Start Taq polymerase, reaction buffer, deoxynucleoside triphosphates and 10 
mM MgCl2. 5 µl of DNA extract was mixed with 15 µl of the amplification mix in a 
glass capillary. The amplification program began with a denaturation step of 10 min 
at 95°C, followed by 60 cycles of PCR, with 1 cycle consisting of denaturation (10 s 
at 95°C), “touchdown” annealing (10 s at 60°C), and extension (45 s at 72°C). 
Samples were thereupon cooled for 2 min at 40°C. 
 
Primers and probes 
Following primers and probes were used for DNA amplification and hybridization: A 
1,000-bp fragment was amplified using Mbak-f283 (5’-GAG TTT GAT CCT GGC TCA 
GGA-3’) (sense) and Mbak-r264 (5’-TGC ACA CAG GCC ACA AGG GA-3’) 
(antisense) primers. Following FRET probes were used: for the detection of MTBC 
species, Mbak TB-F (5’-TCC CAC ACC GCT AAA GCG CTT TCC-3’ fluorescein) 
(antisense) as an anchor probe and Mbak TB-705 (5’ Light Cycler Red 705-CCA 
CAA GAC ATG CAT CCC GTG GTC C- 3’) (antisense) as a sensor probe, and for 
the detection of Mycobacterium spp., Mbak GE-F (5’-CTT AAC TGT GAG CGT GCG 
GGC GAT ACG G-3’ fluorescein) (sense) as an anchor probe and Mbak GE-640 (5’ 
Light Cycler Red 640-CAG ACT AGA GTA CTG CAG GGG AGA CTG G-3’) (sense) 
as a sensor probe. As indicated, sensor probes were labelled with Light Cycler Red 
640 or Light Cycler Red 705 as an acceptor for FRET, and all anchor probes were 
labelled with fluorescein. 






Logistic regression was done with Intercooled Stata version 9.2 (StataCorp LP) 
Statistically significant covariates for lesion occurrence, were identified by multiple 
logistic regression. 
Non-parametric receiver operating characteristic (ROC) analyses were done in Stata. 
The roctab and roccomp procedures were used for the sensitivity and specificity 
calculations for each possible cut-off point, for the calculation of the area under the 
ROC-curve (AUC), for the comparison of AUCs between the tests and for the 
production of the ROC plots. 
Ideal cut-off values for the diagnostic tests were defined as the points from the ROC 
plot with the largest distance from the diagonal line (sensitivity = 1 - specificity) [242]; 
this corresponds to the point with the largest Youden index (J = sensitivity + 
specificity - 1) [243]. For practical reasons, for GENios Pro and SENTRY 100, the 
next multiple of ten with the same sensitivity was considered as ideal cut-off and 
used for test evaluation. For cut-off selection using the misclassification-cost term 
(MCT), the point with the smallest MCT value (MCT = (CFN/CFP)P(1 - Se) + (1 - P)(1 -
 Sp)) was chosen, with CFN and CFP being the cost of false-negative and false 
positive diagnosis, respectively and P being the disease prevalence in the target 
population [243]. We were unable to accurately estimate CFN/CFP but the cost of 
false-negative diagnosis is likely to exceed the cost of false positive diagnosis. 
Therefore, MCT values for each possible cut-off point and different ratios of CFN/CFP 
were calculated and compared, assuming a disease prevalence of 10% and 15%. 
 
Results 
Animals and lesions 
The animal population sampled at abattoirs in southern Chad (N = 954) consisted 
mainly of young males and old females in a relatively bad body condition. The 
majority belonged either to the Arab (N = 658) or Mbororo (N = 286) breed. 
Interestingly, there was a difference in the sex-ratio between the two zebu breeds 
(N = 944; X2 = 24.1; p < 0.001) with a higher proportion of males in Mbororo 
compared to Arab cattle. 108 of 954 animals (11.3%; CI: 9.4 - 13.5%) screened had 




gross visible lesions, which were mostly located in the pre-scapular lymph nodes, the 
mammary lymph nodes and the lungs (table 9). 
 
Total number % of animals with lesions
Animals with lesions 108 100%
Lymphnode lesions 98 91%
Prescapular lymph nodes 64 59%
Mammary lymph nodes* 37 34%
Head associated 8 7%
Popliteal lymph nodes 1 1%




* Altogether, 29 (36.7%) of the female animals showed visible 
mammary lymph node lesions
 
Table 9. Distribution of gross visible lesions. 
 
In a multiple logistic regression model with lesion occurrence as outcome variable, 
age and breed were identified as statistically significant explanatory variables (table 
10). All visible lesions were put in culture; AFB could be detected in cultures of 50 
animals. Using real-time PCR, NTM and MTBC strains could be detected in cultures 
of 13 and 20 animals, respectively; 3 of altogether 30 animals with confirmed 
mycobacterial infections showed a mixed infection of NTM and MTBC strains. 
 
Explanatory variable OR 95% CI p
Sex 0.97 0.57 - 1.64 0.9
Breed 2.20 1.41 - 3.41 <0.001
Age 1.24 1.11 - 1.38 <0.0001
Body condition 1.02 0.66 - 1.59 0.93
Lymph adenopathy 0.66 0.43 - 1.00 0.05
Pseudo R2 = 0.0467
 
Table 10. Logistic model for lesion occurrence. 
 





Diagnostic tests were evaluated on the basis of confirmed MTBC infections and 
lesion occurrence. Using lesion positive and lesion negative animals as positive and 
negative population, respectively, the ability of SICCT to detect gross visible lesions 
was assessed. Performance of SICCT for the detection of lesions was poor, reflected 
by a low AUC (0.60; CI: 0.54 - 0.66; table 11). Using an alternative gold standard 
definition, confirmed MTBC infected animals were used as the positive population 
and lesion negative animals were used as the negative population. In this case, 
SICCT achieved better results (AUC = 0.80; CI: 0.71 - 0.88; table 11; figure 8). We 
defined the point from the ROC curve with the largest distance from the diagonal line 
(sensitivity = 1-specificity) as ideal cut-off point [242]. Using this approach, we 
estimated the best cut-off value to be an increase in skin fold thickness greater than 
2 mm (> 2 mm). Sensitivity and specificity of SICCT using our suggested cut-off 
value and the OIE standard cut-off were 65.0% (CI: 43.3 - 81.9%) / 86.7% (CI: 84.2 - 
88.9%) and 20.0% (CI: 5.7 - 43.7%) / 93.1% (CI: 91.1 - 94.6%), respectively (table 
11). 
We found a tuberculin reactor prevalence of 7.7% (CI: 6.2 - 9.6%) for the OIE cut-off 
and 15.5% (CI: 13.3 -18.0%) for our suggested cut-off (> 2 mm). Mbororo zebus 
showed for both cut-off values significantly more often a positive SICCT outcome 
than Arab zebus (N = 920; X2 = 4.65 and 4.03, p < 0.05). Average SICCT reactor 
prevalence was already high for animals aged two years or less (5.2% or 10.4% 
depending on the cut-off used; figure 7). SICCT reactor prevalence continuously 
increased with age and reached its top in animals aged 5 or 6 years (12.6% or 23%). 







GENios Pro SENTRY 100
Cut-off > 4mm** > 2mm >= 40 >= 20
Apparent prevalence 7.7% (6.2 - 9.6%) 15.5% (13.3 - 18.0%) 11.1% (9.3 - 13.3%) 3.5% (2.4 - 4.8%)
Lesion positive - Lesion negative
Sensitivity 13.9% (8.6 - 21.7%) 32.4% (24.3 - 41.7%) 18.5% (12.3 - 26.9%) 11.1% (6.5 - 18.4%)
Specificity 93.1% (91.1 - 94.6%) 86.7% (84.2 - 88.9%) 89.8% (87.6 - 91.7%) 97.5% (96.2 - 98.4%)
Positive predictive value 20.8% (13.1 - 31.6%) 24.3% (18.0 - 31.9%) 18.9% (12.6 - 27.4%) 36.4% (22.2 - 53.4%)
Negative predictive value 89.2% (86.9 - 91.1%) 90.7% (88.5 - 92.5%) 89.6% (87.4 - 91.5%) 89.6% (87.4 - 91.4%)
AUC 0.57 (0.51 - 0.63) 0.58 (0.52 - 0.64)
MTBC positive - Lesion negative
Sensitivity 20.0% (5.7 - 43.7%)* 65.0% (43.3 - 81.9%) 50.0% (29.9 - 70.1%) 30.0% (14.5 - 51.9%)
Specificity 93.1% (91.1 - 94.6%) 86.7% (84.2 - 88.9%) 89.8% (87.6 - 91.7%) 97.5% (96.2 - 98.4%)
Positive predictive value 6.6% (1.8 - 15.9%)* 10.7% (6.3 - 17.4%) 10.4% (5.8 - 18.1%) 22.2% (10.6 - 40.8%)
Negative predictive value 98.0% (96.7 - 98.7%) 99.0% (98.0 - 99.5%) 98.7% (97.6 - 99.3%) 98.3% (97.2 - 99.0%)
AUC 0.67 (0.52 - 0.82) 0.70 (0.58 - 0.82)
* 95% binomial exact confidence intervals are indicated if (estimated value) x (sample size) ≤ 5, otherwise Wilson confidence intervals are shown
** OIE standard cut-off
SICCT
0.60 (0.54 - 0.66)
0.80 (0.71 - 0.88)
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Figure 7. Lesion prevalence and SICCT reactor prevalence for different age groups, using the OIE and cut-off > 2 mm. The prevalence 
is given in percent of the number of animals of the same age group. The total percentage of positive animals is indicated and the 









































Figure 8. ROC curves for three diagnostic tests: GENios Pro (black), SENTRY 100 (dark grey) and SICCT (light grey). Animals with 
confirmed MTBC infections were considered positive and animals without lesions negative. Arrowheads correspond to the cut-off 
points selected in this study (the point corresponding to the OIE standard cut-off for SICCT is indicated). 
 
Comparative assessment of FPA and SICCT for BTB diagnosis in Chadian cattle 
————————————————————————————————————— 
FPA 
We evaluated two different FPA methods for the diagnosis of BTB, which were 
designated GENios Pro and SENTRY 100 depending on their distinct detection 
system. Low AUCs illustrated that both FPA tests were inappropriate for the 
detection of animals with gross visible lesions (table 11). ROC analysis for the 
detection of MTBC infected versus lesion negative animals suggested that the best 
cut-off point was at 43.3 ∆mP for GENios Pro and between 13.2 ∆mP and 26.3 ∆mP 
for Sentry100 (figure 8). We therefore classified all animals with a GENios Pro result 
higher or equal to 40 ∆mP (≥ 40 ∆mP) and animals with a SENTRY 100 result of 
20 ∆mP or more (≥ 20 ∆mP) as test positive. Using these cut-off values, sensitivity 
and specificity of GENios Pro and SENTRY 100 were 50.0% (CI: 29.9 - 70.1%) / 
89.8% (CI: 87.6 - 91.7%) and 30.0% (CI: 14.5 - 51.9%) / 97.5% (CI: 96.2 - 98.4%), 
respectively. 
 
Comparison of FPA and SICCT 
Comparison of SICCT, GENios Pro and SENTRY 100 on the basis of their ROC plots 
(figure 8) and associated AUCs (table 11) suggested that SICCT generally performed 
better than both FPA tests. However, the confidence intervals for all AUCs were 
overlapping and no statistically significant differences could be identified. In fact, 
most of the confidence intervals for the sensitivities, specificities, positive predictive 
values (PPV) and negative predictive values (NPV) of the different tests were 
overlapping and did rarely show any statistically significant differences (table 11). 
This was most likely due to the small sample size for the confirmed MTBC infected 
animals (N = 20). Although not at statistically significant levels, our observed data 
suggested higher sensitivities of the FPA tests compared to SICCT at the OIE cut-off 
for only somewhat smaller (GENios Pro) or even higher (SENTRY 100) specificities 
(table 3). SICCT test performance was considerably improved when our suggested 
cut-off (> 2 mm) was used (table 11, figure 8). However, from the comparison of the 
test sensitivities for fixed specificities (table 12) and the ROC curve (figure 8) it 
appeared that FPA performed better than SICCT in the high specificity areas. 
 




80% 85% 90% 95%
SICCT 70.0% 66.4% 40.3% 5.0%
Geniospro 50.0% 50.0% 50.0% 40.0%
Sentry100 40.0% 35.0% 35.0% 30.0%
Predictions derived from actual data
Specificity
MTBC infected - Lesion negative
Sensitivity
 




Animals and lesions 
This is the first ever carried out study on the occurrence of bovine tuberculosis in 
southern Chad. The region is bordering on northern Cameroon and the Central 
African Republic. The animal population encountered at the abattoir is as would be 
expected for a cattle production system focusing on milk and herd growth, with 
priority for slaughter given to surplus males and old cows. The different proportion of 
males in the two zebu breeds could indicate different livestock management 
strategies for different breeds. 
In our previous study in N'Djaména the overall proportion of lesions was significantly 
lower compared to the present study in Sarh (7.3%, CI: 6.8%-7.8% vs. 11.3%, CI: 
9.4% - 13.5%) [43]. Also, the percentage of Mbororo animals encountered was lower 
in N’Djaména (26.0%; CI: 25.1% - 26.8%) compared to Sarh (30.0%; CI: 27.2% - 
33.0%). Since Mbororo animals showed a significantly higher lesion prevalence in 
both settings, the higher abundance of Mbororo cattle in Sarh may at least in part 
account for the different overall prevalence between the two settings. Surprisingly 
and very unlike published in other surveys [63,64,168], routine abattoir meat 
inspection at Sarh abattoir identified the pre-scapular lymph nodes to be most often 
affected in animals with lesions (table 9). This suggested that many of these lesions 
did not result from infection with M. bovis. Indeed, SICCT testing provided a 
sensitivity of only 32.4% (CI: 24.3 - 41.7%; using cut-off > 2 mm) for the detection of 
animals with lesion but performed significantly better 65.0% (CI: 43.3 - 81.9%) for the 
detection of MTBC infected animals (table 11). Moreover, in 10 out of 30 




mycobacterial infections detected by real-time PCR, NTM were detected without co-
infecting MTBC strains. Taken together, these results suggest that a considerable 
amount of lesions could have been caused by other bacteria than M. bovis. Similarly, 
in two other recent studies from Chad and Uganda, NTM were isolated from more 
than 40% of the animals exhibiting lesions [58,69]. Considering the unusual 
frequency of pre-scapular lymph node lesions detected we were in particular 
interested whether M. bovis and other lesion causing bacteria might have infected 
distinct cattle organs. We re-evaluated the performance of SICCT for the detection of 
lesions stratified by the lesion location. Although not at statistically significant levels, 
SICCT performance for the detection of lung lesions was better than its ability to 
detect pre-scapular lymph node lesions (AUC = 0.72, CI: 0.58-0.68 vs. AUC = 0.57, 
CI: 0.50-0.65). This suggested that such lesion causing non-MTBC bacteria might 
more often affect locations outside the lungs. Similar findings were also reported in a 
recent study from Mali [47]. 
A relatively high amount of mammary lymph nodes were detected in our survey. This 
is of public health concern as it could also indicate an increased risk of zoonotic 
transmission through raw milk consumption. The finding could also explain the 
relatively high amount of young animals with lesions (figure 7). 
 
SICCT and FPA 
Our results suggest that the optimal cut-off for SICCT (> 2 mm) in our setting is lower 
than the OIE standard cut-off. This finding is of practical relevance and demonstrates 
the importance of optimizing test cut-offs in the target population. In fact, similar 
results were found in a study in Ethiopia [65] and are likely to apply to other countries 
in sub-Saharan Africa. In SICCT reactor prevalence studies in Uganda and Tanzania, 
lower cut-offs than the OIE standard cut-off have been used, however without 
detailed justification [33,36]. Using our adapted cut-off, reactor prevalence rises to 
15.5% (CI: 13.3 - 18.0%; table 10), indicating a previous underestimation of the 
disease prevalence in Chad as former studies in other regions of the country were 
applying higher cut-offs for test interpretation [56,57]. 
We defined the ideal cut-off as the point from the ROC plot with the largest distance 
from the diagonal line (sensitivity = 1-specificity) [242,243]. By using this definition, 
equal weights were given to sensitivity and specificity and it facilitated comparison of 
different diagnostic tests [243]. In order to take disease prevalence and the cost of 




misclassifications into account the calculation of the misclassification-cost term 
(MCT) can be useful for cut-off selection [243]. We were not able to accurately 
quantify the cost of false negative (CFN) and false positive (CFP) diagnosis as required 
for this method. However, because a single infected and undetected cow can infect 
many others and because the economic losses associated with BTB are mostly due 
to losses in meat production, milk production and increased reproduction efforts [19] 
we can suppose that the cost of a false negative diagnosis is likely to exceed the cost 
of a false positive result by several folds. Assuming a disease prevalence of 15% 
(10%) for the calculation of the MCT, the same ideal cut-off point (> 2 mm) would be 
identified for SICCT if the ratio of CFN/CFP was between 1.2 and 7 (2 and 11). The 
selected cut-off values for both FPA tests also gave satisfactory results for these 
estimates. This suggests that our chosen cut-off values may be acceptable for a 
broad range of reasonable CFN/CFP ratios. In-depth cost analysis is required to 
address potential benefits from reduced cut-off values in Africa. 
It could be argued that the lesion negative animal population used for diagnostic test 
evaluation may still contain M. bovis infected cattle since no tuberculous lesions are 
visible at early stages of BTB. Consequently, such animals could have distorted our 
analysis. In order to increase the certainty that the lesion negative animal population 
indeed was uninfected we repeated all ROC analyses with a negative animal 
population that did not show lesions and that in addition showed a ∆PPD value 
(∆PPD-B - ∆PPD-A) equal to or less than zero (≤ 0) (for repeated ROC analysis of 
FPA) or that was in addition negative for both serological tests (for repeated ROC 
analysis of SICCT). In doing so, 303 and 96 animals were additionally removed from 
the lesion negative population, respectively. For all three diagnostic tests, the shape 
of the ROC curve did not distinctly change compared to the initial analysis and AUCs 
differed by less than 1% (data not shown). This suggests that possible M. bovis 
infected lesion negative animals were present at a negligible frequency and did not 
falsify our analyses. 
The low number of PCR confirmed infections with MTBC strains (N = 20) was 
problematical for the evaluation of the diagnostic tests. Consequently, AUCs and 
other performance measures of the different tests differed rarely at statistically 
significant levels. This is a frequent problem in diagnostic test evaluation. To 
overcome the problem of the unknown true disease status of lesion negative animals 
and the low number of confirmed MTBC infected animals, other statistical methods 




such as latent class analysis may offer alternative approaches for diagnostic test 
evaluation [244]. Latent class analysis was beyond the remit of this study; however, 
we are currently trying to develop an approach for Bayesian ROC estimation of 
multiple tests in absence of a gold standard test. 
In a previous study of Jolley et al. [170], GENios Pro results were repeated for 
positive and suspect positive animals using an inhibition assay (also described in the 
Materials and Methods section). In our analysis, application of this confirmatory 
inhibition test lead to an increase of specificity to 99.4% for the detection of lesions at 
the cost of a lower sensitivity of 10.4% for the detection of lesions and 42.1% for the 
detection of confirmed MTBC infected animals. Jolley et al. have also shown a high 
specificity of the test close to 100% but higher values for the sensitivity (61.5% for the 
detection of PCR confirmed M. bovis infections). This discrepancy could be due to a 
relatively small sample size in both studies [170]. 
We were interested to see whether confirmed MTBC infected but SICCT anergic 
animals could be detected by FPA. Using the OIE cut-off and our suggested cut-off, 
4/20 and 13/20 MTBC infected animals were detected by SICCT leaving a 
considerable amount of 16/20 or 7/20 SICCT anergic animals, respectively. GENios 
Pro detected 2 of the 16 or 7 anergic infected animals and SENTRY 100 only 1. 
Although the number of confirmed cases was too small to allow any conclusions, 
there was no indication that anergic animals were more likely to be detected by FPA.  
We would like to encourage further research and development for BTB diagnosis in 
Africa as most of the current work mainly aims at improving diagnostic techniques for 
industrialized countries. Yet, the majority of cattle affected by BTB originate from the 
developing world, which can not apply control measures [32]. Current research into 
improved diagnostic tests does therefore probably not efficiently target the major 
global burden of BTB. 
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Bovine tuberculosis (BTB) today primarily affects developing countries. In Africa, the 
disease is present essentially on the whole continent; however, little accurate 
information on its distribution and prevalence is available. Also, attempts to evaluate 
diagnostic tests for BTB in naturally infected cattle are scarce and mostly 
complicated by the absence of knowledge of the true disease status of the tested 
animals. However, diagnostic test evaluation in a given setting is a prerequisite for 
the implementation of local surveillance schemes and control measures. 
 
Methodology/Principal Findings: 
We subjected a slaughterhouse population of 954 Chadian cattle to single intra-
dermal comparative cervical tuberculin (SICCT) testing and two recently developed 
fluorescence polarization assays (FPA). Using a Bayesian modeling approach we 
computed the receiver operating characteristic (ROC) curve of each diagnostic test, 
the true disease prevalence in the sampled population and the disease status of all 
sampled animals in the absence of knowledge of the true disease status of the 
sampled animals. In our Chadian setting, SICCT performed better if the cut-off for 
positive test interpretation was lowered from > 4 mm (OIE standard cut-off) to 
> 2 mm. Using this cut-off, SICCT showed a sensitivity and specificity of 66% and 
89%, respectively. Both FPA tests showed sensitivities below 50% but specificities 
above 90%. The true disease prevalence was estimated at 8%. Altogether, 11% of 
the sampled animals showed gross visible tuberculous lesions. However, modeling of 
the BTB disease status of the sampled animals indicated that 72% of the suspected 
tuberculosis lesions detected during standard meat inspections were due to other 
pathogens than Mycobacterium bovis. 
 
Conclusions/Significance: 
Our results have important implications for BTB diagnosis in a high incidence sub-
Saharan African setting and demonstrate the practicability of our Bayesian approach 
for diagnostic test evaluation. 
 





Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB) and 
belongs to the M. tuberculosis complex (MTBC) of bacteria [1]. BTB is a major 
problem in developing countries, which bear the largest part of the world-wide 
disease burden and where millions of people are affected by neglected zoonotic 
diseases such as BTB [5,26,29,32]. The disease causes economic loss by its effects 
on animal health and productivity and by international trade restrictions [19]. It can 
also affect health of wildlife [20] and infected wildlife populations serve as reservoirs 
and hamper disease eradication programs in several countries [234]. Moreover, 
M. bovis infections are of public health concern due to the pathogen’s zoonotic 
potential [5,32]. 
 
BTB control and surveillance is scarce in sub-Saharan Africa and mostly limited to 
abattoir meat inspections. However, the performance of meat inspection is rather 
poor and depends on the disease stage in which infected animals reside, the 
accuracy of the carcass examination and the presence of other lesion causing 
pathogens [63,64,162,245,246]. Recent studies have detected a high proportion of 
non-tuberculous mycobacteria (NTM) in lesions from Chadian, Ugandan, Ethiopian 
and Sudanese cattle, suggesting that a considerable amount of lesions detected 
during abattoir meat inspection of African cattle might be due to other bacteria than 
M. bovis [58,62,67,69]. 
 
Current ante mortem diagnosis of BTB mainly relies on the single intra-dermal 
comparative cervical tuberculin (SICCT) test, which, although imperfect, could not yet 
be replaced by any other more accurate diagnostic method [162]. SICCT is based on 
the cell mediated immune (CMI) response against tuberculosis infection. TB in cattle 
is characterized by an early Th1 type CMI response, whilst humoral immune 
responses develop as disease progresses. At late disease stages, the CMI response 
can decrease and SICCT anergic animals can show false negative test results 
[162,165,247]. Moreover, SICCT performance is influenced by animal exposure to 
NTM strains as their antigens can cross-react with tuberculin [162]. Serological tests 
detecting humoral immune responses may be more useful to detect late stage 
diseased animals. Fluorescence polarization assays (FPA) constitute a technique for 




antibody detection with a shown potential for diagnostic purposes [236]. An assay for 
the detection of M. bovis antibodies has been described recently [59,170,237-239].  
 
Attempts to evaluate diagnostic tests for BTB in naturally infected cattle in Africa are 
scarce but a prerequisite for the implementation of surveillance schemes and control 
measures. Gobena et al. have used detailed post mortem examination to define the 
BTB disease status of Ethiopian cattle for the evaluation of SICCT in this setting [65]. 
However, due to the generally low sensitivity and specificity of post mortem meat 
inspection, its use as a gold standard test is not ideal [246]. We have recently 
assessed three different tests for the diagnosis of BTB (SICCT and two newly 
developed FPA methods) in Chadian cattle. Our previous evaluation was also based 
on a gold standard approach using PCR confirmed MTBC infected and lesion 
negative animals as the positive and negative population, respectively [59]. 
Drawbacks of this study were the small number of positive animals and the unknown 
true disease status of the lesion negative cattle. 
 
Choi et al. [248] developed a Bayesian model for the receiver operating characteristic 
(ROC) estimation of two diagnostic tests in the absence of a gold standard test. In 
the present study, we have further extended this model and applied it to evaluate the 
performance of the diagnostic tests previously assessed by the gold standard 
approach [59]. Our Bayesian model integrated information from three different 
diagnostic methods and was independent of a gold standard test; moreover, it 
allowed us to estimate the true BTB prevalence in the sampled population and the 
true disease status of each tested animal. Using this information, we could in addition 
calculate the diagnostic errors of four post-mortem tests (meat inspection, 
microscopic examination of BTB-like lesions, microscopic examination of derived 




A total number of 954 sequentially selected slaughter animals from southern Chad 
were subjected to multiple tests for the diagnosis of BTB. Three ante-mortem tests 
with continuous numerical outcome values (continuous outcome) were used, namely, 
SICCT and two recently developed FPA tests termed S




[59]. Also, four post-mortem tests giving either a positive or negative test result 
(binary outcome) were applied. These tests were the post-mortem meat inspection, 
direct microscopy, culture and microscopy and PCR (see materials and methods for 
details on the applied tests). 
 
Before slaughter, blood samples were collected and animals underwent SICCT 
testing. Altogether, 8% (CI: 6% – 10%) of the animals tested, reacted positively to 
SICCT when the official OIE cut-off (> 4 mm; [163]) was used (table 13). Serum 
extracted from the blood samples was subjected to the FPA tests SENTRY 100 and 
GENios Pro, for which we have determined most appropriate cut-off values within 
this study (results shown below; table 13). After slaughter, cattle carcasses 
underwent meat inspection; lesions suggestive of tuberculosis were isolated from 
108 animals (lesion prevalence: 11%; CI: 9% - 14%; table 13). In lesions of 51 
animals (47% of animals with lesions; CI: 38% - 57%), acid-fast bacilli (AFB) were 
observed by direct microscopy (table 13). Culture of lesions and subsequent 
microscopic examination detected AFB in samples from 50 animals (49% of the 
animals tested; CI: 39% - 59%; table 13). The microscopy results obtained before 
and after culture agreed by 86%. In AFB containing cultures of 20 animals MTBC 
strains could be detected by real-time PCR (table 13). In cultures of 13 animals, NTM 








No. of animals tested Outcome Ante-/post mortem No. of animals tested pos. % pos.
SICCT (OIE cut-off > 4 mm) * 930 continuous ante-mortem 72 7.7%
SICCT (cut-off > 2 mm) * 930 continuous ante-mortem 144 15.5%
SENTRY 100 (cut-off ≥ 15 ∆mP) * 953 continuous ante-mortem 62 6.5%
GENios Pro (cut-off ≥ 38 ∆mP) * 954 continuous ante-mortem 119 12.5%
Meat inspection 954 binary post-mortem 108 11.3%
Direct microscopy 108 binary post-mortem 51 47.2%
Culture and microscopy 102 binary post-mortem 50 49.0%
PCR 50 binary post-mortem 20 40.0%
* SICCT, SENTRY 100 and GENios Pro results without missing data were available for 929 animals 
 
 
Table 13. Tests applied for the diagnosis of BTB in Chadian cattle. % pos.: Number of animals tested positively divided by the total 
number of animals subjected to the respective test. 
 
Bayesian ROC estimation of multiple tests for BTB diagnosis in Chadian cattle 
————————————————————————————————————— 
Model selection 
Based on the same data, we have previously reported the evaluation of SICCT, 
SENTRY 100 and GENios Pro using a subset of animals with either PCR confirmed 
MTBC infections or no visible lesions [59]. Drawbacks of this approach were the 
small number of positive animals and the uncertainty about the true disease status of 
lesion negative animals [59]. The latter is due to the fact that no gross lesions may be 
observed at early stages of BTB. Here, we describe a Bayesian method for the 
estimation of the true disease prevalence in the sampled population and the means 
and variance-covariances of SICCT, SENTRY 100 and GENios Pro test outcomes 
for the diseased and non-diseased animals. In an initial model we have included data 
from the post-mortem tests with binary outcomes and attempted to directly estimate 
their sensitivities and specificities. Prior assumptions and model estimates are 
indicated in table 14 (models 1A and 1B). 
 
Model estimates for tests with binary outcome were highly sensitive to the priors. We 
therefore decided to consider solely tests with continuous outcome for Bayesian 
modeling (model 2A and 2B; table 14). Parameter estimations for these tests did not 
appear to be sensitive to the prior assumptions and were only marginally different in 
models 1A, 1B, 2A and 2B (table 14). 
 
Diagnostic test performances 
Based on the estimates for the means and variance-covariances of SICCT, SENTRY 
100 and GENios Pro test results for the diseased and non-diseased animals in model 
2A (table 14), ROC curves were calculated for each test (figure 9) and the most 
appropriate cut-off for positive test interpretation was defined as the point from the 
ROC curve with the largest distance from the diagonal line (sensitivity = 1- 
specificity). For SICCT, a cut-off greater than 2 mm (> 2 mm) appeared to be most 
appropriate for our setting. For SENTRY 100 and GENios Pro the best cut-off values 
were determined at 15 ∆mP (≥ 15 ∆mP) and 38 ∆mP (≥ 38 ∆mP), respectively. Using 
these values, the sensitivities and specificities of the tests were calculated (table 15). 
The prevalence of M. bovis infection in the sampled population was estimated at 8% 
(CI: 6% - 11%). 




In addition to the parameters described above, Bayesian modeling allowed us to 
compute the latent disease status of the sampled animals. We have used this 
information from model 2A (table 14) to calculate the sensitivities and specificities of 
the post-mortem tests with binary outcome to detect modeled M. bovis infected 
animals (table 15). It must be noted, that these estimates refer to the diagnostic 
performance for our sample, whereas the Bayesian model estimates consider the 
fact that our sample was a sub-population of the general slaughterhouse population. 
 
Surprisingly, 72% of the animals with gross visible tuberculous lesions detected 
during standard meat inspection showed a negative result for modeled M. bovis 
infection. Thus, our analysis suggested that 72% of the animals exhibiting 
tuberculosis-like lesions were infected with other pathogens than M. bovis. 
 
Risk factors 
We performed logistic regression to identify risk factors for modeled M. bovis 
infection. Univariate logistic regression with modeled M. bovis infection as outcome 
variable and age, sex, animal breed and body condition as explanatory variables 
identified age and a very bad body condition as risk factors for modeled M. bovis 
infection (table 16). However, in the multiple model, only age turned out to be 
significantly associated with modeled M. bovis infection (table 16). Interestingly, only 
the presence of organ lesions in general and in particular the presence of lung and 
liver lesions was significantly associated with modeled M. bovis infection (table 17). 
The presence of lymph node lesions was not associated with modeled M. bovis 
infection (table 17). 





Prior Estimate Prior Estimate Prior Estimate Prior Estimate
µd=0 N(0,100) -0.08 (0.08) N(0,100) -0.08 (0.08) N(0,100) -0.04 (0.08) N(10,20) -0.04 (0.08)
τ
d=0 Ga(1,100) 0.25 (0.02) Ga(1,100) 0.25 (0.02) Ga(1,100) 0.24 (0.02) Ga(1,100) 0.24 (0.02)
µd=1 N(0,100) 4.38 (0.55) N(0,100) 4.38 (0.55) N(0,100) 4.63 (0.59) N(10,20) 4.95 (0.63)
τ
d=1 Ga(1,100) 0.04 (0.01) Ga(1,100) 0.04 (0.01) Ga(1,100) 0.04 (0.01) Ga(1,100) 0.04 (0.01)
µd=0 N(0,100) 4.00 (0.22) N(0,100) 3.99 (0.22) N(0,100) 4.00 (0.22) N(10,20) 4.01 (0.22)
τ
d=0 Ga(1,100) 0.03 (0.001) Ga(1,100) 0.03 (0.002) Ga(1,100) 0.03 (0.002) Ga(1,100) 0.03 (0.002)
µd=1 N(0,100) 10.52 (2.98) N(0,100) 10.53 (2.99) N(0,100) 10.88 (3.27) N(10,20) 8.83 (2.53)
τ
d=1 Ga(1,100) 0.001 (0.0001) Ga(1,100) 0.001 (0.0001) Ga(1,100) 0.001 (0.0001) Ga(1,100) 0.001 (0.0001)
µd=0 N(0,100) 19.52 (0.47) N(0,100) 19.51 (0.46) N(0,100) 19.6 (0.46) N(10,20) 19.62 (0.46)
τ
d=0 Ga(1,100) 0.01 (0.0003) Ga(1,100) 0.01 (0.0003) Ga(1,100) 0.01 (0.0003) Ga(1,100) 0.01 (0.0003)
µd=1 N(0,100) 34.56 (3.60) N(0,100) 34.60 (3.60) N(0,100) 35.06 (3.92) N(10,20) 26.43 (3.29)
τ
d=1 Ga(1,100) 0.001 (0.0001) Ga(1,100) 0.001 (0.0001) Ga(1,100) 0.001 (0.0001) Ga(1,100) 0.001 (0.0001)
mS 0.5 0.51 0.2 0.23 - - - -
σ
S 0.1 0.10 0.15 0.16 - - - -
mC 0.9 0.94 0.9 0.90 - - - -
σ
C 0.1 0.02 0.1 0.02 - - - -
mS 0.5 0.51 0.8 0.95 - - - -
σ
S 0.1 0.10 0.15 0.09 - - - -
mC 0.95 0.52 0.95 0.58 - - - -
σ
C 0.1 0.06 0.1 0.06 - - - -
mS 0.75 0.76 0.85 0.87 - - - -
σ
S 0.1 0.10 0.15 0.14 - - - -
mC 0.95 0.56 0.95 0.58 - - - -
σ
C 0.1 0.06 0.1 0.06 - - - -
mS 0.75 0.87 0.85 0.97 - - - -
σ
S 0.1 0.06 0.15 0.04 - - - -
mπ 0.1 0.12 0.05 0.11 0.1 0.08 0.1 0.08











Model 1A Model 1B Model 2A
 
 
Table 14. Priors and model estimates for different parameters. µd: Mean diagnostic 
value for non-diseased (d = 0) and diseased (d = 1) animals, respectively. τd: 
precision of the diagnostic values for non-diseased (d = 0) and diseased (d = 1) 
animals, respectively. mS/σS, mC/σC, mπ/σπ : Mean and standard deviation of the test 
sensitivity, specificity and true disease prevalence, respectively. The normal 
distribution is parametrized in terms of mean and variance. The Gamma distribution 
is parametrized in a non-conventional way in terms of mean and variance instead of 
the shape and scale parameters. Model-based estimates correspond to the posterior 
























































Test AUC 95% CI S 95% CI C 95% CI
SICCT (OIE cut-off > 4 mm) 0.80 0.73 - 0.87 51.1% 42.1 - 60.1% 98.6% 97.9 - 99.2%
SICCT (cut-off > 2 mm) 0.80 0.73 - 0.87 66.3% 57.5 - 74.6% 89.2% 86.6 - 91.5%
SENTRY 100 (cut-off ≥ 15 ∆mP) 0.57 0.51 - 0.65 45.5% 39.3 - 52.9% 96.4% 95.4 - 97.4%
GENios Pro (cut-off ≥ 38 ∆mP) 0.64 0.57 - 0.72 47.2% 39.9 - 54.7% 92.4% 90.7 - 93.9%
Meat inspection* - - 36.1% 26.6 - 46.9% 90.8% 88.6 - 92.5%
Direct microscopy* - - 90.0% 74.4 - 96.5% 66.7% 55.2 - 76.5%
Culture and microscopy* - - 93.3% 78.6 - 98.2% 69.4% 58.0 - 78.8%
PCR* - - 71.4% 52.9 - 84.7% 100.0% 85.1 - 100%
True prevalence 8.4% 6.1 - 11.0%




Table 15. Parameter estimates for different diagnostic tests based on results from model 2A. AUC: Area under the ROC curve; CI: 
confidence interval; S: sensitivity; C: specificity. 
 
Bayesian ROC estimation of multiple tests for BTB diagnosis in Chadian cattle 
————————————————————————————————————— 
Explanatory variable OR 95% CI p OR 95% CI p
Age 1.15 1.05 - 1.26 <0.01 1.14 1.02 - 1.29 <0.05
Sex 1.59 0.96 - 2.64 0.07 1.11 0.61 - 2.01 0.74
Breed 1.28 0.79 - 2.06 0.31 1.54 0.94 -2.54 0.09
Body condition:
   good 1.00 - - 1.00 - -
   bad 1.07 0.66 - 1.73 0.79 0.96 0.58 - 1.58 0.86
   very bad 2.81 1.33 - 5.95 <0.01 1.96 0.88 - 4.38 0.10
*Model was adjusted for age, sex, breed and body condition
Univariate model Multiple model*
 
 
Table 16. Logistic regression for modeled M. bovis infections. 
 
 
N % RR Fisher
Animals with lesions 108 100% N/A N/A
Lymphnode lesions 98 91% 0.66 0.46
Prescapular lymph nodes 64 59% 1.19 0.67
Mammary lymph nodes 37 34% 1.11 0.82
Head associated 8 7% 0.43 0.44
Popliteal lymph nodes 1 1% 0.00 1.00
Organ lesions 22 20% 2.99 <0.01
Lung 17 16% 3.10 <0.01
Liver 8 7% 2.50 <0.04
Others 3 3% 2.50 0.19
 
 
Table 17. Lesion distribution and association between lesion localization and 
modeled M. bovis infection. N: Number of animals with a specific lesion localization. 
%: Percentage of animals with lesions with a specific lesion localization. RR: Risk 
ratio for modeled M. bovis infection. Fisher: Fisher's exact test p-value. 
 
Discussion 
Practicability and significance of Bayesian ROC estimation 
The performance of diagnostic tests is often setting dependent [249]. Thus, 
evaluations of diagnostic tests for a given region are a prerequisite for the 
implementation of local disease surveillance schemes and control measures [249]. 




However, to date, only few studies have assessed the performance of tests for the 
diagnosis of BTB in high incidence countries in Africa. Furthermore, test evaluation is 
hampered by the absence of a gold standard method for the identification of the 
animal’s true disease status. Here, we applied a Bayesian approach for the 
evaluation of multiple tests for the diagnosis of BTB in a naturally infected 
slaughterhouse population of cattle in southern Chad. Our approach did not require 
knowledge of the true disease status of the tested animals. Moreover, it allowed the 
estimation of the true disease prevalence in the sampled population, the calculation 
of the BTB disease status of all sampled animals and the evaluation of four post-
mortem tests for the diagnosis of BTB. 
 
We have previously reported the evaluation of SICCT, SENTRY 100 and GENios Pro 
using a subset of the same data [59]. In a gold standard approach, PCR confirmed 
MTBC infected animals were defined as the positive population and lesion negative 
animals as the negative population and used for the construction of ROC curves for 
each test. Drawbacks of this approach were the relatively small amount of confirmed 
infections and the unknown true disease status of lesion negative animals. Table 18 
compares the results from the present and our previously published study [59]. The 
accordance of our results using the two different approaches further supports the 
accuracy of our estimates and the practicability of our Bayesian method. Noteworthy, 
Bayesian modeling gave rise to parameter estimates with in many cases 




Our results indicated that the most appropriate cut-off for positive SICCT test 
interpretation was significantly lower then the OIE suggested standard cut-off 
(> 2 mm versus > 4 mm). However, our criteria for cut-off selection attributed equal 
weights to sensitivity and specificity and did not consider the disease prevalence and 
the cost of misclassifications. As an alternative approach for cut-off selection, the 
misclassification-cost term (MCT) can be calculated for each point of the ROC curve. 
The point with the lowest MCT value would then be most appropriate for positive test 
interpretation [243]. This method requires to quantify the cost of false negative (CFN) 
and false positive (CFP) diagnosis, which we were not able to accurately do. 




However, the cost of a false negative diagnosis is likely to exceed the cost of a false 
positive result by several folds as disease transmission amplifies the total economical 
losses due to BTB. We found that, assuming a disease prevalence of 8.4% (10.0%), 
a cut-off > 2 mm would be ideal if CFN/CFP lies between 8 and 16 (7 and 13). This 
suggests that our chosen cut-off values may be acceptable for a broad range of 
reasonable CFN/CFP ratios. 
 
A cut-off > 2 mm was also found to be most appropriate for positive SICCT test 
interpretation in a recent study in Ethiopia [65] and in SICCT reactor prevalence 
studies in Uganda and Tanzania, lower cut-offs than the OIE standard cut-off have 
been used, however without detailed justification [33,36]. Accordingly, our results are 
likely to apply for many other countries in sub-Saharan Africa with similar 
environmental and economic conditions. 
 
SICCT showed a relatively low sensitivity irrespective of whether our suggested or 
the OIE cut-off was used (table 15). Comparable results were obtained in previous 
studies in Ireland and Madagascar [87,162]. This relatively weak performance may 
be explained by several factors. A high proportion of pre-allergic animals at an early 
stage of BTB infection or a high amount of SICCT anergic animals at a very late 
disease stage could have accounted for this observation [162]. Antigens of co-
infecting NTM strains, cross reacting with PPD-A could also cause false negative test 
results as well as nutritional stress or concurrent infections with pathogens leading to 
immuno-depression [162]. For SICCT anergy due to generalized BTB, one would 
expect the presence of gross visible lesions. Amongst all animals with a modeled 
M. bovis infection and visible lesions (N = 30), 9 or 19 (30% or 63%) did not show a 
positive reaction to SICCT depending on whether a cut-off > 2 mm or > 4 mm was 
applied, respectively. This indicates a considerable proportion of SICCT anergic 
animals (9 or 19 of altogether 83 animals with modeled M. bovis infection). 
Unfortunately, our sample size was too small to conclusively assess the ability of the 
FPA tests to detect such animals. 
 
Cause of lesions 
Our data suggests that a surprisingly high proportion of lesions detected during 
standard meat inspection at the Sarh abattoir in southern Chad was caused by other 




bacteria than M. bovis. For 72% of the animals in which lesions have been detected, 
no M. bovis infection was modeled. This finding was in line with the relatively low 
amount of MTBC strains detected in animals with lesions (20 of altogether 108 
animals with lesions; table 13). Interestingly, modeled M. bovis infection was only 
significantly associated with organ lesions in general and the presence of lung and 
liver lesions in particular (table 17). The presence of lymph node lesions was not 
associated with modeled M. bovis infection (table 17). Altogether, this suggests that a 
significant amount of gross visible lesions detected during standard meat inspection 
at the Sarh abattoir has been caused by other pathogens than M. bovis and that 
especially a large proportion of the detected lymph node lesions may have been 
caused by these pathogens. 
 
NTM infections without concomitant M. bovis infections have been isolated from 10 
out of 50 animals tested by PCR. This could indicate that some of the lesions may 
have been associated with NTM. This is also supported by the comparatively low 
specificity of Ziehl-Neelsen staining and microscopic examination of extracted lesions 
or bacterial cultures in our setting compared to previous studies (table 15) [250-254]. 
Nevertheless, the low amount of cultures in which AFB have been detected (50 of 
108 animals with lesions) suggests that in addition, other pathogens may have been 
responsible for the detected lesions. 
 
Altogether, our data indicates that the amount of gross visible granulomatous lesions 
caused by other pathogens than M. bovis may be greatly underestimated in this 
setting. Low recovery of M. bovis from cultures of granulomatous lesions have been 
reported in several studies on BTB in sub-Saharan Africa [43,47,62,67]. It is 
conceivable that in many of these cases, lesions may have been caused by other 
pathogens and that these bacteria may have remained undetected e.g. due to the 
decontamination procedure or different culture growth requirements. 
 
However, it has to be noted that the proportion of lesions due to other pathogens 
than M. bovis is dependent on the accuracy of the meat inspection. Inaccurate meat 
inspection e.g. biased toward superficial lymph nodes could have distorted the 
relative proportion of lesions found in different organs. In particular, it is surprising 
that no lesions were detected in the bronchial or mediastinal lymph nodes, as these 




are usually the most often affected tissues in bovine tuberculosis [63,64,255,256]. 
Also, the sensitivity of meat inspection to detect M. bovis infected cattle was lower in 
our setting compared to the results of previous studies [63,64,245,246]. Therefore, 
the proportion of lesions caused by other pathogens than M. bovis may have to be 
interpreted with caution. 
 
Risk factors 
In a previous study on BTB in Chadian cattle we have reported that the prevalence of 
BTB was significantly higher in Mbororo zebus than in Arab zebus [43]. Our results 
from the logistic regression analysis could not show any evidence that M. bovis 
infection was significantly associated with breed (table 16). Nevertheless, the 
presence of lesions was still significantly associated with Mbororo zebus (N = 944, 
χ2 = 5.23, p = 0.02). This observation could suggest that Mbororo breeds in fact, are 
not more likely to be infected with M. bovis but more often develop advanced stages 
of the disease. Host genetic factors as well as environmental factors or animal 
husbandry could account for this observation. 
 
Conclusions  
In summary, the present study shows the practicability of a Bayesian method for the 
evaluation of multiple tests for the diagnosis of BTB in naturally infected cattle and in 
absence of knowledge of the true disease status of the animals. Our model allowed 
us to compute the disease status of each sampled animal and the modeling results 
supported our previous observation that the cut-off for positive SICCT interpretation 
should be lowered to > 2 mm in many countries of sub-Saharan Africa. Moreover, we 
provide evidence that an unexpectedly high proportion of BTB suspect lesions 








SENTRY 100 GENios Pro
Cut-off > 4mm > 2mm ≥ 15 ≥ 38
Bayesian method:
Sensitivity 51.1% (42.1 - 60.1%) 66.3% (57.5 - 74.6%) 45.5% (39.3 - 52.9%) 47.2% (39.9 - 54.7%)
Specificity 98.6% (97.9 - 99.2%) 89.2% (86.6 - 91.5%) 96.4% (95.4 - 97.4%) 92.4% (90.7 - 93.9%)
AUC 0.57 (0.51 - 0.65) 0.64 (0.57 - 0.72)
Gold standard approach:
Sensitivity 20.0% (5.7 - 43.7%)* 65.0% (43.3 - 81.9%) 30.0% (14.5 - 51.9%) 50.0% (29.9 - 70.1%)
Specificity 93.1% (91.1 - 94.6%) 86.7% (84.2 - 88.9%) 94.4% (92.7 - 95.8%) 88.4% (86.1 - 90.4%)
AUC 0.70 (0.58 - 0.82) 0.67 (0.52 - 0.82)
* 95% binomial exact confidence intervals are indicated if (estimated value) x (sample size) ≤ 5, otherwise Wilson confidence 
intervals are shown for estimates of the gold standard approach
SICCT
0.80 (0.73 - 0.87)
0.80 (0.71 - 0.88)
 
 
Table 18. Comparison of parameter estimates derived from the Bayesian model considering no gold standard and from a previously 
employed model (also see last chapter) assuming the PCR confirmed infections (positives) and the absence of lesions (negatives) as 
gold standard. 
 
Bayesian ROC estimation of multiple tests for BTB diagnosis in Chadian cattle 
————————————————————————————————————— 
 
Materials and Methods 
Animals 
The animal population subjected to this study has previously been described, in 
detail [59]. A total of 954 slaughter animals were sampled during three intervals of 
approximately one month between July and November 2005 at abattoirs in southern 
Chad. We can assume that the tested animals constitute a representative sample of 
slaughter cattle from a large number of different herds and a big area in southern 
Chad [59]. Presumably, none of the animals has ever undergone tuberculin skin 
testing. Four types of phenotypic zebu breeds were encountered: Arab (N = 658), 
Mbororo (N = 286), Bogolodjé (N = 7) and cross breeds (N = 3). 
 
Physical examination of animals 
All 954 animals were physically examined before slaughter. Body condition was 
assessed by assigning one of the following three scores: 1 – good body condition, 2 
– bad body condition, 3 – very bad body condition [59]. 
 
SICCT 
Valid SICCT testing results were available for 930 animals. SICCT testing and 
reading was carried out as explained previously and according to standard protocols 
[59,163]. 
 
Fluorescence polarization assays 
Valid SENTRY 100 and GENios Pro FPA results were available for 953 and 954 




After slaughter, all 954 animals underwent meat inspection, which included organ 
and lymph node palpation, visual inspection and incision of organs and lymph nodes 
according to standard procedures [240]. However, we were not able to fully exclude 
potential irregularities during the carcass examinations. Meat inspection was done by 




local meat inspectors at the abattoirs in southern Chad. Gross visible lesions were 
detected in altogether 108 of the 954 sampled animals. Lesion containing tissue 
specimens from all visibly affected organs and lymph nodes were collected and 
transported on ice to the Chadian National Veterinary and Animal Husbandry 
Laboratory (Laboratoire de Recherches Vétérinaries et Zootéchniques de Farcha) in 
N’Djaména and stored at -20°C. 
 
Direct microscopy 
Specimens from all 108 animals with lesions were subjected to direct microscopy and 
processed as previously described [43]. After homogenisation, specimens were 
colorized by Ziehl-Neelsen staining and examined under the light-microscope for the 
presence of Acid-Fast Bacilli (AFB). The samples were decontaminated with N-
acetyl-L-cysteine sodium hydroxide (0.5% NALC 2% NaOH) and again examined for 
the presence of AFB under the microscope. If either of the two microscopic 
examinations revealed presence of AFB the result was considered to be positive. 
 
Culture and microscopy 
Specimens of lesions from altogether 102 animals were subjected to culture and 
microscopy. Decontaminated samples were inoculated into two Middlebrook 7H9 
medium flasks containing OADC and PANTA and either glycerol (0.75%) or pyruvate 
(0.6%) [59]. Samples were put into culture until growth was detected or for a 
minimum of 8 weeks. Presence of AFB in cultures was examined by Ziehl-Neelsen 
staining and microscopy [43]. Bacterial growth was detected in cultures of 102 
animals; cultures of 50 animals showed presence of AFB by Ziehl-Neelsen staining. 
 
Real-time PCR 
AFB containing cultures from 50 animals were subjected to molecular 
characterization. Heat inactivation of the cultures was carried out as previously 
explained [59]. Thermolysates were shipped to the Swiss Reference Centre for 
Mycobacteria, DNA was extracted by means of the InstaGeneTM Matrix (Bio-Rad) 
and identification of MTBC and NTM strains was carried out by means of Light 
Cycler® PCR as previously described by Lachnik et al. [241].  
 





A Bayesian model was developed to estimate the true M. bovis infection status of all 
sampled animals. The model combined the results of the continuous as well as the 
binary diagnostic tests for BTB (SICCT, SENTRY 100, GENios Pro, meat inspection, 
direct microscopy, culture and microscopy and PCR), applied to the same animal 
population without considering a gold standard. It also allowed the estimation of the 
true disease prevalence in the sampled population as well as the sensitivities and 
specificities of the diagnostic tests. A mathematical description of the model and the 
WinBUGS code are provided in appendix 4 and 5, respectively. 
 
Risk factors for the modeled M. bovis infection status were identified by univariate 
and multiple logistic regression analysis in Stata (Stata/IC v10.0). Association 
between lesion localisation and modeled M. bovis infection was assessed by the 
Fisher’s exact test in Stata. 
 
Bayesian modeling of disease status  
We assumed that the distribution of the test values of SICCT, SENTRY 100 and 
GENios Pro was trivarite normal with means and variance-covariances separately 
estimated for the diseased and the non-diseased animals. The normality assumption 
was verified via the shape of the histogram of the test values. In an initial model we 
have included the data from the multiple post mortem tests for the detection of 
M. bovis infected animals (meat inspection, direct microscopy, culture and 
microscopy and PCR) and tried to directly model their sensitivities and specificities 
(models 1A and 1B, table 14). Because the parameter estimations for the binary 
post-mortem tests were highly sensitive to the prior assumptions [63,64,245,246,250-
254,257,258], we eventually excluded the respective data from the Bayesian model 
formulation (models 2A and 2B, table 14). In order to estimate the performance of the 
binary tests, we used the modeled latent M. bovis infection status of each animal to 
calculate sensitivities and specificities of the respective tests. Model fit was done in 
the statistical package WinBUGS (Imperial College and Medical Research Council, 
UK). The mathematical description of the model and the WinBUGS code are shown 
in appendix 4 and 5. Real-time PCR was assumed to be 100% specific and animals 
with a positive PCR test outcome were therefore defined as MTBC infected in all 
Bayesian models. 





ROC curve and cut-off selection 
From the estimates of the means and variance-covariances of the multivariate 
normally distributed continuous test values of SICCT, SENTRY 100 and GENios Pro 
for the diseased and non-diseased animals, a ROC curve was calculated in Stata. 
Pairs of 1-specificity and sensitivity were calculated and plotted for all possible cut-off 
points according to the following formula: 
0 1
0 1
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 are the means of the multivariate normal distribution of the test values 
for the non-diseased (d = 0) and the diseased (d = 1) animal population subjected to 








 are the variance of the non-diseased and the diseased animal 
population subjected to test k, respectively. 
 
We considered the point of the ROC plot with the greatest distance from the diagonal 
line (sensitivity = 1 - specificity) as the best cut-off; this corresponds to the point with 
the largest Youden index (J = sensitivity + specificity - 1) [242,243]. In cases where 
several points showed the same distance, the point with the highest sensitivity was 
chosen. For cut-off selection using the misclassification-cost term (MCT), the point 
with the smallest MCT value [MCT = (CFN / CFP) P (1 - Se) + (1 - P) (1 - Sp)] was 
chosen, with CFN and CFP being the cost of false negative and false positive 
diagnosis, respectively and P being the disease prevalence in the target population 
[243]. We were unable to accurately estimate CFN/CFP but the cost of false-negative 
diagnosis is likely to exceed the cost of false positive diagnosis. Therefore, MCT 
values for each possible cut-off point and different ratios of CFN/CFP were calculated 
and compared, assuming a disease prevalence of 8.4%, as estimated by our model. 
In addition, MCT values for different CFN/CFP ratios were calculated for a 10.0% 
disease prevalence. 
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 Part IV 
General discussion and conclusions 
 Considerations for the control and surveillance of bovine tuberculosis in sub-
Saharan Africa 
Abstract 
Livestock producing countries of the developing world bear most of the global burden 
of bovine tuberculosis (BTB). The disease is present virtually in whole of Africa with 
only few countries being able to apply appropriate control measures. Surveillance is 
generally based on slaughterhouse meat inspection but some countries have 
implemented occasional active surveillance in herds by means of the tuberculin skin 
test. However, recent results suggest that the OIE standard cut-off for tuberculin test 
interpretation may not be appropriate for all countries of sub-Saharan Africa. The 
majority of the cattle in Africa are raised in a traditional extensive livestock production 
system. The characteristics of the local cattle husbandry along with economic, 
political and historical factors and the particular natural environment, have to a large 
extend influenced the distribution and prevalence of BTB. Distinct clonal complexes 
of Mycobacterium bovis are localized to different regions of the continent and several 
studies in different parts of the world including Africa suggest that M. bovis was 
originally imported from Europe. There is accumulating evidence for a particular 
involvement of non-tuberculous mycobacteria in lesion formation in African cattle and 
possibly wildlife. These characteristics and the lack of financial resources have 
important implications with regards to BTB surveillance and control. This review 
summarizes our research results on the molecular epidemiology and diagnosis of 
BTB in Africa and discusses our findings in a broader context by considering the 
specific African background. Moreover, on the basis of the currently available 




Bovine tuberculosis (BTB) is caused by Mycobacterium bovis and constitutes an 
economically important disease, primarily affecting cattle. It influences trade and can 
lead to considerable losses in meat and milk production [19]. Moreover, M. bovis 
infections have been detected in wildlife, where the disease can have severe 
consequences for the ecosystem [20,22]. M. bovis is also of public health concern as 
the bacteria can be transmitted to humans most notably through close contact with 




infected animals and consumption of raw milk [23]. BTB is considered a neglected 
zoonosis and closely related to poverty [26]. In Africa, the disease is present on 
virtually the whole continent [5,32,45]; however, only few countries report to apply 
specific control measures [32]. Data on disease prevalence is generally scarce due 
to the lack of disease surveillance schemes and laboratories with the capacity to 
culture and accurately characterize mycobacterial strains. As a matter of fact, many 
laboratories in Africa rely solely on Ziehl-Neelsen staining and microscopy for the 
diagnosis of tuberculosis infections [32]. Consequently, little information on the 
zoonotic transmission of M. bovis exists, and the frequency of M. bovis infections in 
humans may be underestimated [45]. 
Control measures against BTB in Europe have been based on test and slaughter 
strategies. Animals have been tested using the intra-dermal tuberculin skin test; 
nowadays, the Bovigam® test (Prionics) is increasingly used as an ancillary test 
[162]. Positively tested cattle have been subjected to slaughter. In addition, 
movement restrictions have been implemented [194,259] and cattle carcasses have 
been regularly inspected by veterinary officers at abattoirs [260]. Carcasses 
exhibiting gross visible lesions have been fully or partially condemned according to 
the severity and dissemination of the lesions. Moreover, farmers have been 
compensated for the accruing losses. 
In Africa, BTB control in livestock is mostly limited to slaughterhouse meat 
inspections. In some countries occasional tuberculin skin testing of animals from 
intensive dairy farms is performed; however, attempts to evaluate diagnostic tests for 
BTB in naturally infected cattle in Africa are scarce. Moreover, existing control 
measures are often not well implemented and farmers do not receive compensation 
for culled livestock [45]. 
In the this review, the results from our studies on the population structure of M. bovis 
in Africa and the evaluation of multiple diagnostic tests for BTB in African cattle shall 
be recapitulated and discussed in a broader context. Moreover, the specific 
characteristics of BTB in Africa shall be considered to give recommendations for 
possible adapted interventions and control programs. 
 
Ante-mortem diagnosis of bovine tuberculosis 
Control measures against BTB must primarily target the transmission of M. bovis 
within and between the cattle herds; moreover, wildlife populations can serve as 




reservoirs of M. bovis and have been shown to play an important role in some African 
countries [20,79]. Surveillance aims at early detection of infected animals in order to 
interrupt the transmission of pathogens. However, surveillance is highly dependent 
on the diagnostic tests available and different tests may be appropriate in different 
settings. 
 
A new cut-off for the tuberculin skin test in sub-Saharan Africa 
The single intra-dermal comparative cervical tuberculin (SICCT) test is, although 
imperfect, currently the most widely-used method for the diagnosis of BTB [162]. 
Purified protein derivatives of M. bovis cultures (PPD-B) and M. avium cultures (PPD-
A) are intra-dermally injected and increase in skin-fold thickness is measured 72 h 
after. According to OIE guidelines, the test is positive if the difference between the 
increase in skin thickness at the site of PPD-B and PPD-A injection is more than 4 
mm (> 4 mm), inconclusive if between 1 and 4 mm and negative if zero or less [163]. 
However, receiver operating characteristics (ROC) analyses of SICCT testing in 
Chadian cattle suggested that SICCT would perform considerably better if the cut-off 
value was lowered to > 2 mm (see part III of this thesis: Diagnosis of bovine 
tuberculosis in Chadian cattle, [59,60]). The same result was obtained if ROC 
analysis was based on a gold standard definition with confirmed Mycobacterium 
tuberculosis complex (MTBC) infected animals as the positive population and lesion 
negative animals as the negative population or if a Bayesian approach in absence of 
a gold standard was applied [59,60]. In another study in Ethiopian cattle, similar 
results were obtained [65] and in SICCT reactor prevalence studies in Uganda and 
Tanzania, lower cut-offs than the OIE standard cut-off have been used, although 
without detailed justification [33,36]. Standard SICCT cut-offs should be revised for 
sub-Saharan Africa as a cut-off > 2 mm may be more appropriate in many areas of 
the continent with similar environmental and economical conditions. 
 
Searching the right test 
SICCT testing is based on the early Th1 type cell mediated immune (CMI) response 
and detects the allergic reaction to intra-dermally injected M. bovis antigens. 
Bovigam® is another CMI response based test, which detects and quantifies the 
production of IFN-γ in whole blood cultures exposed to bovine and avian tuberculin 
(PPD-B and PPD-A) [162,164]. The Bovigam® test shows some practical advantages 




compared to SICCT as the test does not directly interfere with the host’s immune 
response and does not affect subsequent retesting of the animals; moreover, 
revisiting of the animals for test interpretation is not necessary with Bovigam® 
[162,164]. However, a disadvantage of Bovigam® is the requirement that collected 
blood samples have to be processed relatively quickly after collection and a good 
laboratory infrastructure is needed [162,164]. The necessity of fast processing of 
blood samples for Bovigam® and the need to revisit cattle herds for test evaluation of 
SICCT makes both tests relatively impractical for the testing of often transhumant 
and nomadic herds in rural Africa. 
SICCT and Bovigam® are both based on the CMI response [165]. However, it was 
shown that CMI responses can wane as BTB disease progresses and animals can 
become anergic; this can result in false negative SICCT and Bovigam® test results 
[162]. The problem is exacerbated by a possibly higher infectivity of late stage 
diseased animals, which are thought to shed higher amounts of infectious bacteria 
[165]. In low income countries, where control measures are absent, the predicted 
higher prevalence of such animals might considerably affect disease spread and 
persistence [162,165,168]. Indeed, our evaluation of multiple diagnostic tests for BTB 
indicated that a considerable amount of SICCT anergic M. bovis infected cattle may 
be present in Chad [59,60] and very likely, this is also the case in many other African 
countries.  
While CMI response is waning towards late disease stages, humoral immune 
response is increasing [162,165]. Hence, serological tests, detecting the presence of 
M. bovis specific antibodies might be more appropriate to detect animals at a late 
stage of BTB. We evaluated two distinct fluorescence polarization assays (FPA), 
which were based on the detection of antibodies against MPB70 protein, for disease 
diagnosis in Chadian cattle [59,60]. Although the number of confirmed MTBC 
infected animals was too small to allow any statistically significant conclusion, there 
was no indication that anergic animals were more likely to be detected by FPA (see 
part III of this thesis, [59,60]). 
Our results suggested that SICCT performed generally better than FPA in its current 
form. For the Chadian setting, we have estimated the sensitivity and specificity of 
SICCT at 66% and 89%, respectively, when our suggested cut-off > 2 mm was 
applied [59,60]. This performance is still very unsatisfactory and raises the question 
of which diagnostic test should be used in sub-Saharan Africa. Ideally, the test 




should be highly sensitive, easy to apply and possibly a serological test, which also 
allows the detection of late stage diseased animals. 
We would therefore strongly encourage further research on the development of 
diagnostic tools for the specific identification of SICCT anergic animals. As already 
stated above, there is evidence that animals with more progressive forms of BTB 
may represent the greatest threat for disease spread [165] and our data supports the 
idea that a considerable proportion of such animals may be present in developing 
countries. 
 
Molecular epidemiology of Mycobacterium bovis infections 
Molecular typing of M. bovis strains isolated from cattle at abattoirs has helped us 
elucidate essential characteristics of BTB in Africa and will continue being of great 
importance for the surveillance of M. bovis infections. The sampling- and typing 
strategies for M. bovis genotyping shall therefore be discussed at this point prior to 
review some of the results that have been obtained from such investigations. 
 
Sampling 
The effectiveness of disease surveillance is highly dependent on the applied 
sampling framework. Surveys on the molecular epidemiology of M. bovis infections in 
cattle in Africa have mostly been based on sampling schemes targeting one or few 
major abattoirs of the country [43,47,52,61,69,261]. I shall therefore discuss the 
appropriateness of such an approach in order to assess the regional bacterial 
population structure of M. bovis. 
Livestock production constitutes the main agricultural output in the arid and semi-arid 
zones of East- and West Africa [28]. Cattle from these areas are generally kept in 
traditional extensive farming systems, which focus on milk production and herd 
growth (A. Shaw, pers. comm.). Moreover, livestock production in the arid and semi-
arid zones of Africa is often characterized by nomadic or transhumant herd 
movements [28]. The situation differs in other areas of Africa. E.g., in our studies at 
Algiers and Blida abattoir in Algeria, mostly exotic breeds, generally used for 
intensive dairy farming, were encountered [261]. However, a common trait of both 
livestock production systems is their focus on milk production and the fact that only 
few animals are sold from the same herds at the same time. Moreover, in many 
cases, the animals are at first sold to different traders, which in turn sell on the 




animals to different butchers (N. Sahraoui and B.N.R. Ngandolo, pers. comm.; 
[47,59,261]). It may be in part due to this, but also due to the frequent transhumant 
livestock movements, that many of the cattle encountered at abattoirs in Africa can 
originate from a very distant area from the abattoir. Transhumance may play a minor 
role in Algeria, nevertheless it has been stated that some of the animals encountered 
at the abattoir of Algiers originated from an approximately 300 km distant region 
around Sétif (N. Sahraoui, pers. comm.). Taken together, the small number of 
animals sold from the same herd at the same time, the multiple selling-on of animals 
through traders and the long distance cattle movements result in an efficient 
intermixing of animals from different origins and herds at the abattoirs. Thus, we can 
assume that the sampling from large slaughter houses constitutes an efficient 
strategy to obtain a random sample of cattle from many herds and an extensive area. 
However, for the same reasons and because of poor documentation of cattle trade in 
most African countries, the actual origin of the individual animals cannot be traced. 
Consequently, molecular epidemiological studies on M. bovis strains isolated from 
slaughter cattle at abattoirs are clearly not suitable for the investigation of the 
geographical distribution of M. bovis genotypes. Sampling from abattoirs may also be 
biased as the considerable amount of animals subjected to private slaughter is 
missed. It is important to emphasize that the sampling from a single abattoir will not 
be sufficient to assess the country-wide bacterial population structure but it may help, 
in the best case, to detect the most frequent genotypes of M. bovis for an extensive 
area. Short sampling periods may constitute another problem for the full assessment 
of circulating M. bovis strains. We performed two slaughterhouse surveys in Chad, 
one at N’Djaména abattoir between 2002 and 2004 and the second in 2005 at Sarh 
abattoir, located approximately 500 km from N’Djaména [43,59]. Of altogether nine 
spoligotype patterns detected in M. bovis strains from Sarh, five were also present in 
strains from N’Djaména (appendix 3, [262]). The three most common types in Sarh 
were also the three most common types in N’Djaména. However, four of nine 
spoligotype patterns from Sarh and seven of twelve spoligotype patterns from 
N’Djaména were not detected in strains from the other study site. Based on our 
results we can conclude, that short period slaughterhouse surveys may give 
satisfactory results for a first identification of the most prominent M. bovis strains 
circulating in a given area, provided that the slaughterhouse cattle population is likely 
to originate from many herds and a large area. However, molecular epidemiological 




studies assessing the geographical distribution of M. bovis strains in Africa would 
gain enormous information if animals could be traced back by e.g. sale or transport 
certificates, transferred from the animal owner, via all intermediaries to the abattoir. 
 
Meat inspection and culture 
Obviously, the correct and systematic execution of the meat inspection at abattoirs is 
crucial for effective post-mortem surveillance of BTB. However, it goes beyond the 
scope of this review to discuss the inspection procedures and I shall therefore refer 
to the specific technical literature that has been published on this subject [240]. The 
same applies to the protocols for mycobacterial culture for which extensive literature 
is available [263]. In a project funded by the Wellcome Trust Livestock for Life 
Initiative we have established an African BTB network of veterinary authorities and 
research representatives from a number of African countries. We have recently 
started to compile standard operating procedures for mycobacterial culture and 
genotyping for this network. The respective protocols shall be made freely available 
in the near future through the network website (http://www.africa-btb.net/). 
 
Molecular typing 
Molecular techniques have replaced the laborious and often erroneous [13,264] 
biochemical methods for the identification and differentiation of MTBC strains in 
industrialized countries. Although, biochemical tests are still used in diagnostic 
laboratories of developing countries, the establishment of molecular techniques in 
these laboratories is essential. Despite enabling the much faster and unambiguous 
identification of MTBC strains, they are indispensable for the investigation of the 
molecular epidemiology of tuberculosis infections. The use of different typing 
techniques for MTBC has been extensively reviewed [17,125-128]. One of the major 
activities within our Wellcome Trust funded African BTB network is devoted to the 
training of laboratory staff in molecular methods for the diagnosis and the molecular 
epidemiology of M. bovis infections. Within this network, we aim at establishing 
simple PCR based techniques for the identification and differentiation of 
Mycobacterium spp. and MTBC in various African laboratories [14,145,265]. 
Moreover, we are assisting the establishment of spoligotyping [53] and VNTR typing 
[1,142] as means for molecular epidemiological investigations. 




Spoligotyping has been our method of choice for an initial assessment of M. bovis 
strain diversities in population surveys and for the identification of possible strain 
families [135,183,184]. Importantly, the construction of extensive spoligotype pattern 
databases (www.Mbovis.org, [136]) has facilitated the comparison of results from 
different countries and helps elucidate the distribution and spread of strains. VNTR 
typing is another simple method for M. bovis genotyping with a higher discriminatory 
power than spoligotyping [1,142]. However, international databases are presently not 
available and the method has not yet been standardized. This may be in part due to 
the observation that distinct loci appear to show a suitable discriminatory power in 
different countries. This can be demonstrated by our following observation: We 
subjected 88 M. bovis strains isolated from Algerian cattle to VNTR analysis targeting 
ETR loci A-E [138,261] and MIRU 26 and 27 ([139]; unpublished results). High 
discriminatory power of VNTR loci defined by a calculated allelic diversity > 0.25 
[142] was obtained for ETR loci A, B, C and MIRU 27. In our previous study on 
M. bovis strains from Chad, in addition to these loci MIRU 26 was also highly 
discriminative [142]. Strains isolated from Belgian and Irish cattle also showed a high 
allelic diversity for MIRU 26 but low diversity for ETR C. Moreover, MIRU 27 did not 
show any discriminatory capacity in strains from Ireland [131,266]. 
An important even though infrequently observed drawback of spoligotyping and 
VNTR typing is the occurrence of homoplasy, that is, the presence of identical typing 
patterns in unrelated strains [1]. E.g., a very frequent ETR A-F pattern (7 5 5 4* 3 3.1) 
of strains from Mali belonging to the provisionally named Af5 clonal complex was 
identical to the pattern of strains isolated from Chadian cattle and belonging to the 
distinct Af1 clonal complex (appendix 3, [262]). Homoplastic markers are less 
appropriate for phylogenetic analyses and LSP and SNP analyses have turned out to 
be more powerful tools for the elucidation of the deep phylogeny and identification of 
clonal complexes of MTBC strains [1,144]. 
 
Population structure of Mycobacterium bovis in Africa 
Clonal complexes 
We have identified a clonal complex of strains of M. bovis present at high frequency 
in cattle from Central-West Africa and we named this group of strains the African 1 
(Af1) clonal complex [262]. Moreover, we showed that sub-populations of Af1 are 
geographically localized to different countries. These findings have been discussed 




previously [262]; however, here, some aspects of particular importance for BTB 
control in Africa shall be highlighted. 
The large spread of Af1 may be explained by the common long distance transhumant 
livestock production system in Africa. However, geographical localization of M. bovis 
sub-populations, identifiable through VNTR typing, suggests that trans-border 
movements of cattle have played a relatively minor role in shaping the present 
M. bovis population structure in the different West African countries. This suggests 
that BTB control could to some extend be accomplished without the collaboration of 
neighboring countries. This was not expected and is as such an important finding. 
However, the role of trans-border cattle migrations for the persistence of BTB may 
increase once national intervention campaigns would have achieved to reduce the 
country-wide disease prevalence. This is especially the case if neighboring countries 
do not apply BTB control measures. In this respect, it is nevertheless worthwhile to 
aim at coordinated control measures in the whole region delimited by the Af1 clonal 
complex. Importantly, our results also highlight the value of establishing molecular 
techniques such as spoligotyping and VNTR typing in order to monitor the 
importation of extra-national strains. 
Our findings and recent work performed at VLA, UK, suggest the presence of other 
clonal complexes in other parts of Africa. In Mali, the presence of two distinct clonal 
groups has been identified (Af1 and provisionally named Af5; figure 4; figure 10). We 
have recently conducted a molecular characterization of strains of M. bovis isolated 
from slaughter cattle at Morogoro abattoir in Tanzania. Our preliminary results also 
suggested the presence of at least two clonal complexes in Tanzania (figure 11). 
One group of strains lacking spacers 3-7 (provisionally named Af2) was similar to 
strains isolated from Ethiopian [66], Ugandan [69] and Burundian (unpublished work 
at VLA, UK) cattle (figure 10; figure 11). Spoligotype patterns of the second group 
characteristically lacked spacers 5, 11 and 12. Absence of spacers 5 and 11 was 
also frequent in strains isolated from cattle in South Africa [86] and unpublished work 
at VLA suggests a link of this group of strains (provisionally named Eu1) to strains 
from UK cattle. Possibly, a third clonal complex exists in Tanzania (Af4) but this 
supposition needs to be verified. However, in summary our results indicate that 
strains from Tanzanian cattle lacking spacers 5 and 11 are linked to strains from 
South Africa (Eu1) and strains lacking spacers 3-7 are linked to strains from Uganda, 
Burundi and Ethiopia (Af2; figure 10). 

























Figure 10. The preliminarily identified clonal complexes in Africa. Strains of Af1 have 
been found in Cameroon, Chad, Mali and Nigeria. Af2 is present in Ethiopia, Uganda, 
Burundi and Tanzania. Af3 is present in Madagascar. Based on work done at VLA, 
another clonal complex, named Af4, is thought to be present in Tanzania. Strains of 
Af5 have been isolated from cattle in Mali and Senegal. Eu1 is present in the UK, 
South Africa and Tanzania. A first survey of M. bovis strains from Algeria could not 
identify strains from any of the 6 clonal complexes Af1-5 and Eu1. However, strains 
from Algerian cattle show a close link to strains from continental Europe. The smaller 













Figure 11: Spoligotypes and VNTR typing patterns of M. bovis strains isolated from slaughter cattle at Morogoro abattoir in Tanzania. 
Spacers 39-43 were absent from all spoligotype patterns. SB numbers were taken from www.Mbovis.org. Pattern TANZANIA1 is not 
reported in www.Mbovis.org. VNTR typing targeted loci ETR A – E [138]. 
 
 
Considerations for the control and surveillance of BTB in sub-Saharan Africa 
————————————————————————————————————— 
Strains of Eu1 have not been observed in Uganda, Burundi or Ethiopia although, 
through Af2, a link between Tanzania and these countries exists. Likewise, Af2 
strains have not been detected in South Africa. Af5 strains, although detected in Mali, 
have not been detected in Nigeria, Chad or Cameroon although, through Af1, a link 
between these countries and Mali exists. This indicates, that the spread of the four 
clonal complexes Af1, Af2, Af5, Eu1 may still be continuing. Alternatively, either of 
the clonal complexes may be replaced by the other more recently emerged group, 
potentially possessing a selective advantage. However, factors related to livestock 
distribution and animal husbandry very likely also play an important role with regards 
to the spreading of the distinct clonal groups. The cattle population density in Africa is 
concentrated in several areas, which are approximately matching the distribution of 
the clonal complexes of M. bovis strains (figure 10, [28,267]). Important factors 
influencing livestock distribution in Africa are the cultural value of the animals, 
availability of food and water and the presence of acute and fatal animal diseases 
like contagious bovine pleuro-pneumonia (CBPP), rinderpest (although almost 
completely eliminated), east coast fever and livestock trypanosomiasis [267]. 
Assuming that environmental conditions have largely influenced the limits of spread 
for different clonal groups of M. bovis, one would expect similar distributions for other 
cattle diseases in Africa. A recent survey on the global genetic population structure of 
Bacillus anthracis revealed the presence of 12 distinct clonal groups throughout the 
world [268]. Interestingly, strains from Tanzania and South Africa belonged to the 
same group but strains from Ethiopia were distinct. Moreover, Maho et al., reported a 
new genotype of B. anthracis strains in Chad, which was not detected in South and 
East African countries [269]. It is conceivable that environmental factors have 
contributed in shaping the molecular population structure of M. bovis in Africa and 
that the same factors could have influenced the distribution of genotypes of other 
cattle pathogens. 
 
Where did Mycobacterium bovis come from? 
The predominance of only few clonal groups in Africa could be explained by a 
selective advantage of these strains. In fact, if Chad, Nigeria and Cameroon had had 
a prior population of M. bovis that was replaced by the Af1 clone it would be difficult 
to explain, without invoking selection, how Af1 went nearly to fixation in three 
countries. 




Alternatively, the predominance of Af1 in West Africa and the other clonal complexes 
in other parts of Africa could be explained by the importation of M. bovis from outside 
Africa and the previous absence of M. bovis on the continent. Thus, clonal expansion 
of the different complexes could be a result of geographical opportunity. Furthermore, 
the observation that strains belonging to the same clonal complexes went nearly to 
fixation in a number of countries could be due to genetic drift [262]. Indeed, evidence 
for a French origin of Af1 strains in Cameroon has been discussed by Njanpop-
Lafourcade et al., [61] and indications that M. bovis has been imported from France 
(or more generally continental Europe) to Mali and Algeria have been discussed 
previously (see part II of this thesis: Molecular epidemiology of Mycobacterium bovis 
infections in Africa, [47,261,262]). Likewise, spoligotype patterns similar to patterns of 
strains from the UK have been found in countries with traditional links to the UK such 
as Ireland [134], Australia, [195] and Argentina [196]. In fact, it would be relatively 
easy to propose a link between most of the strains found outside Europe and strains 
of continental Europe or the UK based on the similarities of the spoligotype patterns. 
E.g., M. bovis isolated from cattle from Brazil [270], Iran [195], the French West 
Indies and Tunisia [179] show spoligotype patterns identical or similar to patterns 
from continental European strains and patterns of strains from Madagascar [88] 
could be derived from European patterns by only one or two spacer deletion events. 
Exportation of M. bovis from Europe to Africa and other continents could be 
explained by close trade links, especially during the colonial periods [61]. M. bovis 
has only been reported in Africa at the beginning of the 20th century [271] and in line 
with these considerations, Meyers and Steele (1969) suggested that M. bovis has 
emerged in Europe and has spread from northern Italy to western Europe and the 
UK. According to Webb (1936), M. bovis was then scattered throughout the world 
through exportation of infected cattle from mainly the UK and the Netherlands to their 
former colonies [20]. However, these thoughts are still speculative and the 
evolutionary relationship between European and other strains of M. bovis may not be 
disclosed before sequencing of a number of strains from in and outside Europe allow 
in-depth genome analyses and the construction of comprehensive phylogenetic 
trees. 
 




Characteristics of bovine tuberculosis in Africa 
Owing to the lack of BTB control schemes and the distinctive livestock production 
system in most of sub-Saharan Africa, BTB exhibits particular characteristics, which 
may be uncommon in other regions and which need to be considered for the 
development of intervention strategies. Some of the specific problems of BTB in 
Africa have been discussed previously [5,32,45]; however, our and other recent 
studies revealed new insights into the epidemiology of BTB and are of importance for 
disease control. 
 
Importance of non-tuberculous mycobacteria 
There is accumulating evidence that non-tuberculous mycobacteria (NTM) infections 
may be responsible for a considerable amount of lesions found in cattle carcasses 
during standard meat inspection at abattoirs in sub-Saharan Africa. 
In previous studies in Chad [58], Uganda [69], Ethiopia [67] and the Sudan [62], a 
high proportion of NTM strains has been isolated from cattle carcasses exhibiting 
gross visible lesions. In Chad and Sudan, especially NTM strains of the closely 
related taxa M. fortuitum and M. farcinogenes were frequently extracted from cattle 
lesions. Bayesian modeling of the M. bovis infection status of slaughter cattle 
sampled at the Sarh abattoir in southern Chad allowed us to estimate the proportion 
of animals with lesions caused by other bacteria than M. bovis at more than 70% 
[60]. From one third of the animals confirmed to be infected with Mycobacterium spp., 
NTM were isolated without any apparent co-infecting strains of M. bovis [60]. This 
could indicate that some of the lesions may have been caused by NTM. Noteworthy, 
prior to our studies on BTB in Chad, it was believed that bovine farcy caused by 
M. farcinogenes, was the primary agent responsible for lesions detected in Chadian 
cattle carcasses (C. Diguimbaye-Djaïbe, PhD thesis). However, in addition, other 
pathogens than Mycobacterium spp. may have been responsible for some of the 
lesions found in slaughter cattle from southern Chad. Interestingly, our Bayesian 
analysis revealed that modeled M. bovis infection was only associated with organ 
lesions but not with lymph node lesions (table 17, [60]). This could indicate that other 
pathogens than MTBC strains may have in particular accounted for lesions detected 
in the lymph node tissues. Similarly, our study at the Bamako abattoir in Mali 
provided evidence that M. bovis was primarily associated with the presence of lung 
lesions and that other pathogens may have accounted for lesion formation in organs 




outside the lung [47]. Preliminary surveys in wildlife populations from Tanzania and 
Ethiopia (unpublished results) also suggested a high prevalence of NTM infections. 
However, isolation of NTM species from animals exhibiting lesions during 
slaughterhouse meat inspection is rare in France (M. Boschiroli, per. comm.) and 
was uncommon in our study in Algeria [261]. Altogether, these results suggest a 
particular involvement of other bacteria than M. bovis and in particular NTM strains in 
lesion formation in cattle of sub-Saharan Africa. 
Exposure to NTM strains has been implicated in the induction of a low-level 
protection from M. bovis infection [272] but can also cause interferences in disease 
diagnosis [272-274] and affect the BCG protection efficacy [275] due to certain cross 
reacting antigens. The possible high frequency of NTM infections in cattle of sub-
Saharan Africa is therefore of considerable relevance with regards to BTB 
surveillance and intervention programs. 
 
Late stage diseased animals 
The importance of SICCT anergic and late stage diseased animals with regards to 
diagnosis of BTB has been discussed before. A high frequency of SICCT anergic 
animals in Africa could be explained by the absence of control measures and by the 
locally predominant livestock production system. Because of the focus on milk 
production, mainly young males and old cows are slaughtered. Older cows are only 
slaughtered when milk production decreases or when the animals become too weak 
to continue herd migration. Therefore, in absence of any regular BTB control 
schemes, disease can progress without restraint. Also, because late stage diseased 
animals are thought to be more infective [165], old cows are likely to contribute more 
to disease spread than younger animals. 
Interestingly, in our study in Chad, the mean age of the male cattle encountered at 
the abattoir of Sarh was rather low (3.4 years; CI: 3.1 – 3.6 years) although 
comparable with the situation in other livestock systems in West Africa [276]. The 
selling of relatively young males may indicate herd de-stocking, because of poor 
grazing in this area or other problems (A. Shaw, pers. comm.). 
 
Transmission 
The primary site of M. bovis infection in cattle is the respiratory tract; this is also 
reflected by the predominant occurrence of lesions in the lung and associated lymph 




nodes. M. bovis is therefore mainly transmitted by inhalation of infectious aerosol 
droplets. In intensive (“landless” [28]) livestock production systems, the close contact 
of animals in a confined area promotes transmission of the infectious agent; BTB 
prevalence rates are therefore generally higher in intensive farming systems than in 
extensive free-range production systems [5,31,32,93]. In our study at Bamako 
abattoir in Mali, the apparent lesion prevalence was 1.8% [47] and significantly lower 
than the SICCT reactor prevalence previously measured in 36 cattle herds from the 
peri-urban region of Bamako (18.6%; [46]). One explanation for this discrepancy 
could be a high abundance of early stage infected animals, which do not show visible 
lesions. However, given the fact that an extensive amount of animals encountered at 
the abattoir of Bamako originated from the pastoral area, a more likely explanation is 
the lower prevalence of BTB in these animals compared to animals from the peri-
urban region of Bamako. 
In transhumant and nomadic livestock production systems, disease transmission is 
thought to occur at places where close contact of animals is frequent, such as water 
points. In Africa, grazing animals usually gather at night for protection from predators; 
moreover, during daytime, they often assemble under trees or other shaded areas 
[5]. A recent study from Ethiopia reported a distinct lesion distribution in cattle grazing 
outside in pastures compared to cattle kept indoors [31]. Mesenteric lymph nodes 
were significantly more often affected in cattle that were kept outdoors, indicating that 
pathogen ingestion may be an important transmission route in pastoral animals [31]. 
In this respect, it may be conceivable that pasture gets contaminated through e.g. 
fecal excretion of M. bovis. Moreover, it has been shown that M. bovis can survive in 
feces for up to four weeks [277]. An important route of transmission however, may 
also be the very early infection of suckling calves with M. bovis infected milk. In our 
study in southern Chad, a high proportion of young animals reacted positively to 
SICCT and the mammary lymph nodes were the second most affected tissues with 
lesions (table 9). Young animals may remain latently infected until they become 
themselves lactating and develop active tuberculosis. An emerging working 
hypothesis could be that under extensive pastoral conditions animal to animal 
transmission may take place to a high extend by the ingestion of infected milk and 
less by environmental contamination and aerosol transmission. 
Customs or cultural practices can also influence the transmission of M. bovis in 
cattle. E.g., in Chad, animals are often exposed to smoke from fire places in order to 




protect the cattle from mosquito bites. However, smoke can affect the nasal mucosa 
of the animals, rendering them more susceptible to infection with airborne infectious 
aerosol.  
 
Influence of host genetics 
The influence of host genetics on tuberculosis disease is currently extensively 
investigated for human tuberculosis. Some host gene polymorphisms have been 
associated with the development of diseases such as polymorphisms in the solute 
carrier family 11, member 1 (SLC11A1, formerly NRAMP1) [278,279] and recent 
findings suggest a variable host-pathogen compatibility of distinct human ethnic 
groups and different strains of M. tuberculosis [150]. 
There is evidence for a differential susceptibility to tuberculosis between exotic and 
local cattle breeds in Africa [32]. E.g., in a recent study in Ethiopia, BTB prevalence 
in exotic Holstein cattle was significantly higher than in zebu or cross-breeds [41]. 
Unpublished results from our study in Algeria also suggested a higher prevalence of 
M. bovis infections in exotic animals compared to indigenous animals and cross-
breeds. But differences in susceptibility may also exist between different local zebu 
breeds. In Chad, prevalence of gross visible lesions and BTB was significantly higher 
in Mbororo than in Arab zebu breeds [43,59]. However, Bayesian modeling of the 
infection status of slaughter cattle from southern Chad could not show any evidence 
that modeled M. bovis infection was significantly associated with breed [60]. 
Altogether, this could suggest that Mbororo breeds may in fact not more likely 
become infected with M. bovis but more often develop advanced stages of the 
disease [60]. 
However, it is a difficulty to prove that observed discrepancies in disease prevalence 
are due to inherent genetic factors of different cattle breeds. Instead, the observation 
could be confounded by a differential breed specific animal husbandry or by 
environmental influences. In our study in Chad, although Arab and Mbororo cattle 
have been frequently intermixed in the same herds regardless of the cattle owners’ 
ethnicity, we have observed a significantly different sex ratio between the two breeds 
at the abattoirs [59]. This could indicate different livestock management strategies for 
different breeds. At the shore of lake Chad, Mbororo animals were observed to be 
more closely situated to the water than Arab breeds. Although highly speculative, this 
could e.g. expose Mbororo animals more often to waterborne parasitic diseases (e.g. 




Fasciola spp.), which in turn could enhance their susceptibility to BTB. Interestingly, 
despite distinct phenotypic characteristics, analysis of the genetic relatedness of both 
breeds using a set of 21 microsatellite loci could not reveal any significant difference 
between Mbororo and Arab cattle (appendix 1). 
Identification of BTB resistant breeds or cattle husbandry practices that may account 
for increased susceptibility to BTB would be of great value. Therefore, further 
research on the influence of host genetic factors as well as animal husbandry 
practices of different ethnic groups of pastoralists, is highly needed to identify drivers 
of susceptibility in BTB. Moreover, differential susceptibility in animal diseases in 
Africa should always be considered from the reality of multi parasitism. 
 
Implications for bovine tuberculosis control in Africa 
The particular characteristics of BTB in sub-Saharan Africa must be taken into 
account for considering potential control options. Due to several factors, and above 
all the general lack of financial resources, conventional test and slaughter schemes 
may not be feasible or ill suited for Africa. Therefore, new approaches for BTB control 
should be considered. 
From a public health perspective, the first priority with regards to BTB control is the 
prevention of zoonotic transmission of M. bovis from animals to humans. Next, the 
control of the disease in cattle needs to be addressed. BTB is primarily of economic 
concern and infections in domestic cattle may account for the majority of the disease 
burden. Finally, M. bovis infections have to be controlled in wildlife populations. 
Although the importance of wildlife infections in Africa has not yet been sufficiently 
investigated, it is well-known that wildlife reservoirs can pose great difficulties to BTB 
eradication programs [20,22]. Moreover, infections in wildlife can have considerable 
consequences for the ecosystem, which are difficult to predict and can indirectly 
affect many areas of private and economic interest. 
 
Prevention of zoonotic transmission 
Although eradication of BTB in cattle will also decrease the prevalence of M. bovis 
infections in humans, transmission may be more directly and cost-effectively 
prevented by implementation of regular milk pasteurization schemes. In the USA and 
probably in most other industrialized countries, the public health benefits obtained 
from BTB control programs were primarily a result of milk pasteurization and to a 




lesser extend due to the eradication of BTB in cattle [89]. Abattoir meat inspections 
can play another important role for the prevention of zoonotic M. bovis transmission if 
consumption of raw or undercooked meat is practiced. In Africa, implementation of 
both control measures could be relatively easy and inexpensive. Importantly, such 
interventions would not only target M. bovis infections but also transmission of other 
zoonotic diseases such as Brucellosis and Q-fever. Moreover, in light of the high 
frequency of NTM infections detected in lesioned cattle of sub-Saharan Africa, other 
Mycobacterium spp. might pose a considerable health threat to humans and 
contaminated beef can be efficiently removed through abattoir meat inspections. 
Although meat inspection is theoretically enforced in many countries, it is often not 
correctly accomplished and poorly implemented in rural areas. Losses from meat 
confiscations can generally not be refunded by the government. This situation 
promotes fraud and (illegal) private slaughter of animals. To overcome this problem, 
community funds could be established and financed by meat traders whose animals 
are subjected to meat inspection. Compensations for cattle condemnations could 
then be disbursed from these funds. 
Interventions promoting milk pasteurization and meat inspection should specifically 
target remote areas where the population appears to be most frequently affected by 
zoonotic diseases [26]. However, it may be particularly difficult to eliminate the 
problem of private slaughter in rural settings. Also, implementation of pasteurization 
schemes may not be a trivial task as wood is often scarce and a precious resource, 
especially in arid zones. To overcome this problem it may be possible to concentrate 
milk pasteurization at specific points. The establishment of a dairy cooperative in the 
peri-urban region of Bamako where milk from small scale producers was pooled and 
pasteurized proved to cost-effectively promote the production of healthy dairy 
products (www.laitsain.com; [280]). However, in rural areas and pastoralist 
communities, close contact between humans and animals may pose another 
important risk factor for zoonotic transmission of M. bovis. In this respect, the 
promotion of public awareness would be most crucial to prevent the zoonotic 
transmission of M. bovis. 
 
Bovine tuberculosis control in cattle 
Implementation of control schemes for BTB in African cattle is a major challenge, 
starting with the difficulty of disease surveillance in livestock. A major problem is the 




lack of adequate diagnostic tests. Despite a number of drawbacks, SICCT is still the 
most frequently used test for ante-mortem diagnosis of BTB in Africa and to date, no 
satisfactory serological tests exist, which would allow the detection of M. bovis 
infected but SICCT anergic animals. Our finding of the better performance of SICCT 
in Chad and probably many other countries of sub-Saharan Africa if the cut-off for 
positive test interpretation is lowered to > 2 mm is therefore of high practical 
relevance [59,60]. A lowered cut-off will increase the test sensitivity, albeit at the cost 
of a decreased specificity. However, in view of the economic consequences of BTB 
in Africa we believe that the cost of a false-negative test outcome exceeds the cost of 
a false positive outcome by several folds [59,60]. Therefore, a high sensitivity of a 
diagnostic test to detect more of the infected cattle may be more important than a 
high specificity. 
As mentioned previously, post mortem examination at abattoirs are primarily of 
importance from a food-safety perspective. Identification of the origin of animals 
exhibiting gross visible lesions is currently not possible in Africa, due to poor 
documentation. However, tracing of herd origin could be achieved e.g., by 
earmarking animals in the herds, by the establishment of sale or transport certificates 
and by the construction of databases of known herds and their location. It may be 
particularly difficult to get reliable information on the latter for moving populations 
although transhumant herds usually migrate along reasonably well defined routes 
[222]. Such a system would allow a detailed nation-wide surveillance of BTB and 
relatively rapid and targeted actions in regions and herds with high disease 
prevalence. It could thus effectively complement ante-mortem surveillance programs 
in cattle herds. 
It has been shown that joint human- and animal health interventions in remote areas 
of Africa were significantly more successful than independent delivery of health 
services; this in terms of both, the total amount of individuals who received treatment 
as well as the cost-effectiveness of the intervention programs [281]. 
Similarly, delivery of public health services, campaigns to raise awareness for the risk 
factors of zoonotic disease transmission, livestock vaccination programs, cattle 
marking, the construction of herd specific databases and possibly ante-mortem 
testing of animals in herds could be conducted in a combined manner. To further 
reduce costs, diagnostic testing of cattle could target specific risk groups such as old 
cows. Importantly, such health interventions should also aim at improving the 




relationship between governmental institutions and the pastoralist communities as 
they are so far to a large extend excluded from many social services. Still, their 
contribution to the national economy is extensive and may be considerably 
increasing in the future, especially in view of the rapid population growth in Africa and 
the resulting larger demand for dairy products and meat. Finally, extensive livestock 
production systems also represent a method to fight the problem of BTB in Africa as 
they generally show a lower prevalence of the disease compared to intensive 
production systems. This also includes the keeping of local or cross breeds, which 
may be less susceptible to BTB than exotic breeds. 
As outlined before, establishment of laboratories for regular molecular typing of 
MTBC strains would be of great value for BTB surveillance in Africa. Connecting 
molecular epidemiology and herd tracing as it was explained above could further 
enhance the power of molecular epidemiological investigations. The nation-wide 
population structure and distribution of M. bovis strains could be resolved. That is, 
the potential association of specific geographical regions within a country and 
bacterial genotypes could be investigated. Our molecular typing results on the Af1 
clonal complex revealed the geographical localization on a country level of strains of 
M. bovis in West Africa; however, the same may be true on a more regional scale. 
Molecular epidemiology could also allow the detection of temporal changes within the 
population structure of M. bovis; this includes e.g. movements of bacterial clones 
from one region to another or changes within the population structure during 
interventions campaigns. Most importantly however, regular molecular typing of 
strains of M. bovis isolated from cattle carcasses at abattoirs and the possibility to 
trace the origin of the animals would allow the early detection of disease outbreaks, 
their localization and the identification of the specific strains involved. 
The geographical localization of strains of M. bovis within the Af1 clonal complex [60] 
suggests that BTB control programs in their initial phase can be implemented on a 
national level without consideration of neighboring countries. However, the large 
spread of distinct clonal complexes of M. bovis in Africa highlights that cross border 
movements of cattle could become important at later stages of BTB control 
campaigns when disease prevalence is decreasing. In this respect, the establishment 
of concerted disease control schemes for all countries that are affected by the same 
clonal groups of M. bovis may be most effective. The recently founded BTB network 
in Africa could play an important role to coordinate such interventions. It can also 




help to raise awareness for the problem of BTB in governmental institutions and help 
to efficiently share the available resources for BTB control. 
Molecular typing results indicated that several European countries may have actually 
exported BTB to Africa, presumably during the colonial period. This raises the 
question to what extend these countries should contribute in helping to fight the 
disease in Africa. This is especially important in view of the financial obstacles that 
hinder the implementation of control programs. But solid evidence for a European 
source of M. bovis in Africa requires further genomic analysis. 
 
Control in wildlife 
Our knowledge about the importance of M. bovis infections in wildlife in Africa is 
limited. The disease could have considerable consequences for the wildlife 
populations and the entire ecosystem. Moreover, it could pose an important threat to 
disease eradication programs in livestock as it is the case in the UK, Ireland and New 
Zealand [39,95,96] 
In Africa, contact between wildlife and livestock is difficult to control. In sedentary 
livestock production systems, it could be prevented using e.g. perimeter fences but 
occasional direct contacts or contact between infectious wildlife excreta and cattle is 
almost unavoidable in extensive transhumant livestock production systems. Direct 
interventions in wildlife populations e.g. through test and slaughter schemes seem to 
be difficult to accomplish [20]. Moreover, assuming a relatively low transmission rate 
between wildlife and livestock, the intervention expenses may be exceedingly high 
and disproportional to the revenues for the livestock sector. In such a scenario, 
vaccination of wildlife and/or livestock may be the most cost-effective intervention. 
However, administration of vaccines to wildlife populations might be very difficult and 
as mentioned previously, the currently available vaccines are not satisfactorily 
efficient [282]. Moreover, vaccinated and infected cattle cannot be distinguished 
using the presently available diagnostic tests. Research into the development of new 
vaccines and diagnostic tests therefore needs to be highly coordinated in order to 
allow a differential diagnosis for uninfected, infected and vaccinated individuals 
[155,282]. A major strategy for vaccine development is the improvement of the 
protective efficacy of BCG by boosting it with a second subunit vaccine, consisting of 
a cocktail of multiple antigens or a fusion protein [282,283]. It is improbable that a 
similar strategy would be usable for the vaccination of cattle or wildlife in Africa, 




considering the difficulties to retrieve a specific cattle herd, let alone an individual wild 
animal. A more suitable approach for domestic cattle in Africa may be neonatal 
vaccination. BCG vaccination of 1-day-old calves was shown to induce significant 
protection against M. bovis challenge in several studies [7,178]. Neonatal vaccination 
may be especially useful in African settings as it can circumvent potential problems 
associated with the exposure to environmental NTM [7]. 
 
Recommendations for future research 
In many countries and specifically rural areas of Africa, still not much is known about 
the prevalence of BTB. Baseline studies, assessing the SICCT reactor prevalence in 
the herds would be highly needed. Such surveys should ideally be conducted in a 
coordinated manner, investigating both, animal reactor prevalence and human 
exposure to tuberculosis.  
Current research into the development of new diagnostic tests, mainly aims at 
increasing test sensitivities for the detection of animals at very early infection stages. 
However, considering the characteristics of BTB in Africa and other developing 
countries and in order to most effectively target the major global burden of BTB, 
future research should also aim at developing serological tests, which allow the 
identification of anergic animals. 
Most of the molecular epidemiological investigations in Africa so far only included few 
slaughterhouses in a country. New studies should survey several locations; 
moreover, tracing of the herd of origin would allow investigating the distribution of 
M. bovis strains inside a country. This approach would be most useful if implemented 
within a regular slaughterhouse surveillance scheme. 
In addition, it would be particularly interesting to specifically investigate the strains 
and prevalence of BTB in cattle submitted to private slaughter compared to cattle 
sent to abattoirs. 
To elucidate the global phylogeny of M bovis it would be necessary to sequence the 
genomes of different, distantly related strains of M. bovis. Our method of identifying 
clonal complexes offers an approach to recognize distinct clades throughout the 
world; representatives of each clade could then be selected for genome sequencing. 
Comparison of the sequence data would then allow the identification of SNPs, which 
could be used to reconstruct the phylogeny and to clarify the origin of M. bovis. 




From our work and other studies, the importance of NTM infections in African cattle 
has become evident. It still remains to be proven that NTM can be a primary lesion 
causing agent. Artificial infections in animal models or in cattle could help to answer 
this question. Subsequently, the possibility of transmission of NTM strains should be 
explored and specific molecular epidemiological techniques may have to be invented. 
Much more needs to be known about the influence of cattle husbandry and the 
livestock production strategies of nomadic pastoralists. Such studies could help to 
identify routes and risk factors for the transmission of M. bovis between animals and 
between animals and humans. 
Economic investigations on BTB in Africa including cost and revenue analyses for all 
sectors are a prerequisite for the elaboration of intervention and control strategies. 
Almost no investigations have been conducted in this respect. Moreover, considering 
the high amount of NTM strains isolated from cattle of sub-Saharan Africa it may be 
worthwhile to assess the economic relevance of NTM infections in Africa. 
Screening and testing of wildlife populations would help to assess the prevalence of 
M. bovis infections in wildlife and to estimate the transmission rate between cattle 
and wildlife. This in turn would allow to build up M. bovis transmission models that 
incorporate the wildlife reservoir and allow economic considerations concerning 
interventions in wildlife populations. 
There is evidence that zoonotic transmission of M. bovis is mainly observed in 
pastoral areas. Future research should therefore specifically target this risk group in 
order to assess the importance of zoonotic M. bovis transmissions. 
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In previous studies significant differences in Mycobacterium bovis infection 
prevalence was reported between two Chadian cattle breeds. Those findings and the 
established differentiation due to phenotypic characteristics suggest that the two 
breeds (Arab and Mbororo) are genetically different. To evaluate the genetic 
structure and the differences between these breeds, the genetic diversity within and 
between breeds was evaluated based on a total of 205 multilocus genotypes (21 
microsatellite loci). All of the loci under investigation were polymorphic and the 
number of alleles ranged from 4-14 within the two populations. The analysis of 
population fixation resulted in a FST value of 0.006, further the population 
assignment of the individual genotypes and the exact test of population differentiation 
did not support the hypothesis, that the samples drawn out of the two populations are 
genetically different. Population admixture and sample collection are discussed as 
possible reasons for the rejection of the hypothesis. Finally, recommendations for 
sample collection in extensive systems are given. 
 
Introduction 
Mycobacterium bovis (M. bovis) is the causative agent of bovine tuberculosis (BTB). 
Bovine tuberculosis is a zoonotic disease and one question of interest is its 
importance in the human tuberculosis epidemic, fostered by HIV/AIDS in different 
parts of Africa (Ayele et al., 2004; Cosivi et al., 1998). Such investigations are 
extensive, as the tuberculosis epidemic and spread depend on a variety of factors 
such as complex interactions between different Mycobacterium tuberculosis complex 
strains, non-tuberculous mycobacteria, susceptibility of host cattle breeds, the public 
health status and other environmental factors. To further investigate those 
complexities a large project is currently running in cooperation with Laboratoire de 
Recherches Vétérinaires et Zootechniques de Farcha, N’Djaména, Chad; Sokoine 
University of Agriculture, Morogoro, Tanzania; Laboratoire Central Vétérinaire, 
Bamako, Mali; Ecole Inter-Etats des Sciences et de Médecine Vétérinaires, Dakar, 
Senegal; the Swiss Tropical Institute (STI), Basel, Switzerland and the Swiss Federal 
Institute of Technology (ETH), Zurich, Switzerland.  
In a previous study differences between host cattle breeds regarding the prevalence 
of infections with M. bovis were reported (Hilty, 2006). In Chad as well as in 





comparison with the Arab breed and the hypothesis was, that the distinct prevalence 
might be due to a differential susceptibility of the two breeds. Further research on the 
susceptibility of different host breeds and the genetic diversity between these breeds 
are goals of the overall project. So far, the genetic characterizations of the samples 
collected at the slaughterhouses in Chad are completed and subject of the presented 
study. 
As compared to Europe, characterization of animal genetic resources (AnGR) in 
Africa receives less attention. In a study on the Kuri cattle breed mentioned in the 
country report of Chad (FAO, 2007b), no molecular characterization of Chadian cattle 
breeds was reported. However, adequate characterization of AnGR is a prerequisite 
for successful management programs and for informed decision making in national 
livestock development (FAO, 2007a). Even if the two breeds Mbororo and Arab are 
not under risk of extinction (derived from FAO, 2007c) the data collected at the 
slaughterhouses in Chad is expected to be worth for a detailed analysis of molecular 
aspects of them.  
The aim of this study was the molecular characterization of the two breeds including 
the assessment of genetic diversity within and between populations. Such a 
characterization is of primary interest regarding the differences in BTB prevalence of 
the two breeds but also in respect to the description of indigenous African cattle 
breeds and African cattle husbandry systems. 
 
Material and Methods 
Breeds  
The genotyped animals belong to the two breeds Mbororo and Arab. All of them were 
kept in a long distance transhumant system by pastoralists, thereby passed the 
border between Chad and Central African Republic and spent the dry season in the 
Central African Republic. The transhumant system is the main cattle production 
system in Chad. Seventy five percent of the national herds are kept by pastoralists 
and almost 50% of Chadian export revenues are generated within this system (FAO, 
2007b).  
The Mbororo cattle, also known as Red Fulani, belong to the subgroup Fulani of the 
West African Zebu cattle. In Chad a population size of 300’000 heads was reported 
in year 1992 (derived from FAO, 2007c). This breed has long, lyre-shaped horns and 





lactation yield is poor with 2 kg of milk per day at the peak of lactation (FAO, 2007b). 
The carcass dressing out is low (40% - 42%), but FAO (2007b) reported the good 
quality of the breed’s hides for leather production. The breed is robust and adapted to 
different climates, i.e. the breed is kept in dry as well as humid regions of Chad 
(FAO, 2007b). 
The Arab zebu (or Shewa) has a well developed dewlap and short horns (Zibrowski, 
1997). Coat color is red – maroon in the Sahel-zone and predominantly white in the 
south-east and west (FAO, 2007b). Figure 13 shows some Arab animals from Chad 
before slaughter. Milk yield per lactation varies from a minimum of 454 kg to a 
maximum of 1814 kg and lactation length varies from 240 to 396 days (derived from 
DAGRIS, 2007). Beside the totally deserted regions, the breed is kept in all other 
regions of Chad. It is estimated, that 75% to 90% of Chadian cattle belong to this 
breed (FAO, 2007b). A population size of 4’902’000 heads was reported in year 1992 












Figure 13. Arab cattle at the slaughterhouse in Chad (photo Ngandolo B.N.R.). 
 
Genotyping 
Blood samples were from animals before slaughter at three different abattoirs in 
southern Chad. Additionally, information about the breed, the age, sex, the 
transhumance system, borders passed, the residence during dry season and the 
location of the slaughter house of each individual was recorded. The age structure 
and gender of the sampled individuals is subject of table 19.  
Blood was allowed to clot, transported on ice to the Laboratoire de Recherches 
Vétérinaires et Zootechniques in Farcha and stored at -80°C until further processing. 
DNA was extracted using the QIAamp® DNA Blood Mini Kit (QIAGEN, Cat. No. 
51106) from clotted blood corresponding to 238 individual animals. Handling was 
carried out according to the Blood and Body Fluid Spin protocol (derived from 
Qiagen, 2007). DNA was transported to Europe where genotyping was conducted by 
Van Haeringen Laboratories, Wageningen, Netherlands. All microsatellites were 
chosen from the FAO-list (FAO, 2004).  
A remarkable degradation of the DNA was observed over time. This problem caused 
a high fraction of missing genotypes, especially for the most recent genotyped 





markers were omitted from further analysis. Finally, 205 genotypes (131 Arab and 74 
Mbororo) for 21 microsatellites were included for statistical analysis. 
 
1 2 3 4 5 6 7 8 9 10 11
male 34 4.206 6 4 6 2 6 3 3 2 2 0 0
female 97 6.701 2 1 3 6 6 20 26 21 9 1 2
male 38 3.079 2 18 7 4 4 0 2 1 0 0 0
female 36 5.611 1 5 3 2 2 6 9 7 1 0 0Mbororo
N age (mean)Breed sex Number of animals per age class (years)
Arab
 




For the statistical investigations the packages ARLEQUIN 3.01 (Excoffier et al., 
2005), STRUCTURE 2.1 (Pritchard et al., 2000) and FSTAT 2.9.3.2 (Goudet, 1995) 
were applied. Deviation from Hardy-Weinberg- Equilibrium (HWE) was tested for 
each locus in each population using ARLEQUIN (number of steps in MCMC 
=100´000). The significance level was set to p-value <0.001.  
FAO- markers are assumed to be selectively neutral and to segregate independently 
from other loci (FAO, 2004). In ARLEQUIN a likelihood ratio test of linkage 
disequilibrium is implemented for genotypic data with unknown gametic phase. This 
test was conducted on the data setting the number of permutations to 10´000 and the 
significance level to 0.05.  
The number of alleles per locus, the average number of alleles per breed, the 
observed and expected heterozygosity per locus and breed were calculated as 
indicators for the genetic variability within the two breeds. The relevant results were 
part of the testing on HWE with ARLEQUIN. Further breed specific alleles (i.e. private 
alleles) were counted. 
FSTAT (Goudet, 1995) was used for the assessment of Wrights fixation indices and 
the respective standard errors. Further, the computations given in ARLEQUIN to 
conduct population comparisons and population differentiation were conducted. 





Clustering analysis was conducted with STRUCTURE 2.1 (Pritchard et al., 2000). 
The length of burning period for the MCMC was set to 10000 with 100000 
replications after burning. The number of clusters was varied from 2 to 5. 
 
Results  
Information content of markers and genetic variability within populations 
Table 20 gives an overview of the genotyped markers, the number of individuals with 
a genotype (N), the number of observed alleles, the fraction of animals with missing 
genotypes, the observed heterozygosity and the expected heterozygosity and the 
respective p-value for HWE-testing for the two populations Arab and Mbororo, 
separately. 
 
Genetic diversity between populations and cluster analysis 
The total degree of population subdivision according to Weir and Cockerham (1984) 
was found to be: 
 
FIT= 0.042 (± 0.008) 
FST= 0.006 (± 0.002) 
FIS= 0.037 (± 0.008). 
 
Figure 14 shows the results for the genotype assignment implemented in 
ARLEQUIN. The program calculates the log-likelihood of each genotype under the 
assumption that it belongs to the respective population. 
The results of the clustering analysis assuming two clusters are given in figure 15. 
The number of clusters (k) investigated is user defined. The k resulting in the highest 
logarithmic probability is seen as the most probable number of subpopulations. For 




 Marker N alleles missing obs_het exp_het p-value N alleles missing obs_het exp_het p-value
BM1818 129 9 1.50% 0.814 0.813 0.894 69 9 6.80% 0.783 0.844 0.238
BM1824 131 7 0.00% 0.672 0.746 0.003 74 4 0.00% 0.703 0.743 0.91
BM2113 131 8 0.00% 0.771 0.827 0.809 74 9 0.00% 0.824 0.822 0.734
CSRM60 131 10 0.00% 0.595 0.568 0.677 74 8 0.00% 0.541 0.61 0.202
CSSM66 131 11 0.00% 0.771 0.832 0.322 74 9 0.00% 0.757 0.838 0.006
ETH10 129 8 1.50% 0.798 0.769 0.382 74 8 0.00% 0.797 0.803 0.237
ETH225 129 9 1.50% 0.605 0.635 0.725 74 8 0.00% 0.689 0.714 0.341
ETH3 131 8 0.00% 0.618 0.6 0.504 74 7 0.00% 0.514 0.553 0.842
HAUT27 113 7 13.70% 0.664 0.744 0.374 66 7 10.80% 0.727 0.746 0.797
ILSTS006 126 10 3.80% 0.651 0.687 0.631 70 10 5.40% 0.786 0.75 0.654
INRA23 130 12 0.80% 0.708 0.745 0.526 74 10 0.00% 0.595 0.665 0.281
SPS115 131 7 0.00% 0.496 0.497 0.81 74 7 0.00% 0.338 0.348 0.766
TGLA122 126 14 3.80% 0.683 0.716 0.154 72 11 2.70% 0.722 0.704 0.686
TGLA126 131 8 0.00% 0.786 0.755 0.756 74 8 0.00% 0.716 0.756 0.055
TGLA227 131 10 0.00% 0.618 0.621 0.287 74 11 0.00% 0.5 0.572 0.223
TGLA53* 93 16 29.00% 0.763 0.787 0.747 60 15 18.90% 0.567 0.768 0.002
ETH152 131 6 0.00% 0.511 0.525 0.827 73 5 1.40% 0.507 0.527 0.815
ETH185 129 14 1.50% 0.806 0.823 0.478 74 11 0.00% 0.662 0.757 0.282
HEL5* 96 7 26.70% 0.573 0.77 0 52 6 29.70% 0.5 0.751 0
ILSTS005 121 6 7.60% 0.76 0.792 0.386 71 5 4.10% 0.732 0.752 0.895
INRA32 126 10 3.80% 0.714 0.826 0.033 72 10 2.70% 0.806 0.815 0.949
INRA35 128 8 2.30% 0.5 0.534 0.091 71 7 4.10% 0.577 0.671 0.004
MM12 131 14 0.00% 0.832 0.839 0.962 74 11 0.00% 0.838 0.859 0.489
Mean** 9.3 0.684 0.709 8.3 0.672 0.707
SD** 2.5 0.106 0.113 2.1 0.133 0.127
* excluded
Arab (131) Mbororo (74)
** after exlcusion of markers TGLA53 and HEL5
 
 
Table 20. Overview of genotyping parameters. Number of genotypes (N), number of alleles, fraction of missing genotypes observed 




















Figure 14. Log-likelihood of each individual’s multilocus genotype in the population sample Arab and Mbororo, respectively, assuming 


















Information content of markers and genetic variability within populations 
Marker HEL5 highly significant deviates from HWE and is therefore excluded from 
further analysis. Further TGLA53 was omitted, as its fraction of missing genotypes 
was above 20%. After exclusion of the above mentioned markers, 205 individual 
genotypes for totally 21 microsatellites remained for further analysis (table 20).  
Testing on linkage disequilibrium revealed that for each population three pairs of loci 
do not segregate independently (p<0.001) (results not shown). However, as all of the 
markers in linkage disequilibrium are mapped to different chromosomes, the markers 
are informative regarding diversity studies and are not excluded from further analysis 
(Peter, 2005). 
The number of alleles per locus ranged from 4 up to 14. The minimum was found in 
the Mbororo sample at the loci BM1824, the maximum at the three loci TGLA122, 
ETH185 and MM12 of the Arab sample (table 20). These findings show that the two 
populations are polymorphic for all of the 21 loci under investigation. The chosen loci 
all fulfill the rule of thumb given by FAO, that markers for diversity studies should 
segregate with at least 4 alleles per population (FAO, 2004). The mean number of 
alleles was 9.3 (± 2.5) for the genotypes belonging to the breed Arab and 8.3 (± 2.1) 
for the genotypes belonging to the Mbororo breed, averaging 8.8 (± 2.3) (table 20) for 
the total sample. 
28 alleles at 13 loci out of the 203 alleles were found to be so called private alleles 
(results not shown). A private allele is defined as an allele found in one population 
but in no other (Woolliams and Toro, 2007). In our study the highest frequency of a 
private allele was 2.8% only. Thus, their influence on differences in the allelic 
frequencies between populations is expected to be low. 
The average observed heterozygosity was found to be 0.684 (± 0.106) in Arab and 
0.672 (± 0.133) in Mbororo, respectively. The average expected heterozygosity was 
0.709 (± 0.113) for population Arab, and 0.707 (± 0.127) for the population Mbororo 
(table 20). The mean number of alleles per locus and the expected heterozygosity 
are seen as informative measures for the assessment of genetic diversity within 
populations (Hanotte and Jianlin, 2005; Toro and Caballero, 2004). The mean 
number of alleles per locus found in the present study is lower than the 11.5 alleles 
per microsatellite locus observed by Ibeagha-Awemu et al. (2004) in west/central 





investigated by Ibeagha-Awemu et al. (2004) ranged from 0.703 – 0.744. Our 
estimates correspond with the lower end of this range. 
Generally, it has to be questioned if the samples drawn for our study reflect random 
samples from the Mbororo and Arab breed or not. The number of animals sampled is 
adequate, however, the animals were all kept in one region of southern Chad and the 
size of the two samples was not equal. A balanced affiliation of both sexes is not 
given for the Arab sample (table 19). Further, the animals from a pastoralist system 
arriving at abattoir do not necessarily cover all age classes of a population. This 
expectation is supported with table 19. For both breeds the average age of the 
sampled cows is about 2.5 years higher than the average age of the sampled bulls 
(table 19). Considering bulls, animals from the older age classes (> 6 years) are 
under represented in both breeds, indicating that the majority of bulls are slaughtered 
in younger years (table 19). Older animals might have undergone selection as they 
had to survive dry season, long treks, disease pressure and other forces arising 
within this system. Due to these various factors, the assumption of two random 
samples can not be warranted. 
 
Genetic diversity between populations and cluster analysis 
The FST indicates that the genetic diversity between the two samples is very low. A 
high proportion of the FIT is accounted for by the within-heterozygote deficiency 
(FIS). The low FST is seen as a first incidence, that it might be hard to elaborate 
genetic differences between the samples of Mbororo and Arab cattle. 
The distributions of the log-likelihoods for the genotype assignment shown in figure 
14 overlap to a certain amount. Again it is not possible to clearly distinguish between 
the two populations. This result was further confirmed with the exact test of 
population differentiation implemented in ARLEQUIN (results not shown). The 
differentiation test between all samples revealed in p-value > 0.05, i.e. based on the 
genotypic information, the two populations do not significantly differ.  
 
The algorithm implemented in STRUCTURE (Pritchard et al., 2000) constructs 
genetic clusters from a collection of individual multilocus genotypes. Therefore the 
fraction of each individuals genotype that belongs to each cluster is estimated 






The bars in figure 15 show, that for none of the 205 individuals the genome can be 
clearly assigned to the Arab cluster or the Mbororo cluster. Furthermore, no relation 
between the participation of an individual’s genome fraction and its initially assigned 
population (x-axis in figure 15) was found. 
Rosenberg et al. (2001) showed that the power of clustering depends on the 
variability of markers, the number of markers and the number of individuals 
genotyped. For less diverged populations they propose to genotype more than 12-15 
markers for 15-20 individuals of the hypothetical populations to get accurate 
clustering results. For our data those recommendations are fulfilled. Therefore the 
clustering results further support, that the samples under investigation do not reflect 
genetically different populations. 
Before slaughtering the sampled individuals were phenotypically assigned to the two 
breeds Mbororo and Arab. Even if relying on different individuals sampled, the 
reported differences in BTB prevalence between the two breeds (Hilty, 2006) lead to 
the hypothesis, that genetic differences exist and might become obvious investigating 
the molecular diversity. However, the analysis of the samples investigated here and 
the chosen microsatellites do not support this hypothesis. Those findings are 
somewhat unexpected. They might be explained with effects regarding the sampling 
of animals kept in transhumance systems. Unfortunately, no data about the herd 
affiliation was available. As already mentioned above different age structures were 
observed between sexes. There is a certain chance that “old” female individuals (5 to 
8 years) are the ones that survived for example BTB infection and are therefore 
“overrepresented” in both samples. Such sampling effects can result in diminished 
differences between breeds. 
Mbororo and Arab animals are kept by nomadic pastoralists of two different ethnic 
groups, named according to their cattle breeds. This connection appears to be rather 
loose and both groups often keep Arab and Mbororo cattle inter-mixed in their herds 
(Dr. C. Diguimbaye-Djaïbe and B.N.R. Ngandolo, personal communications). Another 
possibility is that migration of animals between herds and breeds occur. These 
aspects support the rejection of the hypothesis due to population admixture. 
Admixture between populations homogenizes allele frequencies between 
populations. Therefore, the exploration of differences in allele frequencies between 





further supported by the Country Report of Chad (FAO, 2007b) which records, that 
important admixture between Arab and Mbororo exists. 
Based on our study, we fully support the statement, that sample collection is the most 
important step in any diversity study (FAO, 2007a). In extensive production system 
the lack of pedigree information (Eding and Meuwissen, 2001; Ruane, 1999) may 
hamper the collection of representative samples. To overcome this difficulty a well 
planned data collection and the collection of additional information like herd affiliation, 
records of geographical coordinates and photo documentation of sampling sites, 
animals and flocks. are highly recommended (FAO, 2007a). Otherwise, the 
interpretation of genotyping results and statistical analysis become hard and loose 
the explanatory power.  
 
Conclusions 
Considering phenotypes solely, one would have presumed two different breeds. 
However, our study does not confirm genetic differences between the two samples. 
Here, the potential of genetic characterization studies in extensive systems becomes 
obvious. The presented results increase information about cattle breeds kept in 
pastoralists system and support that regular admixture between the two breeds 
occurs.  
Collecting sample at slaughterhouses for semi-feral populations seems promising in 
comparison with the complex collection of field samples. Even though, careful 
sample collection procedure remains the most important step. In this context the 
need for supplementary information (description of the breeds, herd information, 
information about herd management etc.) is underlined. For this purpose, the 
pastoralists arriving at slaughterhouse might be asked to fill in a questionnaire. 
Future research also requires investigations on cattle husbandry and herding 
practices of African pastoral communities where very little information is available. No 
detailed information about the influence of non-genetic factors on differences in 
disease prevalence (i.e. BTB) between breeds is available.  
Increased information about the genetic composition of breeds as well as their 
production system allows for better understanding of pastoralists system in general 
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 Appendix 2: 
Supplementary data for: “Molecular characterization of Mycobacterium bovis 
strains isolated from cattle slaughtered at two abattoirs in Algeria” 
 
Spoligotype ETR-A ETR-B ETR-C ETR-D ETR-E
4 ' G SB0121 4 3 5 3* 3
6 SB0837 6 4 3 4* 3
8 SB0121 6 4 3 4* 3
9 ' G SB0860 5 3 5 4* 3
9 SB0120 5 5 5 4* 4
10 SB0120 5 5 2 4* 3
11 ' SB1448 7 4 5 4* 3
13 SB0120 5 5 2 4* 3
14 ' SB0121 6 4 3 4* 3
14 SB0120 4 5 3 4* 3
16 ' SB1450 4 5 5 4* 3
16 SB0120 4 5 5 2* 3
17 ' C SB0121 6 4 3 4* 3
17 SB0121 6 4 3 4* 3
18 SB0121 6 4 3 4* 3
20 ' SB0121 6 4 3 4* 3
21 ' SB0120 5 3 5 4* 3
21 p SB0941 6 7 3 4* 3
22 ' SB0120 5 3 5 4* 3
22 SB0120 5 4 5 4* 3
23 SB0120 4 5 5 4* 3
26 ' SB0134 3 5 5 5* 3
26 SB0941 6 5 3 4* 3
27 SB0120 4 5 5 4* 3
28 SB0828 5 5 5 4* 4
29 ' G SB0134 7 4 5 4* 3
31 ' C SB0120 3 2 5 4* 3
32 ' p SB1200 4 6 5 4* 3
33 SB0850 5 5 5 4* 3
34 ' G SB0120 4 5 5 4* 3
36 G SB0134 4 4 5 3* 4
38 SB0120 3 5 5 4* 4
39 ' SB0121 6 4 3 4* 3
44 ' SB0121 6 4 3 4* 3
44 p SB1086 3 3 5 4* 3
45 SB0120 7 5 4 3* 3
46 ' SB0120 4 5 3 4* 3
47 ' T SB0331 3 3 5 4* 3
47 SB0867 4 5 5 4* 3
49 ' SB0121 6 4 3 4* 3
49 SB0120 4 5 5 2* 3
50 ' T SB0121 6 4 3 4* 3
51 ' SB0121 6 4 3 4* 3
56 F SB0120 5 5 5 4* 3







Spoligotype ETR-A ETR-B ETR-C ETR-D ETR-E
57 SB0121 6 4 4 4* 3
61 ' SB0120 4 5 5 3* 3
62 p SB0822 3 5 5 4* 3
64 SB0120 4 4 5 4* 3
65 ' SB0120 5 5 5 4* 4
65 SB0120 4 5 2 4* 3
66 ' SB0822 5 7 5 4* 3
68 ' SB0120 4 5 5 4* 3
72 ' SB1451 6 4 3 4* 5
72 p SB0873 5 6 5 4* 3
74 ' SB0941 6 5 3 4* 3
74 SB0120 3 4 5 3* 3
75 p SB1452 6 4 5 3* 3
77 SB1449 6 4 5 4* 2
79 SB0121 5 3 5 4* 3
80 ' SB0120 5 4 4 4* 3
81 p SB0941 6 5 3 4* 3
84 p SB0941 6 5 3 4* 3
85 ' SB0121 6 4 3 4* 3
85 p SB0941 6 5 3 4* 3
86 ' SB0120 5 5 2 4* 3
87 ' SB0120 4 4 5 4* 3
88 ' SB0121 6 4 3 4* 3
89 ' SB0162 5 5 5 4* 3
89 SB0121 6 4 3 4* 3
90 ' SB0120 4 5 5 3* 3
90 p SB0121 6 4 3 4* 3
92 p SB0121 6 4 3 4* 3
93 ' SB0132 6 4 3 4* 3
93 G SB0120 4 8 5 4* 3
95 ' SB1447 6 5 5 4* 3
97 p SB0120 5 5 2 4* 3
98 SB0120 4 5 3 4* 3
102 ' SB1450 6 5 5 4* 3
105 ' SB0120 4 5 5 4* 3
106 ' SB0134 7 4 5 4* 3
107 ' SB0134 7 4 5 4* 3
108 ' SB0860 5 4 5 4* 3
110 ' SB0120 4 7 3 4* 3
111 ' SB0120 5 6 5 4* 3
114 ' SB0850 5 4 5 4* 3
117 ' SB0120 4 5 5 4* 3
118 ' SB0120 4 5 5 3* 3




Supplementary data 1. Original sample name, spoligotype number according to 
www.Mbovis.org and ETR A-E typing results for all 89 MTBC strains isolated. 
 
 Appendix 3: 
Supplementary data for: “African 1; an epidemiologically important clonal complex of Mycobacterium bovis dominant in 
Mali, Nigeria, Cameroon and Chad” 
 
Lab. ID Strain ID Spoligotype VNTR RDAf1 Spacer 30 Accesion Where isolated When isolated (Month, Year)
Chad 1 90 TUB/G SB0944 ND deleted absent N'Djaména Abattoir, southwestern Chad 07.08.2000
n = 65 2 106PM/P SB0944 3 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 22.08.2000
3 117PM/P SB0951 7 5 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 09.09.2000
4 120PM/P SB1025 4 3 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 09.09.2000
5 215PM/P SB0951 X X X X 3 X deleted absent N'Djaména Abattoir, southwestern Chad 09.09.2000
37 234GG/G SB1418 3 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 02.08.2001
micro-array 38 86PM/P SB1103 7 5 5 4* 3 3.1 intact absent seq Af1 intact N'Djaména Abattoir, southwestern Chad 04.08.2000
39 453GG/P SB0952 5 5 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 27.07.2002
40 465GG/P SB1025 ND deleted absent N'Djaména Abattoir, southwestern Chad 25.07.2002
41 500GG/P SB1027 X X X X 3 X deleted absent N'Djaména Abattoir, southwestern Chad 05.08.2002
42 579GG/P SB0951 2 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 23.08.2002
43 587GG/P SB1025 4 3 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 24.08.2002
44 94GG/P SB1027 4 6 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 09.08.2000
45 241GG/P SB0944 3 5 5 4* 3 3.1 deleted absent EU887550 N'Djaména Abattoir, southwestern Chad 15.10.2001
46 466*GG/P SB0944 ND deleted absent N'Djaména Abattoir, southwestern Chad 25.07.2002
47 474GG/P SB1027 X X X X 3 2.1 deleted absent N'Djaména Abattoir, southwestern Chad 29.07.2002
48 506PM/G SB1099 X X X 4* 3 X deleted absent N'Djaména Abattoir, southwestern Chad 07.08.2002
49 564GG/P SB0944 5 5 3 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 22.08.2002
50 572GG/P SB1098 4 5 5 4* 3 3.1 deleted absent EU887551 N'Djaména Abattoir, southwestern Chad 22.08.2002
micro-array 51 111GG/P SB0952 ND deleted absent N'Djaména Abattoir, southwestern Chad 01.09.2000
52 245GG/P SB0944 4 7 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 05.10.2001
53 468GG/G SB0952 5 5 5 4* 3 2.1 deleted absent N'Djaména Abattoir, southwestern Chad 26.07.2002
micro-array 54 486GG/P SB0944 4 8 5 4* 3 3.1 deleted absent EU887558 N'Djaména Abattoir, southwestern Chad 01.08.2002
55 510PM/G SB1025 X 3 4 4* 3 X deleted absent EU887556 N'Djaména Abattoir, southwestern Chad 07.08.2002
56 573GG/P SB0944 4 7* 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 22.08.2002
57 570GG/P SB1027 4 4 5 4* 3 2.1 deleted absent N'Djaména Abattoir, southwestern Chad 22.08.2002
58 216PM/P SB0944 3 5 3 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 07.08.2001
60 488GG/P SB1100 4 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 01.08.2002
61 600GG/P SB1098 4 5 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 26.08.2002
62 605GG/P SB0944 4 3 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 26.08.2002









64 617*GG/P SB0951 4 X 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 26.08.2002
65 630*PM/G SB0951 4 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 28.08.2002
66 638GG/P SB0951 4 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 28.08.2002
67 646GG/P SB1101 ND deleted absent N'Djaména Abattoir, southwestern Chad 27.08.2002
69 653PM/G SB1025 4 3 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 29.08.2002
70 659*GG/G SB1025 5 5 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 29.08.2002
71 660GG/G SB0951 4 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 29.08.2002
72 220PM/P SB0944 4 5 6 4* 2 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 25.08.2001
73 221GG/P SB0944 4 5 5 2 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 25.08.2001
75 449GG/P SB0944 3 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 22.07.2002
76 450GG/P SB0944 X X 5 4* 3 X deleted absent N'Djaména Abattoir, southwestern Chad 22.07.2002
77 452GG/P SB1103 7 5 5 4* 3 3.1 intact absent N'Djaména Abattoir, southwestern Chad 22.07.2002
78 471PM/6 SB0944 X X 5 X 3 X deleted absent N'Djaména Abattoir, southwestern Chad 29.07.2002
79 472PM/P SB0328 5 5 3 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 29.07.2002
80 473GG/P SB0944 4 8 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 29.07.2002
81 491PM/G SB0944 4 7 6 4* 3 3.1 deleted absent EU887549 N'Djaména Abattoir, southwestern Chad 02.08.2002
82 493GG/P SB0944 4 6 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 03.08.2002
83 496GG/P SB1101 4 X 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 05.08.2002
84 511GG/G SB1102 3 X X 4* 3 3.1 intact present N'Djaména Abattoir, southwestern Chad 07.08.2002
86 514GG/P SB1025 4 3 4 4* 3 3.1 deleted absent EU887557 N'Djaména Abattoir, southwestern Chad 07.08.2002
micro-array 87 515PM/P SB1102 X X 5 4* 4 3.1 intact present seq Af1 intact N'Djaména Abattoir, southwestern Chad 07.08.2002
88 516GG/P SB1025 4 3 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 07.08.2002
89 523PM/P SB0944 4 5 6 5* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 08.08.2002
90 552PM/P SB0944 4 7* 5 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 21.08.2002
91 577GG/P SB1025 4 3 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 23.08.2002
92 581GG/P SB0944 4 5 6 5* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 23.08.2002
93 583PM/P SB1025 4 3 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 23.08.2002
94 584GG/P SB1025 4 3 4 4* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 23.08.2002
95 588PM/P SB1025 4 X X X 3 X deleted absent N'Djaména Abattoir, southwestern Chad 24.08.2002
96 550GG/P SB0944 4 5 5 2 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 21.08.2002
953 542 SB0944 ND deleted absent N'Djaména Abattoir, southwestern Chad 16.07.2002
957 633 SB0944 ND deleted absent N'Djaména Abattoir, southwestern Chad 28.08.2002
977 635 SB0944 4 8 5 3* 3 3.1 deleted absent N'Djaména Abattoir, southwestern Chad 28.08.2002








Chad, Sarh 13 HPS  pm P SB0944 X 2 X 4* 3 3.1 ND absent Sarh abattoir, southern Chad July-November 2005
n = 24 18 HPS  pm G SB0951 4 6 5 4* 3 3.1 deleted absent EU887548 Sarh abattoir, southern Chad July-November 2005
19 HPS gg prescap P SB0944 3 X 5 4* 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
208 gg prescap G SB1099 4 5 5 X 3 3.1 deleted absent EU887547 Sarh abattoir, southern Chad July-November 2005
208 pm P SB0944 3 5 5 4* 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
28 HPS gg mam P SB1025 ND deleted absent Sarh abattoir, southern Chad July-November 2005
30 HPS  pm P SB0944 4 4 5 X 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
322 gg prescap P SB1453 X X X 4* 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
368 pm P SB1104 X X 5 4* 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
43 HPS gg prescap P SB1025 ND deleted absent Sarh abattoir, southern Chad July-November 2005
526 gg prescap G SB1454 4 X 6 4* 3 3.1 deleted absent EU887546 Sarh abattoir, southern Chad July-November 2005
526 gg prescap P SB0850 4 X 6 4* 3 3.1 deleted absent EU887545 Sarh abattoir, southern Chad July-November 2005
54 HPS gg prescap G SB0944 4 5 5 4* 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
57 HPS  pm P SB1025 4 3 4 4* 3 3.1 deleted absent EU887544 Sarh abattoir, southern Chad July-November 2005
65 HPS gg mam P SB1025 5 5 4 4* 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
656 gg mam P SB0944 X X X X 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
685 gg mam G SB1103 7 5 5 4* 3 3.1 intact absent Sarh abattoir, southern Chad July-November 2005
709 gg prescap G SB0944 ND ND absent Sarh abattoir, southern Chad July-November 2005
806 rein P SB1104 2 X 5 4* 3 3.1 deleted absent EU887543 Sarh abattoir, southern Chad July-November 2005
827 gg mam P SB1099 3 5 5 4* 3 3.1 deleted absent Sarh abattoir, southern Chad July-November 2005
853 gg mam P SB0951 X X X 4* 3 3.1 ND absent Sarh abattoir, southern Chad July-November 2005
866 pm P SB0951 ND ND absent Sarh abattoir, southern Chad July-November 2005
940 gg prescap P SB0944 ND ND absent Sarh abattoir, southern Chad July-November 2005
950 gg mam P SB0944 4 X 5 4* 3 3.1 deleted absent EU887542 Sarh abattoir, southern Chad July-November 2005
Nigeria 4 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
Published strains 7 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
n = 15 10 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
11 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
21 SB0952 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
33 SB1025 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
34 SB0952 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
36 SB0944 4 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
37 SB0952 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
43 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
44 SB1026 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
45 SB1025 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
47 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003
49 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria 2003




Nigeria 5 B5-05 SB1420 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
new strains 6 B6-05 SB1420 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
n = 163 175 B175-05 SB1420 5 5 6 4* 3 2.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
2 B2-05 SB1421 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
3 B3-05 SB1421 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
4 B4-05 SB1421 X 5 5 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
7 B7-05 SB1421 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
8 B8-05 SB1421 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
80 B80-05 SB1421 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
55 B55-05 SB1444 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
66 B66-05 SB1444 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
169 B169-05 SB1444 5 2 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
170 B170-05 SB1444 5 2 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
160 B160-05 SB1445 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
107 B107-05 SB1445 X 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
13 B13-05 SB1027 4 4 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
18 B18-05 SB1027 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
22 B22-05 SB1027 5 5 5 4* X 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
25 B25-05 SB1027 5 X 5 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
44 B44-05 SB1027 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
52 B52-05 SB1027 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
54 B54-05 SB1027 5 5 5 4* 2 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
56 B56-05 SB1027 5 6 5 4*3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
57 B57-05 SB1027 4 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
65 B65-05 SB1027 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
72 B72-05 SB1027 4 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
74 B74-05 SB1027 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
81 B81-05 SB1027 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
82 B82-05 SB1027 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
88 B88-05 SB1027 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
94 B94-05 SB1027 4 2 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
101 B101-05 SB1027 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
105 B105-05 SB1027 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
108 B108-05 SB1027 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
111 B111-05 SB1027 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
122 B122-05 SB1027 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
123 B123-05 SB1027 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
155 B155-05 SB1027 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
159 B159-05 SB1027 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
165 B165-05 SB1027 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
26 B26-05 SB1025 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
29 B29-05 SB1025 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
42 B42-05 SB1025 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
43 B43-05 SB1025 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
117 B117-05 SB1025 4 3 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
144 B144-05 SB1025 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
103 B103-05 SB1443 X 5 5 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
180 B180-05 SB1422 X 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004




167 B167-05 SB1424 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
179 B179-05 SB1424 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
162 B162-05 SB1425 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
127 B127-05 SB1441 5 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
134 B134-05 SB1442 4 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
112 B112-05 SB1426 ND Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
154 B154-05 SB1427 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
136 B136-05 SB1428 ND Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
121 B121-05 SB1429 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
119 B119-05 SB1430 X 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
120 B120-05 SB1430 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
100 B100-05 SB1431 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
1 B1-05 SB1099 4 5 5 4* 3 3.1 Deleted absent poor seq Af1 deleted Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
99 B99-05 SB1099 4 X 5 4* 3 X ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
20 B20-05 SB1432 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
87 B87-05 SB1432 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
93 B93-05 SB1432 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
115 B115-05 SB1432 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
79 B79-05 SB1433 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
39 B39-05 SB0951 5 3 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
163 B163-05 SB0951 5 3 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
171 B171-05 SB0951 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
32 B32-05 SB1434 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
24 B24-05 SB1437 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
21 B21-05 SB1436 5 5 5 4* 4 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
19 B19-05 SB1435 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
89 B89-05 SB1435 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
11 B11-05 SB0328 4 4 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
128 B128-05 SB0328 4 4 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
130 B130-05 SB0328 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
131 B131-05 SB0328 4 5 3 4* 2 4.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
176 B176-05 SB0328 3 4 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
9 B9-05 SB1438 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
137 B137-05 SB1438 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
133 B133-05 SB1439 5 5 3 3* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
141 B141-05 SB1439 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
147 B147-05 SB1439 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
70 B70-05 SB1440 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
129 B129-05 SB1440 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
149 B149-05 SB1440 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
156 B156-05 SB1428 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
10 B10-05 SB0944 5 5 3 X 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
14 B14-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
15 B15-05 SB0944 5 5 3 4* 3 3.1 Deleted absent EU887555 Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
16 B16-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
17 B17-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
27 B27-05 SB0944 5 4 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
28 B28-05 SB0944 4 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
30 B30-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
31 B31-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
34 B34-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
35 B35-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004




37 B37-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
38 B38-05 SB0944 5 4 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
40 B40-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
41 B41-05 SB0944 6 4 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
45 B45-05 SB0944 5 4 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
46 B46-05 SB0944 ND Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
50 B50-05 SB0944 5 6 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
51 B51-05 SB0944 5 X 5 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
53 B53-05 SB0944 5 4 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
59 B59-05 SB0944 5 4 5 4* 3 1.3 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
60 B60-05 SB0944 5 4 5 4* 3 1.3 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
61 B61-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
62 B62-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
63 B63-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
64 B64-05 SB0944 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
67 B67-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
68 B68-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
69 B69-05 SB0944 5 X 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
71 B71-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
73 B73-05 SB0944 X 5 5 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
76 B76-05 SB0944 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
77 B77-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
78 B78-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
83 B83-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
84 B84-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
85 B85-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
86 B86-05 SB0944 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
90 B90-05 SB0944 5 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
91 B91-05 SB0944 5 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
92 B92-05 SB0944 6 4 7 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
95 B95-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
96 B96-05 SB0944 X 2 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
97 B97-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
98 B98-05 SB0944 5 4 5 4* 2 1.3 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
104 B104-05 SB0944 X 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
106 B106-05 SB0944 5 5 6 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
109 B109-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
110 B110-05 SB0944 X 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
113 B113-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
114 B114-05 SB0944 X 5 3 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
116 B116-05 SB0944 5 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
125 B125-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
126 B126-05 SB0944 5 5 X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
132 B132-05 SB0944 X X X 4* 3 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
135 B135-05 SB0944 5 5 3 4* 3 1.3 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
138 B138-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
140 B140-05 SB0944 5 5 4 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
142 B142-05 SB0944 4 4 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
145 B145-05 SB0944 5 5 3 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
148 B148-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
151 B151-05 SB0944 X 5 X 4* X 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
152 B152-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004






157 B157-05 SB0944 3 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
164 B164-05 SB0944 5 3 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
168 B168-05 SB0944 5 5 3 4* X 3.1 ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
173 B173-05 SB0944 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
177 B177-05 SB0944 5 5 5 4* 3 3.1 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
178 B178-05 SB0944 5 5 3 4* 3 1.3 Deleted absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
161 SB0944 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
58 SB0944 ND ND absent Bodija Abattoir (Ibadan, Southwestern-Nigeria  April to August 2004
Cameroon 55N SB0951 4 6 5 4* 3 3.1 Deleted absent
n = 17 54N SB0951 4 6 5 4* 3 3.1 Deleted absent
27N SB0944 5 5 3 4* 3 3.1 Deleted absent
130 SB0944 5 3 4 4* 4 2.1 Deleted absent
128 SB0944 5 5 5 4* 3 2.1 Deleted absent EU887553
164 SB0944 5 5 3 4* 3 3.1 Deleted absent
165 SB0944 5 5 5 4* 3 2.1 Deleted absent
151 SB0952 5 5 5 4* 3 3.1 Deleted absent
96 SB1419 5 5 5 4* 3 3.1 Deleted absent
19N SB0952 5 5 6 4* 3 3.1 Deleted absent
108 SB0952 5 5 5 4* 3 3.1 Deleted absent
66G SB0944 5 5 5 4* 3 2.1 Deleted absent
259 SB0951 3/4 6 5 4* 3 3.1 Deleted absent
3438 SB0953 5 5 5 4* 3 3.1 Deleted absent EU887554
3442 SB0953 5 5 5 4* 3 3.1 Deleted absent
3470 SB0953 5 5 5 4* 3 3.1 Deleted absent
3441 SB0953 2 5 5 4* 3 3.1 Deleted absent
Mali 06b SB0134 6 5 5 4* 3 3.1 Intact present Bamako abattoir, southwestern Mali March, April 2007
n = 20 11b SB0300 5 2 5 4* 3 3.1 Deleted absent EU887538 Bamako abattoir, southwestern Mali March, April 2007
17b SB1411 7 4 5 4* 3 3.1 Deleted absent EU887539 Bamako abattoir, southwestern Mali March, April 2007
18b SB0991 7 5 5 4* 3 3.1 Intact present Bamako abattoir, southwestern Mali March, April 2007
24b SB1412 3 4 5 4* 3 3.1 Deleted absent EU887540 Bamako abattoir, southwestern Mali March, April 2007
32b SB0134 7 5 5 4* 3 3.1 Intact present Bamako abattoir, southwestern Mali March, April 2007
33b SB0300 5 5 5 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007
35b SB0300 5 5 5 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007
37b SB0300 5 2 5 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007
38b SB0300 5 5 3 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007
40b SB0134 7 5 5 4* 3 3.1 Intact present Bamako abattoir, southwestern Mali March, April 2007
47b SB0134 5 5 5 4* 3 3.1 Intact present Bamako abattoir, southwestern Mali March, April 2007
48b SB0300 5 5 3/5 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007
51b SB0134 6 5 5 4* 3 3.1 Intact present Bamako abattoir, southwestern Mali March, April 2007
52b SB0944 4 5 5 4* 3 3.1 Deleted absent EU887552 Bamako abattoir, southwestern Mali March, April 2007
53b SB1410 5 6 5 4* 3 3.1 Deleted absent EU887541 Bamako abattoir, southwestern Mali March, April 2007
54b SB1410 5 6 5 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007
57b SB0300 5 5 5 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007
58b SB0300 5 2 5 4* 3 3.1 Deleted absent Bamako abattoir, southwestern Mali March, April 2007






Uganda B2 SB1464 Intact present Kalerwe Abattoir, North of Kampala Sep 04
n = 13  B3 SB1464 Intact present Kalerwe Abattoir, North of Kampala Sep 04
 B5 SB1405 Intact present Kalerwe Abattoir, North of Kampala Nov 04
 B6 SB1468 Intact present Kalerwe Abattoir, North of Kampala Dez 04
 B7 SB1471 Intact present Kalerwe Abattoir, North of Kampala Dez 04
 B8 SB1470 Intact present Kalerwe Abattoir, North of Kampala Dec-04
 B9 SB1470 Intact present Kalerwe Abattoir, North of Kampala Dec-04
 B11 SB1470 Intact present Kalerwe Abattoir, North of Kampala Dec-04
 B12 SB1470 Intact present Kalerwe Abattoir, North of Kampala Dec-04
 B13 SB1470 Intact present Kalerwe Abattoir, North of Kampala Feb-05
 B15 SB1467 Intact present Kalerwe Abattoir, North of Kampala March-05
B16 SB1467 Intact present Kalerwe Abattoir, North of Kampala March-05
B17 SB1469 Intact present Kalerwe Abattoir, North of Kampala April -05
Burundi 940130 53 SB0303 Intact present Slaughterhouse Bujumbura Sep. 1993
n = 10 940133 54 SB0304 Intact present Slaughterhouse Bujumbura Sep. 1993
940326 55 SB0303 Intact present Gatumba Dec. 1993
940139 56 SB0303 Intact present Gatumba Dec. 1993
940329 57 SB0303 Intact present Gatumba Dec. 1993
940437 58 SB1388 Intact present Slaughterhouse Bujumbura Jan. 1994
940439 59 SB1388 Intact present Slaughterhouse Bujumbura Jan. 1994
940440 60 SB1388 Intact present Slaughterhouse Bujumbura Jan. 1994
940443 62 SB1388 Intact present Slaughterhouse Bujumbura Mar. 1994
940824 68 SB0303 Intact present Maramvya Mai 94
South Africa 213D SB0121 Intact present various 1993 - 2003
n = 11 268 SB0265 Intact present various 1993 - 2003
392/94 SB0130 Intact present various 1993 - 2003
251G SB0163 Intact absent various 1993 - 2003
251E SB0163 Intact absent various 1993 - 2003
781 SB1163 Intact present various 1993 - 2003
1307 ND Intact ND various 1993 - 2003
1497 SB0121 Intact present various 1993 - 2003
4572 SB0130 Intact present various 1993 - 2003
4524 SB0121 Intact present various 1993 - 2003
1502 SB0131 Intact present various 1993 - 2003
Madagascar 83B1 SB0136 intact present various July, 1996
n = 8 27B3 SB1157 intact present various June, 1997
34B3 SB1161 intact present various June, 1997
44B3 SB0888 intact present various June, 1997
84B3 SB1160 intact present various July, 1997
85B3 SB1153 intact present various July, 1997
129B3 SB1159 intact present various July, 1997







Tanzania 1 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
n = 14 11 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
18 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
34 SB0425 4 6 5 4* 4 intact absent Morogoro abattoir, eastern Tanzania
B3 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
D3 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
E1 SB1446 X 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
G2 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
H1 SB0425 4 5 5 4* 4 intact absent Morogoro abattoir, eastern Tanzania
J1 SB0425 4 5 5 4* 4 intact absent Morogoro abattoir, eastern Tanzania
P2 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
R1 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
6 SB0133 3 2 5 4* 3 intact present Morogoro abattoir, eastern Tanzania
S1 SB0425 4 5 5 4* 4 intact absent Morogoro abattoir, eastern Tanzania
Algeria 4 SB0121 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
n = 23 11 SB1448 intact absent Algiers and Blida abattoir, northern Algeria August-November 2007
26 SB0134 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
31 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
34 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
46 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
47 SB0331 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
61 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
61 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
89 SB0162 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
95 SB1447 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
102 SB1450 intact absent Algiers and Blida abattoir, northern Algeria August-November 2007
114 SB0850 intact absent Algiers and Blida abattoir, northern Algeria August-November 2007
28 SB0828 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
33 SB0850 intact absent Algiers and Blida abattoir, northern Algeria August-November 2007
38 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
45 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
49 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
56 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
62 SB0822 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
64 SB0120 intact present Algiers and Blida abattoir, northern Algeria August-November 2007
75 SB1452 intact present Algiers and Blida abattoir, northern Algeria August-November 2007







Ethiopia BTB-422 SB1477 intact present Jinka abattoir, southern Ethiopia 2006
n = 15 BTB-691 SB0133 intact present Jinka abattoir, southern Ethiopia 2007
BTB-746 SB0133 intact present Jinka abattoir, southern Ethiopia 2007
BTB-890 SB0133 intact present Ghimbi abattoir, western Ethiopia 2007
BTB-891 SB1476 intact present Ghimbi abattoir, western Ethiopia 2007
BTB-895 SB1476 intact present Ghimbi abattoir, western Ethiopia 2007
BTB-897 SB1476 intact present Ghimbi abattoir, western Ethiopia 2007
BTB-918 SB1476 intact present Gondar abattoir, northern Ethiopia 2007
BTB-919 SB1476 intact present Gondar abattoir, northern Ethiopia 2007
BTB-923 SB1476 intact present Gondar abattoir, northern Ethiopia 2007
BTB-1090 SB0133 intact present Jinka abattoir, southern Ethiopia 2007
BTB-1091 SB0133 intact present Jinka abattoir, southern Ethiopia 2007
BTB-1383 SB1176 intact absent Addis Ababa abattoir, central Ethiopia 2007
BTB-1387 SB1176 intact absent Addis Ababa abattoir, central Ethiopia 2007
BTB-1388 SB1176 intact absent Addis Ababa abattoir, central Ethiopia 2007
Mozambique 1 SB0961 intact present Busi District, central Mozambique Feb. 2007
n = 20 2 SB0961 intact present Busi District, central Mozambique Feb. 2007
3 SB0961 intact present Busi District, central Mozambique Feb. 2007
4 SB0961 intact present Busi District, central Mozambique Feb. 2007
5 SB0961 intact present Busi District, central Mozambique Feb. 2007
7 SB0961 intact present Busi District, central Mozambique Feb. 2007
9 SB0961 intact present Busi District, central Mozambique Feb. 2007
10 SB0961 intact present Busi District, central Mozambique Feb. 2007
11 SB0961 intact present Busi District, central Mozambique Feb. 2007
12 SB0961 intact present Busi District, central Mozambique Feb. 2007
13 SB0961 intact present Busi District, central Mozambique Feb. 2007
14 SB0961 intact present Busi District, central Mozambique Feb. 2007
15 SB0961 intact present Busi District, central Mozambique Feb. 2007
16 SB0961 intact present Busi District, central Mozambique Feb. 2007
17 SB0961 intact present Busi District, central Mozambique Feb. 2007
468 SB0140 intact present Marracuene District, southern Mozambique Nov. 2007
660 SB0140 intact present Machava abattoir, Southern Mozambique (from Manhica Distric)) Nov. 2007
1086 SB0140 intact present Xai-xai abattoir, Southern Mozambique Mar. 2008
348 SB0120 intact present Nampula abattoir, Northen Mozambique Nov. 2007
851 SB0961 intact present Manica abattoir, Central Mozambique Mar.2008
ND  = Not Determined
X = Not Determined
 
 Appendix 4: 
Mathematical description of Bayesian model in: “Bayesian receiver operating 
characteristic estimation of multiple tests for diagnosis of bovine tuberculosis 
in Chadian cattle” 
 
Let dkiY  denote the diagnostic test values of the ith animal, i = 1,…,m with disease 
status d (d = 0 for non-diseased; d = 1 for diseased) for test k (k = 1 for SICCT; k = 2 
for SENTRY 100; k = 3 for GENios Pro). We assume that the test scores of the three 
tests are multivariate normally distributed, that is 1 2 3( , , ) ~ ( , )d d d d T d di i i i iY Y Y Y MVN= Σµ  
where 1 2 3( , , )d d d d Ti i i iµ µ µ=µ  and cov( , )d d d dkl ik il klY Y σΣ = =  with k, l = 1,2,3. We write the 
likelihood as a product of the following factors: 
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klρ is a correlation parameter between tests k and l and it is defined in terms of the 


























 = Φ −
 + 
 with Φ  being the cumulative distribution function of a 
standard normal variable. For identifiability we assume that 0 1d dk kµ µ= =< , which holds 
for our diagnostic tests. 
In an initial model, in addition to both FPA methods and SICCT, we have taken into 
account the results of a number of binary tests (meat inspection, direct microscopy, 
culture and microscopy, PCR), assuming that they had imperfect sensitivity and 
specificity, with the exception of PCR, which has been considered to be 100% 
specific. Let π be the unknown true disease prevalence in the sampled population 
and jp  the observed prevalence estimated from the jth test (j = 1 for meat inspection; 
j = 2 direct microscopy; j = 3 for culture and microscopy; j = 4 for PCR). Moreover, let 
Ti be the latent variable that indicates the true disease status of the ith animals (1 for 
diseased and 0 for non-diseased animals) and let Zij be the observed disease status 
from the jth test. We assume that  ~  ( )ij jZ Bernoulli p ,   ~  ( )iT Bernoulli pi  and define 
TTi where 
 if PCR result is negative
  








 as we consider positive values of PCR 
to be the gold standard and (1 )(1 )j j jp S Cpi pi= + − −  where jS  and jC  denote the 
sensitivity and specificity of test j, respectively. 
To estimate the model parameters we formulate the model within the Bayesian 
framework of inference and use Markov chain Monte Carlo (MCMC) simulation for 
model fit. The following prior distributions were adopted for the parameters: 




= ,  ~  (-1,1)dkk Uniformρ  and 
 ~  ( , )Betapi α β . α and β can be re-written in terms of mean ( mpi ) and variance ( 2piσ ) 
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Based on our previous observations we have set mpi  to 0.1 and 2piσ  to 0.05. 
In addition, we assume ( )~ , , 1,..., 4S Sj j jS Beta jα β =  and ( )~ , , 1,2,3C Cj j jC Beta jα β =  
and 4 1C = . Again, Sjα  and Sjβ  or Cjα  and Cjβ  can be re-written in terms of means 





indicated in table I. Initial means for the individual test sensitivities and specificities 
were based on previously published estimates [63,64,245,246,250-254,257,258].  
The models were fitted in WinBUGS and convergence was achieved before 30000 
iterations. Convergence was assessed informally by inspection of the ergodic 
averages of selected parameters.  
 
 Appendix 5: 
WinBUGS code for : ”Bayesian receiver operating characteristic estimation of 
multiple tests for diagnosis of bovine tuberculosis in Chadian cattle” 
 
(model 2A; table 14) 
 
model { 
for (i in 1:929) { 
  tuber[i] ~ dnorm(mu1[i],tau1[i])   # test 1 
  sentry100[i] ~ dnorm(condmu[i],condtau[i]) # test 2  (test2 |test1) 
  genios[i]~ dnorm(condmu1[i],condtau1[i]) # test 3  (test3 |test2,test1) 
  T[i]~dbern(prev_true)    # latent disease state 
 
# mean and precision for the test values of test 1: 
  mu1[i] <- lambda1[TT[i]] 
  tau1[i] <- gamma1[TT[i]] 
 
# conditional mean and precision for the test values of test 2: 
  condmu[i] <-  
lambda2[TT[i]]+rho12[TT[i]]*sqrt(gamma1[TT[i]]/gamma2[TT[i]])*(tuber[i]-
lambda1[TT[i]]) 
  condtau[i] <- (gamma2[TT[i]])/(1-pow(rho12[TT[i]],2)) 
 
# conditional mean and precision for the test values of test 3: 















# considering the 100% specificity of PCR for the latent disease status 
for (i in 1:929) { 










# prior for the mean of test 1-3 for the diseased and non-diseased population: 
lambda1[1] ~ dnorm(0,0.01)I(lambda1[2],)  
lambda2[1] ~ dnorm(0,0.01)I(lambda2[2],)  
lambda3[1] ~ dnorm(0,0.01)  
lambda1[2] ~ dnorm(0,0.01)  
lambda2[2] ~ dnorm(0,0.01)  
lambda3[2] ~ dnorm(0,0.01)  
 
# prior for the correlation coefficients: 
rho12[1] ~ dunif(-1,1)  
rho12[2] ~ dunif(-1,1)  
rho31[1] ~ dunif(-1,1)  
rho31[2] ~ dunif(-1,1)  
rho32[1] ~ dunif(-1,1)  
rho32[2] ~ dunif(-1,1)  
 
# prior for the precision of test 1-3 for the diseased and non-diseased population: 
gamma1[1] ~ dgamma(0.01,0.01)  
gamma2[1] ~ dgamma(0.01,0.01)  





gamma1[2] ~ dgamma(0.01,0.01)  
gamma2[2] ~ dgamma(0.01,0.01)  
gamma3[2] ~ dgamma(0.01,0.01)  
 
# variance of test 1-3 for the diseased and non-diseased population: 
sigma1[1] <- 1/gamma1[1]  
sigma1[2] <- 1/gamma1[2]  
sigma2[1] <- 1/gamma2[1]  
sigma2[2] <- 1/gamma2[2]  
sigma3[1] <- 1/gamma3[1]  
sigma3[2] <- 1/gamma3[2]  
 
# AUC for each test : 
AUC1 <- phi(-(lambda1[2]-lambda1[1])/sqrt(sigma1[2]+sigma1[1])) 
AUC2 <- phi(-(lambda2[2]-lambda2[1])/sqrt(sigma2[2]+sigma2[1])) 
AUC3 <- phi(-(lambda3[2]-lambda3[1])/sqrt(sigma3[2]+sigma3[1])) 
 
# Sensitivities/specificities for each test for given cut-off values 
Se1 <- 1-phi((2.5-lambda1[1])/sqrt(sigma1[1])) 
Sp1 <- phi((2.5-lambda1[2])/sqrt(sigma1[2])) 
Se1OIE <- 1-phi((4.5-lambda1[1])/sqrt(sigma1[1])) 
Sp1OIE <- phi((4.5-lambda1[2])/sqrt(sigma1[2])) 
Se2 <- 1-phi((15-lambda2[1])/sqrt(sigma2[1])) 
Sp2 <- phi((15-lambda2[2])/sqrt(sigma2[2])) 
Se3 <- 1-phi((38-lambda3[1])/sqrt(sigma3[1])) 
Sp3 <- phi((38-lambda3[2])/sqrt(sigma3[2])) 
} 
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